74809e5c的个人主页 - 老虎社区

74809e5c

暂无个人介绍

IP属地：未知

403关注

22粉丝

0主题

0勋章

2021-08-02

Yes yes

抱歉，原内容已删除

2021-11-15

👌

抱歉，原内容已删除

2021-10-07

👌

抱歉，原内容已删除

2021-07-22

Go to the moon

AMC Smokes Shorts Again: What's Next?<blockquote>AMC再次抽短裤：下一步是什么？</blockquote>

2021-07-27

🍎👍

Apple Earnings Face High Expectations<blockquote>苹果盈利面临高预期</blockquote>

2021-07-18

👌

抱歉，原内容已删除

2021-08-09

🍎👍🆙🆙🆙

抱歉，原内容已删除

2021-12-16

👌

These were the 10 best performing IPOs of 2021 amid a record year for stock market debuts<blockquote>这些是2021年股市首次亮相创纪录的10家表现最佳的IPO</blockquote>

2021-11-01

👌

抱歉，原内容已删除

2021-10-13

👌

5 Stocks To Watch For October 13, 2021<blockquote>2021年10月13日值得关注的5只股票</blockquote>

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4087514122562540","uuid":"4087514122562540","gmtCreate":1624411411383,"gmtModify":1624845918848,"name":"74809e5c","pinyin":"ann1228","introduction":"","introductionEn":"","signature":"","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":22,"headSize":403,"tweetSize":102,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.11","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"80.21%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":691966549,"gmtCreate":1640127466269,"gmtModify":1640127466515,"author":{"id":"4087514122562540","authorId":"4087514122562540","name":"74809e5c","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087514122562540","authorIdStr":"4087514122562540"},"themes":[],"htmlText":"😱","listText":"😱","text":"😱","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691966549","repostId":"1148529089","repostType":4,"repost":{"id":"1148529089","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640098401,"share":"https://www.laohu8.com/m/news/1148529089?lang=zh_CN&edition=full","pubTime":"2021-12-21 22:53","market":"us","language":"en","title":"Vaccine stocks fell sharply in morning trading, with Vir Biotechnology falling more than 10%.<blockquote>疫苗股早盘大跌，维尔生物跌超10%。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1148529089","media":"Tiger Newspress","summary":"Vaccine stocks fell sharply in morning trading, with Vir Biotechnology falling more than 10%.\nPfizer","content":"<p>Vaccine stocks fell sharply in morning trading, with Vir Biotechnology falling more&nbsp;than 10%.</p><p><blockquote>疫苗股早盘大跌，维尔生物跌超10%。</blockquote></p><p> Pfizer&nbsp;fell&nbsp;more&nbsp;than&nbsp;5%,&nbsp;Novavax&nbsp;fell&nbsp;nearly&nbsp;10%.<img src=\"https://static.tigerbbs.com/8965c7ba2ab9d4149e37dd1a91113e13\" tg-width=\"717\" tg-height=\"600\" width=\"100%\" height=\"auto\"></p><p><blockquote>辉瑞跌超5%，诺瓦瓦克斯跌近10%。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine stocks fell sharply in morning trading, with Vir Biotechnology falling more than 10%.<blockquote>疫苗股早盘大跌，维尔生物跌超10%。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine stocks fell sharply in morning trading, with Vir Biotechnology falling more than 10%.<blockquote>疫苗股早盘大跌，维尔生物跌超10%。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-21 22:53</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Vaccine stocks fell sharply in morning trading, with Vir Biotechnology falling more&nbsp;than 10%.</p><p><blockquote>疫苗股早盘大跌，维尔生物跌超10%。</blockquote></p><p> Pfizer&nbsp;fell&nbsp;more&nbsp;than&nbsp;5%,&nbsp;Novavax&nbsp;fell&nbsp;nearly&nbsp;10%.<img src=\"https://static.tigerbbs.com/8965c7ba2ab9d4149e37dd1a91113e13\" tg-width=\"717\" tg-height=\"600\" width=\"100%\" height=\"auto\"></p><p><blockquote>辉瑞跌超5%，诺瓦瓦克斯跌近10%。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","NVAX":"诺瓦瓦克斯医药","VIR":"Vir Biotechnology, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1148529089","content_text":"Vaccine stocks fell sharply in morning trading, with Vir Biotechnology falling more than 10%.\nPfizer fell more than 5%, Novavax fell nearly 10%.","news_type":1,"symbols_score_info":{"NVAX":0.9,"VIR":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":3902,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693757324,"gmtCreate":1640087488781,"gmtModify":1640087489055,"author":{"id":"4087514122562540","authorId":"4087514122562540","name":"74809e5c","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087514122562540","authorIdStr":"4087514122562540"},"themes":[],"htmlText":"👌👍","listText":"👌👍","text":"👌👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693757324","repostId":"1142422285","repostType":4,"repost":{"id":"1142422285","kind":"news","pubTimestamp":1640083121,"share":"https://www.laohu8.com/m/news/1142422285?lang=zh_CN&edition=full","pubTime":"2021-12-21 18:38","market":"us","language":"en","title":"5 Stocks To Watch For December 21, 2021<blockquote>2021年12月21日值得关注的5只股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1142422285","media":"Benzinga","summary":"Some of the stocks that may grab investor focus today are:\n\nWall Street expects General Mills, Inc. ","content":"<p><div> Some of the stocks that may grab investor focus today are:  Wall Street expects General Mills, Inc. to report quarterly earnings at $1.05 per share on revenue of $4.84 billion before the opening bell....</p><p><blockquote><div>今天可能吸引投资者关注的一些股票有：华尔街预计通用磨坊公司将在开盘前报告季度收益为每股1.05美元，营收为48.4亿美元....</div></blockquote></p><p>  <a href=\"https://www.benzinga.com/news/earnings/21/12/24714267/5-stocks-to-watch-for-december-21-2021\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://www.benzinga.com/news/earnings/21/12/24714267/5-stocks-to-watch-for-december-21-2021\">网页连接</a></blockquote></p><p></p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks To Watch For December 21, 2021<blockquote>2021年12月21日值得关注的5只股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks To Watch For December 21, 2021<blockquote>2021年12月21日值得关注的5只股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Benzinga</strong><span class=\"h-time small\">2021-12-21 18:38</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> Some of the stocks that may grab investor focus today are:  Wall Street expects General Mills, Inc. to report quarterly earnings at $1.05 per share on revenue of $4.84 billion before the opening bell....</p><p><blockquote><div>今天可能吸引投资者关注的一些股票有：华尔街预计通用磨坊公司将在开盘前报告季度收益为每股1.05美元，营收为48.4亿美元....</div></blockquote></p><p>  <a href=\"https://www.benzinga.com/news/earnings/21/12/24714267/5-stocks-to-watch-for-december-21-2021\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://www.benzinga.com/news/earnings/21/12/24714267/5-stocks-to-watch-for-december-21-2021\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.benzinga.com/news/earnings/21/12/24714267/5-stocks-to-watch-for-december-21-2021\">Benzinga</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FDS":"辉盛研究系统","NKE":"耐克","MU":"美光科技","BB":"黑莓","GIS":"通用磨坊"},"source_url":"https://www.benzinga.com/news/earnings/21/12/24714267/5-stocks-to-watch-for-december-21-2021","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1142422285","content_text":"Some of the stocks that may grab investor focus today are:\n\nWall Street expects General Mills, Inc. to report quarterly earnings at $1.05 per share on revenue of $4.84 billion before the opening bell. General Mills shares slipped 1.3% to $66.91 in after-hours trading.\nNIKE, Inc. reported stronger-than-expected results for its second quarter on Monday. Nike shares gained 3.8% to $162.98 in the after-hours trading session.\nAnalysts are expecting FactSet Research Systems Inc. to have earned $2.99 per share on revenue of $419.13 million for the latest quarter. The company will release earnings before the markets open. FactSet Research shares gained 1% to $475.44 in after-hours trading.\nMicron Technology reported upbeat results for its first quarter and issued strong revenue guidance for the current quarter. Micron shares climbed 6.8% to $87.60 in the after-hours trading session.\nAnalysts expect BlackBerry Limited to report a quarterly loss at $0.07 per share on revenue of $177.25 million after the closing bell. BlackBerry shares gained 0.9% to $8.96 in after-hours trading.","news_type":1,"symbols_score_info":{"FDS":0.9,"MU":0.9,"NKE":0.9,"GIS":0.9,"BB":0.9}},"isVote":1,"tweetType":1,"viewCount":3679,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693071723,"gmtCreate":1639955477935,"gmtModify":1639955478261,"author":{"id":"4087514122562540","authorId":"4087514122562540","name":"74809e5c","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087514122562540","authorIdStr":"4087514122562540"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693071723","repostId":"1130704419","repostType":4,"repost":{"id":"1130704419","kind":"news","pubTimestamp":1639953553,"share":"https://www.laohu8.com/m/news/1130704419?lang=zh_CN&edition=full","pubTime":"2021-12-20 06:39","market":"us","language":"en","title":"Nike, Micron, BlackBerry, CarMax, and Other Stocks for Investors to Watch This Week<blockquote>Nike、Micron、黑莓、CarMax等本周值得投资者关注的股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1130704419","media":"Barrons","summary":"Stock and bond markets around the world will be closed Friday in observance of Christmas. Before the holiday break,Nike and Micron Technology report on Monday,BlackBerry and General Mills on Tuesday, and CarMax,Cintas,and Paychex on Wednesday.It will be a busy week of economic data releases. On Monday, the Conference Board publishes its Leading Economic Index for November, followed by its Consumer Confidence Index for December on Wednesday.On Thursday, the Bureau of Economic Analysis reports per","content":"<p>Stock and bond markets around the world will be closed Friday in observance of Christmas. Before the holiday&nbsp;break,Nike&nbsp;and&nbsp;Micron Technology&nbsp;report on Monday,BlackBerry&nbsp;and&nbsp;General Mills&nbsp;on Tuesday, and&nbsp;CarMax,Cintas,and&nbsp;Paychex&nbsp;on Wednesday.</p><p><blockquote>世界各地的股票和债券市场将于周五休市以庆祝圣诞节。假期前，Nike和Micron Technology将于周一发布报告，黑莓和通用磨坊将于周二发布报告，CarMax、Cintas和Paychex将于周三发布报告。</blockquote></p><p> It will be a busy week of economic data releases. On Monday, the&nbsp;Conference Board publishes its Leading Economic Index for November, followed&nbsp;by its Consumer Confidence Index for December on Wednesday.</p><p><blockquote>这将是经济数据发布繁忙的一周。周一，世界大型企业联合会将公布11月份领先经济指数，随后将于周三公布12月份消费者信心指数。</blockquote></p><p> On Thursday, the&nbsp;Bureau of Economic Analysis reports personal income and consumption expenditures for November. Consumer earnings are forecast to have risen 0.6% while spending is seen climbing 0.5%. The Federal Reserve’s preferred measure of inflation, the core&nbsp;PCE price index, is expected to have spiked 4.5% in November.</p><p><blockquote>周四，经济分析局将公布11月份个人收入和消费支出。消费者收入预计将增长0.6%，而支出预计将增长0.5%。美联储首选的通胀指标核心PCE物价指数预计11月份将飙升4.5%。</blockquote></p><p> Also Thursday, the Census Bureau releases the durable goods report for November, which will provide a window into investment spending in the economy. New orders are forecast to have risen 2.1%. Housing-market indicators out this week include existing-home sales for November on Wednesday and new-home sales for November on Thursday.</p><p><blockquote>同样在周四，人口普查局发布了11月份耐用品报告，这将为了解经济中的投资支出提供一个窗口。新订单预计将增长2.1%。本周公布的房地产市场指标包括周三公布的11月份成屋销售和周四公布的11月份新房销售。</blockquote></p><p> <b>Monday 12/20</b></p><p><blockquote><b>星期一12/20</b></blockquote></p><p> Micron Technology and Nike report quarterly results.</p><p><blockquote>美光科技和耐克公布季度业绩。</blockquote></p><p> <b>The Conference Board</b> releases its Leading Economic Index for November. Consensus estimate is for a 119 reading, which would be 0.6% more than October’s level. The Conference Board currently projects a 5% growth rate for fourth-quarter gross domestic product and a slower but still robust 2.6% for 2022.</p><p><blockquote><b>世界大型企业联合会</b>发布11月份领先经济指数。普遍估计读数为119，比10月份的水平高出0.6%。世界大型企业联合会目前预计第四季度国内生产总值增长率为5%，2022年增长率较慢但仍强劲的2.6%。</blockquote></p><p> <b>Tuesday 12/21</b></p><p><blockquote><b>星期二12/21</b></blockquote></p><p> BlackBerry,FactSet Research Systems,and General Mills announce earnings.</p><p><blockquote>黑莓、FactSet Research Systems和通用磨坊公布财报。</blockquote></p><p> <b>Wednesday 12/22</b></p><p><blockquote><b>星期三12/22</b></blockquote></p><p> <b>The NAR reports</b> existing-home sales for November. Economists forecast a seasonally adjusted annual rate of 6.4 million homes sold, slightly more than in October and the highest since the beginning of the year.</p><p><blockquote><b>NAR报告</b>11月份现房销售。经济学家预测，经季节调整后的房屋销售量年率为640万套，略高于10月份，为年初以来的最高水平。</blockquote></p><p> CarMax, Cintas, and Paychex hold conference calls to discuss quarterly results.</p><p><blockquote>CarMax、Cintas和Paychex评级召开会议讨论季度业绩。</blockquote></p><p> <b>The Bureau of Economic</b> Analysis reports its third and final estimate for third-quarter GDP. Economists forecast a 2.1% seasonally adjusted annual growth rate, unchanged from November’s second estimate.</p><p><blockquote><b>经济局</b>分析报告了对第三季度GDP的第三次也是最终估计。经济学家预测，经季节调整后的年增长率为2.1%，与11月的第二次估计持平。</blockquote></p><p> <b>The Conference Board</b> releases its Consumer Confidence Index for December. Expectations are for a 110 reading, roughly even with the November data. The index is 15% lower than the postpandemic peak reached in June of this year, due to concerns about rising prices and, to a lesser degree, Covid-19 variants.</p><p><blockquote><b>世界大型企业联合会</b>发布12月份消费者信心指数。预期读数为110，与11月数据大致持平。该指数比今年6月达到的大流行后峰值低15%，原因是对价格上涨以及较小程度上对Covid-19变种的担忧。</blockquote></p><p> <b>Thursday 12/23</b></p><p><blockquote><b>星期四12/23</b></blockquote></p><p> <b>The Department of Labor</b> reports initial jobless claims for the week ending on Dec. 18. Jobless claims have averaged 225,667 a week in November and December, and have finally reached prepandemic levels.</p><p><blockquote><b>劳工部</b>报告截至12月18日当周首次申请失业救济人数。11月和12月平均每周申请失业救济人数为225,667人，最终达到了大流行前的水平。</blockquote></p><p> <b>The Census Bureau</b> reports new-home sales for November. Consensus estimate is for a seasonally adjusted annual rate of 770,000 new single-family houses sold, 25,000 more than in October. The median sales price of new houses sold in October was $407,700, while the average sales price was $477,800—both record highs.</p><p><blockquote><b>人口普查局</b>报告11月份新房销售。市场普遍估计，经季节调整后的新单户住宅年增长率为77万套，比10月份增加2.5万套。10月份售出的新房销售价格中位数为40.77万美元，而平均销售价格为47.78万美元——均创历史新高。</blockquote></p><p> <b>The BEA reports</b> personal income and consumption expenditures for November. Economists forecast a 0.6% monthly increase for income and 0.5% for consumption. This compares with gains for 0.5% and 1.3%, respectively, in October. The Federal Reserve’s preferred inflation gauge, the core PCE price index, jumped 4.1% year over year in October, the fastest rate since 1991. Predictions are for it to spike 4.6% in November.</p><p><blockquote><b>东亚银行报告</b>11月份个人收入和消费支出。经济学家预测收入每月增长0.6%，消费每月增长0.5%。相比之下，10月份的涨幅分别为0.5%和1.3%。美联储首选的通胀指标核心PCE价格指数10月份同比上涨4.1%，为1991年以来最快增速。预计11月份将飙升4.6%。</blockquote></p><p> <b>The Census Bureau</b> releases the durable goods report for November. New orders for durable manufactured goods are expected to increase 2.1%, to $265.6 billion. Excluding transportation, new orders are seen gaining 0.6%, compared with a 0.5% rise in October.</p><p><blockquote><b>人口普查局</b>发布11月份耐用品报告。耐用品新订单预计将增长2.1%，达到2656亿美元。不包括运输，新订单预计将增长0.6%，而10月份为增长0.5%。</blockquote></p><p> <b>Friday 12/24</b></p><p><blockquote><b>星期五12/24</b></blockquote></p><p> <b>U.S. equity</b>&nbsp;and fixed-income markets are closed in observance of Christmas.</p><p><blockquote><b>美国股票</b>固定收益市场因圣诞节而休市。</blockquote></p><p></p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nike, Micron, BlackBerry, CarMax, and Other Stocks for Investors to Watch This Week<blockquote>Nike、Micron、黑莓、CarMax等本周值得投资者关注的股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNike, Micron, BlackBerry, CarMax, and Other Stocks for Investors to Watch This Week<blockquote>Nike、Micron、黑莓、CarMax等本周值得投资者关注的股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Barrons</strong><span class=\"h-time small\">2021-12-20 06:39</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Stock and bond markets around the world will be closed Friday in observance of Christmas. Before the holiday&nbsp;break,Nike&nbsp;and&nbsp;Micron Technology&nbsp;report on Monday,BlackBerry&nbsp;and&nbsp;General Mills&nbsp;on Tuesday, and&nbsp;CarMax,Cintas,and&nbsp;Paychex&nbsp;on Wednesday.</p><p><blockquote>世界各地的股票和债券市场将于周五休市以庆祝圣诞节。假期前，Nike和Micron Technology将于周一发布报告，黑莓和通用磨坊将于周二发布报告，CarMax、Cintas和Paychex将于周三发布报告。</blockquote></p><p> It will be a busy week of economic data releases. On Monday, the&nbsp;Conference Board publishes its Leading Economic Index for November, followed&nbsp;by its Consumer Confidence Index for December on Wednesday.</p><p><blockquote>这将是经济数据发布繁忙的一周。周一，世界大型企业联合会将公布11月份领先经济指数，随后将于周三公布12月份消费者信心指数。</blockquote></p><p> On Thursday, the&nbsp;Bureau of Economic Analysis reports personal income and consumption expenditures for November. Consumer earnings are forecast to have risen 0.6% while spending is seen climbing 0.5%. The Federal Reserve’s preferred measure of inflation, the core&nbsp;PCE price index, is expected to have spiked 4.5% in November.</p><p><blockquote>周四，经济分析局将公布11月份个人收入和消费支出。消费者收入预计将增长0.6%，而支出预计将增长0.5%。美联储首选的通胀指标核心PCE物价指数预计11月份将飙升4.5%。</blockquote></p><p> Also Thursday, the Census Bureau releases the durable goods report for November, which will provide a window into investment spending in the economy. New orders are forecast to have risen 2.1%. Housing-market indicators out this week include existing-home sales for November on Wednesday and new-home sales for November on Thursday.</p><p><blockquote>同样在周四，人口普查局发布了11月份耐用品报告，这将为了解经济中的投资支出提供一个窗口。新订单预计将增长2.1%。本周公布的房地产市场指标包括周三公布的11月份成屋销售和周四公布的11月份新房销售。</blockquote></p><p> <b>Monday 12/20</b></p><p><blockquote><b>星期一12/20</b></blockquote></p><p> Micron Technology and Nike report quarterly results.</p><p><blockquote>美光科技和耐克公布季度业绩。</blockquote></p><p> <b>The Conference Board</b> releases its Leading Economic Index for November. Consensus estimate is for a 119 reading, which would be 0.6% more than October’s level. The Conference Board currently projects a 5% growth rate for fourth-quarter gross domestic product and a slower but still robust 2.6% for 2022.</p><p><blockquote><b>世界大型企业联合会</b>发布11月份领先经济指数。普遍估计读数为119，比10月份的水平高出0.6%。世界大型企业联合会目前预计第四季度国内生产总值增长率为5%，2022年增长率较慢但仍强劲的2.6%。</blockquote></p><p> <b>Tuesday 12/21</b></p><p><blockquote><b>星期二12/21</b></blockquote></p><p> BlackBerry,FactSet Research Systems,and General Mills announce earnings.</p><p><blockquote>黑莓、FactSet Research Systems和通用磨坊公布财报。</blockquote></p><p> <b>Wednesday 12/22</b></p><p><blockquote><b>星期三12/22</b></blockquote></p><p> <b>The NAR reports</b> existing-home sales for November. Economists forecast a seasonally adjusted annual rate of 6.4 million homes sold, slightly more than in October and the highest since the beginning of the year.</p><p><blockquote><b>NAR报告</b>11月份现房销售。经济学家预测，经季节调整后的房屋销售量年率为640万套，略高于10月份，为年初以来的最高水平。</blockquote></p><p> CarMax, Cintas, and Paychex hold conference calls to discuss quarterly results.</p><p><blockquote>CarMax、Cintas和Paychex评级召开会议讨论季度业绩。</blockquote></p><p> <b>The Bureau of Economic</b> Analysis reports its third and final estimate for third-quarter GDP. Economists forecast a 2.1% seasonally adjusted annual growth rate, unchanged from November’s second estimate.</p><p><blockquote><b>经济局</b>分析报告了对第三季度GDP的第三次也是最终估计。经济学家预测，经季节调整后的年增长率为2.1%，与11月的第二次估计持平。</blockquote></p><p> <b>The Conference Board</b> releases its Consumer Confidence Index for December. Expectations are for a 110 reading, roughly even with the November data. The index is 15% lower than the postpandemic peak reached in June of this year, due to concerns about rising prices and, to a lesser degree, Covid-19 variants.</p><p><blockquote><b>世界大型企业联合会</b>发布12月份消费者信心指数。预期读数为110，与11月数据大致持平。该指数比今年6月达到的大流行后峰值低15%，原因是对价格上涨以及较小程度上对Covid-19变种的担忧。</blockquote></p><p> <b>Thursday 12/23</b></p><p><blockquote><b>星期四12/23</b></blockquote></p><p> <b>The Department of Labor</b> reports initial jobless claims for the week ending on Dec. 18. Jobless claims have averaged 225,667 a week in November and December, and have finally reached prepandemic levels.</p><p><blockquote><b>劳工部</b>报告截至12月18日当周首次申请失业救济人数。11月和12月平均每周申请失业救济人数为225,667人，最终达到了大流行前的水平。</blockquote></p><p> <b>The Census Bureau</b> reports new-home sales for November. Consensus estimate is for a seasonally adjusted annual rate of 770,000 new single-family houses sold, 25,000 more than in October. The median sales price of new houses sold in October was $407,700, while the average sales price was $477,800—both record highs.</p><p><blockquote><b>人口普查局</b>报告11月份新房销售。市场普遍估计，经季节调整后的新单户住宅年增长率为77万套，比10月份增加2.5万套。10月份售出的新房销售价格中位数为40.77万美元，而平均销售价格为47.78万美元——均创历史新高。</blockquote></p><p> <b>The BEA reports</b> personal income and consumption expenditures for November. Economists forecast a 0.6% monthly increase for income and 0.5% for consumption. This compares with gains for 0.5% and 1.3%, respectively, in October. The Federal Reserve’s preferred inflation gauge, the core PCE price index, jumped 4.1% year over year in October, the fastest rate since 1991. Predictions are for it to spike 4.6% in November.</p><p><blockquote><b>东亚银行报告</b>11月份个人收入和消费支出。经济学家预测收入每月增长0.6%，消费每月增长0.5%。相比之下，10月份的涨幅分别为0.5%和1.3%。美联储首选的通胀指标核心PCE价格指数10月份同比上涨4.1%，为1991年以来最快增速。预计11月份将飙升4.6%。</blockquote></p><p> <b>The Census Bureau</b> releases the durable goods report for November. New orders for durable manufactured goods are expected to increase 2.1%, to $265.6 billion. Excluding transportation, new orders are seen gaining 0.6%, compared with a 0.5% rise in October.</p><p><blockquote><b>人口普查局</b>发布11月份耐用品报告。耐用品新订单预计将增长2.1%，达到2656亿美元。不包括运输，新订单预计将增长0.6%，而10月份为增长0.5%。</blockquote></p><p> <b>Friday 12/24</b></p><p><blockquote><b>星期五12/24</b></blockquote></p><p> <b>U.S. equity</b>&nbsp;and fixed-income markets are closed in observance of Christmas.</p><p><blockquote><b>美国股票</b>固定收益市场因圣诞节而休市。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.barrons.com/articles/nike-micron-blackberry-carmax-and-other-stocks-for-investors-to-watch-this-week-51639944183?mod=hp_LEAD_5\">Barrons</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","KMX":"车美仕",".IXIC":"NASDAQ Composite","GIS":"通用磨坊","CTAS":"信达思","MU":"美光科技",".DJI":"道琼斯","PAYX":"沛齐"},"source_url":"https://www.barrons.com/articles/nike-micron-blackberry-carmax-and-other-stocks-for-investors-to-watch-this-week-51639944183?mod=hp_LEAD_5","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1130704419","content_text":"Stock and bond markets around the world will be closed Friday in observance of Christmas. Before the holiday break,Nike and Micron Technology report on Monday,BlackBerry and General Mills on Tuesday, and CarMax,Cintas,and Paychex on Wednesday.\nIt will be a busy week of economic data releases. On Monday, the Conference Board publishes its Leading Economic Index for November, followed by its Consumer Confidence Index for December on Wednesday.\nOn Thursday, the Bureau of Economic Analysis reports personal income and consumption expenditures for November. Consumer earnings are forecast to have risen 0.6% while spending is seen climbing 0.5%. The Federal Reserve’s preferred measure of inflation, the core PCE price index, is expected to have spiked 4.5% in November.\nAlso Thursday, the Census Bureau releases the durable goods report for November, which will provide a window into investment spending in the economy. New orders are forecast to have risen 2.1%. Housing-market indicators out this week include existing-home sales for November on Wednesday and new-home sales for November on Thursday.\nMonday 12/20\nMicron Technology and Nike report quarterly results.\nThe Conference Board releases its Leading Economic Index for November. Consensus estimate is for a 119 reading, which would be 0.6% more than October’s level. The Conference Board currently projects a 5% growth rate for fourth-quarter gross domestic product and a slower but still robust 2.6% for 2022.\nTuesday 12/21\nBlackBerry,FactSet Research Systems,and General Mills announce earnings.\nWednesday 12/22\nThe NAR reports existing-home sales for November. Economists forecast a seasonally adjusted annual rate of 6.4 million homes sold, slightly more than in October and the highest since the beginning of the year.\nCarMax, Cintas, and Paychex hold conference calls to discuss quarterly results.\nThe Bureau of Economic Analysis reports its third and final estimate for third-quarter GDP. Economists forecast a 2.1% seasonally adjusted annual growth rate, unchanged from November’s second estimate.\nThe Conference Board releases its Consumer Confidence Index for December. Expectations are for a 110 reading, roughly even with the November data. The index is 15% lower than the postpandemic peak reached in June of this year, due to concerns about rising prices and, to a lesser degree, Covid-19 variants.\nThursday 12/23\nThe Department of Labor reports initial jobless claims for the week ending on Dec. 18. Jobless claims have averaged 225,667 a week in November and December, and have finally reached prepandemic levels.\nThe Census Bureau reports new-home sales for November. Consensus estimate is for a seasonally adjusted annual rate of 770,000 new single-family houses sold, 25,000 more than in October. The median sales price of new houses sold in October was $407,700, while the average sales price was $477,800—both record highs.\nThe BEA reports personal income and consumption expenditures for November. Economists forecast a 0.6% monthly increase for income and 0.5% for consumption. This compares with gains for 0.5% and 1.3%, respectively, in October. The Federal Reserve’s preferred inflation gauge, the core PCE price index, jumped 4.1% year over year in October, the fastest rate since 1991. Predictions are for it to spike 4.6% in November.\nThe Census Bureau releases the durable goods report for November. New orders for durable manufactured goods are expected to increase 2.1%, to $265.6 billion. Excluding transportation, new orders are seen gaining 0.6%, compared with a 0.5% rise in October.\nFriday 12/24\nU.S. equity and fixed-income markets are closed in observance of Christmas.","news_type":1,"symbols_score_info":{"KMX":0.9,"CTAS":0.9,"GIS":0.9,".IXIC":0.9,"PAYX":0.9,"MU":0.9,".SPX":0.9,".DJI":0.9}},"isVote":1,"tweetType":1,"viewCount":2831,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690587631,"gmtCreate":1639693324011,"gmtModify":1639693324265,"author":{"id":"4087514122562540","authorId":"4087514122562540","name":"74809e5c","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087514122562540","authorIdStr":"4087514122562540"},"themes":[],"htmlText":"👌","listText":"👌","text":"👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690587631","repostId":"1108384523","repostType":4,"repost":{"id":"1108384523","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639667369,"share":"https://www.laohu8.com/m/news/1108384523?lang=zh_CN&edition=full","pubTime":"2021-12-16 23:09","market":"us","language":"en","title":"Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity against omicron<blockquote>Vir Biotechnology在显示出对奥密克戎的中和活性后，早盘继续上涨超过7%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1108384523","media":"Tiger Newspress","summary":"Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity a","content":"<p>Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity against omicron.<img src=\"https://static.tigerbbs.com/07fe5a6b831322eef2c479861ad70527\" tg-width=\"766\" tg-height=\"563\" width=\"100%\" height=\"auto\">The company&nbsp;announced&nbsp;new preclinical data, published to the preprint server&nbsp;bioRxiv, demonstrating the impact of the significant antigenic shift of the new COVID-19 omicron variant (B.1.1.529).&nbsp;</p><p><blockquote>Vir Biotechnology在显示出对奥密克戎的中和活性后，在早盘交易中继续上涨超过7%。该公司宣布了新的临床前数据，发布到预印本服务器bioRxiv，证明了新的COVID-19奥密克戎变种（B.1.1.529）的显著抗原转变的影响。</blockquote></p><p> A significant reduction in plasma neutralizing activity was observed against omicron in sera from vaccinated and convalescent individuals.&nbsp;</p><p><blockquote>在接种疫苗和恢复期个体的血清中观察到针对奥密克戎的血浆中和活性显著降低。</blockquote></p><p> Researchers also tested the in vitro neutralizing activity of 44 monoclonal antibodies (mAbs) (eight of which are currently authorized or approved).&nbsp;</p><p><blockquote>研究人员还测试了44种单克隆抗体（mAb）的体外中和活性（其中8种目前已获得授权或批准）。</blockquote></p><p> Data demonstrate that sotrovimab and five other preclinical mAbs, developed by Vir in conjunction with&nbsp;GlaxoSmithKline plc&nbsp;(NYSE:&nbsp;GSK), retained their in vitro neutralizing activity against omicron.</p><p><blockquote>数据显示，由Vir与葛兰素史克公司（纽约证券交易所股票代码：GSK）联合开发的sotrovimab和其他五种临床前单克隆抗体保留了对奥密克戎病的体外中和活性。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity against omicron<blockquote>Vir Biotechnology在显示出对奥密克戎的中和活性后，早盘继续上涨超过7%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity against omicron<blockquote>Vir Biotechnology在显示出对奥密克戎的中和活性后，早盘继续上涨超过7%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-16 23:09</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity against omicron.<img src=\"https://static.tigerbbs.com/07fe5a6b831322eef2c479861ad70527\" tg-width=\"766\" tg-height=\"563\" width=\"100%\" height=\"auto\">The company&nbsp;announced&nbsp;new preclinical data, published to the preprint server&nbsp;bioRxiv, demonstrating the impact of the significant antigenic shift of the new COVID-19 omicron variant (B.1.1.529).&nbsp;</p><p><blockquote>Vir Biotechnology在显示出对奥密克戎的中和活性后，在早盘交易中继续上涨超过7%。该公司宣布了新的临床前数据，发布到预印本服务器bioRxiv，证明了新的COVID-19奥密克戎变种（B.1.1.529）的显著抗原转变的影响。</blockquote></p><p> A significant reduction in plasma neutralizing activity was observed against omicron in sera from vaccinated and convalescent individuals.&nbsp;</p><p><blockquote>在接种疫苗和恢复期个体的血清中观察到针对奥密克戎的血浆中和活性显著降低。</blockquote></p><p> Researchers also tested the in vitro neutralizing activity of 44 monoclonal antibodies (mAbs) (eight of which are currently authorized or approved).&nbsp;</p><p><blockquote>研究人员还测试了44种单克隆抗体（mAb）的体外中和活性（其中8种目前已获得授权或批准）。</blockquote></p><p> Data demonstrate that sotrovimab and five other preclinical mAbs, developed by Vir in conjunction with&nbsp;GlaxoSmithKline plc&nbsp;(NYSE:&nbsp;GSK), retained their in vitro neutralizing activity against omicron.</p><p><blockquote>数据显示，由Vir与葛兰素史克公司（纽约证券交易所股票代码：GSK）联合开发的sotrovimab和其他五种临床前单克隆抗体保留了对奥密克戎病的体外中和活性。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VIR":"Vir Biotechnology, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108384523","content_text":"Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity against omicron.The company announced new preclinical data, published to the preprint server bioRxiv, demonstrating the impact of the significant antigenic shift of the new COVID-19 omicron variant (B.1.1.529). \nA significant reduction in plasma neutralizing activity was observed against omicron in sera from vaccinated and convalescent individuals. \nResearchers also tested the in vitro neutralizing activity of 44 monoclonal antibodies (mAbs) (eight of which are currently authorized or approved). \nData demonstrate that sotrovimab and five other preclinical mAbs, developed by Vir in conjunction with GlaxoSmithKline plc (NYSE: GSK), retained their in vitro neutralizing activity against omicron.","news_type":1,"symbols_score_info":{"VIR":0.9}},"isVote":1,"tweetType":1,"viewCount":3208,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690311192,"gmtCreate":1639633092338,"gmtModify":1639633092597,"author":{"id":"4087514122562540","authorId":"4087514122562540","name":"74809e5c","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087514122562540","authorIdStr":"4087514122562540"},"themes":[],"htmlText":"👌","listText":"👌","text":"👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690311192","repostId":"1170403163","repostType":4,"repost":{"id":"1170403163","kind":"news","pubTimestamp":1639631616,"share":"https://www.laohu8.com/m/news/1170403163?lang=zh_CN&edition=full","pubTime":"2021-12-16 13:13","market":"us","language":"en","title":"These were the 10 best performing IPOs of 2021 amid a record year for stock market debuts<blockquote>这些是2021年股市首次亮相创纪录的10家表现最佳的IPO</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1170403163","media":"Markets Insider","summary":"2021 was a record year for IPOs, with 2,388 new companies listing their shares around the globe.\nThe","content":"<p><ul>  <li><b>2021 was a record year for IPOs, with 2,388 new companies listing their shares around the globe.</b></li>  <li><b>The red-hot IPO market this year occurred amid a relentless grind higher in the broader stock market.</b></li>  <li><b>These are the 10 best performing US stocks that went public in 2021.</b></li> </ul> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4fc9bdacbbacd4a99b22407604d69e6e\" tg-width=\"790\" tg-height=\"395\" width=\"100%\" height=\"auto\"><span>A stock trader claps at the end of trade at the New York Stock Exchange.</span></p><p><blockquote><ul><li><b>2021年是IPO创纪录的一年，全球有2,388家新公司上市。</b></li><li><b>今年IPO市场火爆之际，大盘不断走高。</b></li><li><b>这些是2021年上市的10只表现最好的美国股票。</b></li></ul><p class=\"t-img-caption\"><span>一名股票交易员在纽约证券交易所交易结束时鼓掌。</span></p></blockquote></p><p> Record highs in the stock market&nbsp;have facilitated a boom in new company listings this year, with a record 2,388 firms going public around the globe, according to&nbsp;data from Ernst and Young.</p><p><blockquote>安永（Ernst and Young）的数据显示，股市创纪录的高点推动了今年新公司上市的热潮，全球有创纪录的2,388家公司上市。</blockquote></p><p> Helping drive a resurgence in new company listings were SPACs, which peaked in early 2021 after a surge last year. Altogether, companies have raised $453 billion in proceeds from their IPOs, representing a 67% increase relative to 2020 and a more than doubling from 2019 levels.</p><p><blockquote>SPAC帮助推动了新公司上市的复苏，在去年激增后，SPAC于2021年初达到顶峰。总的来说，公司通过IPO筹集了4530亿美元的资金，比2020年增长了67%，比2019年的水平增加了一倍多。</blockquote></p><p> Firms going public have predominately been in the technology sector, and the Nasdaq Exchange captured the most IPOs relative to other global stock exchanges.High profile IPOs&nbsp;this year include electric vehicle startups&nbsp;Rivian&nbsp;and&nbsp;Lucid Group, and direct-to-consumer brands&nbsp;Allbirds&nbsp;and&nbsp;Warby Parker.</p><p><blockquote>上市公司主要集中在科技行业，相对于其他全球证券交易所，纳斯达克交易所的IPO数量最多。今年备受瞩目的IPO包括电动汽车初创公司Rivian和Lucid Group，以及直接面向消费者的品牌Allbirds和Warby Parker。</blockquote></p><p> And with more than 900 IPOs this year on US exchanges alone, there have been plenty of big winners and losers.</p><p><blockquote>今年仅美国交易所就有900多起IPO，其中不乏大赢家和大输家。</blockquote></p><p> These are the 10 best performing US IPOs of 2021 of companies with at least a $1 billion market capitalization. All performance data is as of December 15 and was sourced from&nbsp;Koyfin.&nbsp;(However, the chart action shown below reflects performance based on the opening price of a stock on its first day of trades, not its IPO price.)</p><p><blockquote>这些是2021年美国市值至少10亿美元的10家公司中表现最好的IPO。所有业绩数据截至12月15日，均来自Koyfin。（但是，下面显示的图表操作反映的业绩基于股票首日交易的开盘价，而不是IPO价格。）</blockquote></p><p> <b>10. Prometheus Biosciences</b></p><p><blockquote><b>10.普罗米修斯生物科学公司</b></blockquote></p><p> <b>Ticker:RXDX</b></p><p><blockquote><b>股票代码：RXDX</b></blockquote></p><p> <b>Gain Since IPO Price: 72%</b></p><p><blockquote><b>自IPO价格以来的涨幅：72%</b></blockquote></p><p> <b>Market Capitalization: $1.3 billion</b></p><p><blockquote><b>市值：13亿美元</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/bfb6ec8f3b653138c4425868d1d79de9\" tg-width=\"647\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p> <b>9. Verve Therapeutics</b></p><p><blockquote><b>9.神韵疗法</b></blockquote></p><p> <b>Ticker:VERV</b></p><p><blockquote><b>股票代码：VERV</b></blockquote></p><p> <b>Gain Since IPO Price: 75%</b></p><p><blockquote><b>自IPO价格以来的涨幅：75%</b></blockquote></p><p> <b>Market Capitalization: $1.6 billion</b></p><p><blockquote><b>市值：16亿美元</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3dc78c11f5c162a9c1e7a279f1708126\" tg-width=\"639\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p> <b>8. TaskUs</b></p><p><blockquote><b>8.我的任务</b></blockquote></p><p> <b>Ticker:TASK</b></p><p><blockquote><b>股票代码：任务</b></blockquote></p><p> <b>Gain Since IPO Price: 91%</b></p><p><blockquote><b>自IPO价格以来的涨幅：91%</b></blockquote></p><p> <b>Market Capitalization: $4.3 billion</b></p><p><blockquote><b>市值：43亿美元</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f59d1387b908b8e02697da615a3f5ba4\" tg-width=\"656\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p> <b>7. Kanzhun</b></p><p><blockquote><b>7.看准</b></blockquote></p><p> <b>Ticker:BZ</b></p><p><blockquote><b>股票代码：BZ</b></blockquote></p><p> <b>Gain Since IPO Price: 93%</b></p><p><blockquote><b>自IPO价格以来的涨幅：93%</b></blockquote></p><p> <b>Market Capitalization: $14.7 billion</b></p><p><blockquote><b>市值：147亿美元</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f04f7fc1885d88d97c1864a339e25d32\" tg-width=\"656\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p> <b>6. Dutch Bros</b></p><p><blockquote><b>6.荷兰兄弟</b></blockquote></p><p> <b>Ticker:BROS</b></p><p><blockquote><b>股票代码：兄弟</b></blockquote></p><p> <b>Gain Since IPO Price: 98%</b></p><p><blockquote><b>自IPO价格以来的涨幅：98%</b></blockquote></p><p> <b>Market Capitalization: $7.5 billion</b></p><p><blockquote><b>市值：75亿美元</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5b915d62d3fdfce5ea3188beb282ab47\" tg-width=\"668\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p> <b>5. Doximity</b></p><p><blockquote><b>5.剂量</b></blockquote></p><p> <b>Ticker:DOCS</b></p><p><blockquote><b>股票代码：DOCS</b></blockquote></p><p> <b>Gain Since IPO Price: 108%</b></p><p><blockquote><b>自IPO价格以来的涨幅：108%</b></blockquote></p><p> <b>Market Capitalization: $10.1 billion</b></p><p><blockquote><b>市值：101亿美元</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7d03dbe2dc83a8512105da91ac5151dc\" tg-width=\"669\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p> <b>4. Affirm</b></p><p><blockquote><b>4.确认</b></blockquote></p><p> <b>Ticker:AFRM</b></p><p><blockquote><b>股票代码：AFRM</b></blockquote></p><p> <b>Gain Since IPO Price: 111%</b></p><p><blockquote><b>自IPO价格以来的涨幅：111%</b></blockquote></p><p> <b>Market Capitalization: $29.0 billion</b></p><p><blockquote><b>市值：290亿美元</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/27a04903a7c07c0ecf5edf3ddaf2d730\" tg-width=\"670\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p> <b>3. Global-e Online</b></p><p><blockquote><b>3.Global-E Online</b></blockquote></p><p> <b>Ticker:GLBE</b></p><p><blockquote><b>股票代码：GLBE</b></blockquote></p><p> <b>Gain Since IPO Price: 120%</b></p><p><blockquote><b>自IPO价格以来的涨幅：120%</b></blockquote></p><p> <b>Market Capitalization: $8.0 billion</b></p><p><blockquote><b>市值：80亿美元</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0d88ded78988981e08d54b1287cbf948\" tg-width=\"664\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p> <b>2. ZIM Integrated Shipping Services</b></p><p><blockquote><b>2.以星综合航运服务</b></blockquote></p><p> <b>Ticker:ZIM</b></p><p><blockquote><b>股票代码：ZIM</b></blockquote></p><p> <b>Gain Since IPO Price: 208%</b></p><p><blockquote><b>自IPO价格以来的涨幅：208%</b></blockquote></p><p> <b>Market Capitalization: $5.8 billion</b></p><p><blockquote><b>市值：58亿美元</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f32668f19b1e8678dcd33e3bbe3b0d9c\" tg-width=\"613\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p> <b>1. Digital World Acquisition</b></p><p><blockquote><b>1.数字世界收购</b></blockquote></p><p> <b>Ticker:DWAC</b></p><p><blockquote><b>股票代码：DWAC</b></blockquote></p><p> <b>Gain Since IPO Price: 508%</b></p><p><blockquote><b>自IPO价格以来的涨幅：508%</b></blockquote></p><p> <b>Market Capitalization: $1.9 billion</b></p><p><blockquote><b>市值：19亿美元</b></blockquote></p><p></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/573ffacec216fcb41798f52b67583456\" tg-width=\"615\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These were the 10 best performing IPOs of 2021 amid a record year for stock market debuts<blockquote>这些是2021年股市首次亮相创纪录的10家表现最佳的IPO</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese were the 10 best performing IPOs of 2021 amid a record year for stock market debuts<blockquote>这些是2021年股市首次亮相创纪录的10家表现最佳的IPO</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Markets Insider</strong><span class=\"h-time small\">2021-12-16 13:13</span>\n</p>\n</h4>\n</header>\n<article>\n<p><ul>  <li><b>2021 was a record year for IPOs, with 2,388 new companies listing their shares around the globe.</b></li>  <li><b>The red-hot IPO market this year occurred amid a relentless grind higher in the broader stock market.</b></li>  <li><b>These are the 10 best performing US stocks that went public in 2021.</b></li> </ul> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4fc9bdacbbacd4a99b22407604d69e6e\" tg-width=\"790\" tg-height=\"395\" width=\"100%\" height=\"auto\"><span>A stock trader claps at the end of trade at the New York Stock Exchange.</span></p><p><blockquote><ul><li><b>2021年是IPO创纪录的一年，全球有2,388家新公司上市。</b></li><li><b>今年IPO市场火爆之际，大盘不断走高。</b></li><li><b>这些是2021年上市的10只表现最好的美国股票。</b></li></ul><p class=\"t-img-caption\"><span>一名股票交易员在纽约证券交易所交易结束时鼓掌。</span></p></blockquote></p><p> Record highs in the stock market&nbsp;have facilitated a boom in new company listings this year, with a record 2,388 firms going public around the globe, according to&nbsp;data from Ernst and Young.</p><p><blockquote>安永（Ernst and Young）的数据显示，股市创纪录的高点推动了今年新公司上市的热潮，全球有创纪录的2,388家公司上市。</blockquote></p><p> Helping drive a resurgence in new company listings were SPACs, which peaked in early 2021 after a surge last year. Altogether, companies have raised $453 billion in proceeds from their IPOs, representing a 67% increase relative to 2020 and a more than doubling from 2019 levels.</p><p><blockquote>SPAC帮助推动了新公司上市的复苏，在去年激增后，SPAC于2021年初达到顶峰。总的来说，公司通过IPO筹集了4530亿美元的资金，比2020年增长了67%，比2019年的水平增加了一倍多。</blockquote></p><p> Firms going public have predominately been in the technology sector, and the Nasdaq Exchange captured the most IPOs relative to other global stock exchanges.High profile IPOs&nbsp;this year include electric vehicle startups&nbsp;Rivian&nbsp;and&nbsp;Lucid Group, and direct-to-consumer brands&nbsp;Allbirds&nbsp;and&nbsp;Warby Parker.</p><p><blockquote>上市公司主要集中在科技行业，相对于其他全球证券交易所，纳斯达克交易所的IPO数量最多。今年备受瞩目的IPO包括电动汽车初创公司Rivian和Lucid Group，以及直接面向消费者的品牌Allbirds和Warby Parker。</blockquote></p><p> And with more than 900 IPOs this year on US exchanges alone, there have been plenty of big winners and losers.</p><p><blockquote>今年仅美国交易所就有900多起IPO，其中不乏大赢家和大输家。</blockquote></p><p> These are the 10 best performing US IPOs of 2021 of companies with at least a $1 billion market capitalization. All performance data is as of December 15 and was sourced from&nbsp;Koyfin.&nbsp;(However, the chart action shown below reflects performance based on the opening price of a stock on its first day of trades, not its IPO price.)</p><p><blockquote>这些是2021年美国市值至少10亿美元的10家公司中表现最好的IPO。所有业绩数据截至12月15日，均来自Koyfin。（但是，下面显示的图表操作反映的业绩基于股票首日交易的开盘价，而不是IPO价格。）</blockquote></p><p> <b>10. Prometheus Biosciences</b></p><p><blockquote><b>10.普罗米修斯生物科学公司</b></blockquote></p><p> <b>Ticker:RXDX</b></p><p><blockquote><b>股票代码：RXDX</b></blockquote></p><p> <b>Gain Since IPO Price: 72%</b></p><p><blockquote><b>自IPO价格以来的涨幅：72%</b></blockquote></p><p> <b>Market Capitalization: $1.3 billion</b></p><p><blockquote><b>市值：13亿美元</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/bfb6ec8f3b653138c4425868d1d79de9\" tg-width=\"647\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p> <b>9. Verve Therapeutics</b></p><p><blockquote><b>9.神韵疗法</b></blockquote></p><p> <b>Ticker:VERV</b></p><p><blockquote><b>股票代码：VERV</b></blockquote></p><p> <b>Gain Since IPO Price: 75%</b></p><p><blockquote><b>自IPO价格以来的涨幅：75%</b></blockquote></p><p> <b>Market Capitalization: $1.6 billion</b></p><p><blockquote><b>市值：16亿美元</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3dc78c11f5c162a9c1e7a279f1708126\" tg-width=\"639\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p> <b>8. TaskUs</b></p><p><blockquote><b>8.我的任务</b></blockquote></p><p> <b>Ticker:TASK</b></p><p><blockquote><b>股票代码：任务</b></blockquote></p><p> <b>Gain Since IPO Price: 91%</b></p><p><blockquote><b>自IPO价格以来的涨幅：91%</b></blockquote></p><p> <b>Market Capitalization: $4.3 billion</b></p><p><blockquote><b>市值：43亿美元</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f59d1387b908b8e02697da615a3f5ba4\" tg-width=\"656\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p> <b>7. Kanzhun</b></p><p><blockquote><b>7.看准</b></blockquote></p><p> <b>Ticker:BZ</b></p><p><blockquote><b>股票代码：BZ</b></blockquote></p><p> <b>Gain Since IPO Price: 93%</b></p><p><blockquote><b>自IPO价格以来的涨幅：93%</b></blockquote></p><p> <b>Market Capitalization: $14.7 billion</b></p><p><blockquote><b>市值：147亿美元</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f04f7fc1885d88d97c1864a339e25d32\" tg-width=\"656\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p> <b>6. Dutch Bros</b></p><p><blockquote><b>6.荷兰兄弟</b></blockquote></p><p> <b>Ticker:BROS</b></p><p><blockquote><b>股票代码：兄弟</b></blockquote></p><p> <b>Gain Since IPO Price: 98%</b></p><p><blockquote><b>自IPO价格以来的涨幅：98%</b></blockquote></p><p> <b>Market Capitalization: $7.5 billion</b></p><p><blockquote><b>市值：75亿美元</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5b915d62d3fdfce5ea3188beb282ab47\" tg-width=\"668\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p> <b>5. Doximity</b></p><p><blockquote><b>5.剂量</b></blockquote></p><p> <b>Ticker:DOCS</b></p><p><blockquote><b>股票代码：DOCS</b></blockquote></p><p> <b>Gain Since IPO Price: 108%</b></p><p><blockquote><b>自IPO价格以来的涨幅：108%</b></blockquote></p><p> <b>Market Capitalization: $10.1 billion</b></p><p><blockquote><b>市值：101亿美元</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7d03dbe2dc83a8512105da91ac5151dc\" tg-width=\"669\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p> <b>4. Affirm</b></p><p><blockquote><b>4.确认</b></blockquote></p><p> <b>Ticker:AFRM</b></p><p><blockquote><b>股票代码：AFRM</b></blockquote></p><p> <b>Gain Since IPO Price: 111%</b></p><p><blockquote><b>自IPO价格以来的涨幅：111%</b></blockquote></p><p> <b>Market Capitalization: $29.0 billion</b></p><p><blockquote><b>市值：290亿美元</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/27a04903a7c07c0ecf5edf3ddaf2d730\" tg-width=\"670\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p> <b>3. Global-e Online</b></p><p><blockquote><b>3.Global-E Online</b></blockquote></p><p> <b>Ticker:GLBE</b></p><p><blockquote><b>股票代码：GLBE</b></blockquote></p><p> <b>Gain Since IPO Price: 120%</b></p><p><blockquote><b>自IPO价格以来的涨幅：120%</b></blockquote></p><p> <b>Market Capitalization: $8.0 billion</b></p><p><blockquote><b>市值：80亿美元</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0d88ded78988981e08d54b1287cbf948\" tg-width=\"664\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p> <b>2. ZIM Integrated Shipping Services</b></p><p><blockquote><b>2.以星综合航运服务</b></blockquote></p><p> <b>Ticker:ZIM</b></p><p><blockquote><b>股票代码：ZIM</b></blockquote></p><p> <b>Gain Since IPO Price: 208%</b></p><p><blockquote><b>自IPO价格以来的涨幅：208%</b></blockquote></p><p> <b>Market Capitalization: $5.8 billion</b></p><p><blockquote><b>市值：58亿美元</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f32668f19b1e8678dcd33e3bbe3b0d9c\" tg-width=\"613\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p> <b>1. Digital World Acquisition</b></p><p><blockquote><b>1.数字世界收购</b></blockquote></p><p> <b>Ticker:DWAC</b></p><p><blockquote><b>股票代码：DWAC</b></blockquote></p><p> <b>Gain Since IPO Price: 508%</b></p><p><blockquote><b>自IPO价格以来的涨幅：508%</b></blockquote></p><p> <b>Market Capitalization: $1.9 billion</b></p><p><blockquote><b>市值：19亿美元</b></blockquote></p><p></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/573ffacec216fcb41798f52b67583456\" tg-width=\"615\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://markets.businessinsider.com/news/stocks/2021-stock-market-review-10-best-performing-ipo-dwac-afrm-2021-12\">Markets Insider</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BROS":"Dutch Bros Inc.","VERV":"Verve Therapeutics","BZ":"BOSS直聘","AFRM":"Affirm Holdings, Inc.",".SPX":"S&P 500 Index",".DJI":"道琼斯","ZIM":"以星航运","DOCS":"Doximity, Inc.",".IXIC":"NASDAQ Composite","TASK":"TaskUs Inc.","RXDX":"Prometheus Biosciences, Inc.","GLBE":"Global-E Online Ltd."},"source_url":"https://markets.businessinsider.com/news/stocks/2021-stock-market-review-10-best-performing-ipo-dwac-afrm-2021-12","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1170403163","content_text":"2021 was a record year for IPOs, with 2,388 new companies listing their shares around the globe.\nThe red-hot IPO market this year occurred amid a relentless grind higher in the broader stock market.\nThese are the 10 best performing US stocks that went public in 2021.\n\nA stock trader claps at the end of trade at the New York Stock Exchange.\nRecord highs in the stock market have facilitated a boom in new company listings this year, with a record 2,388 firms going public around the globe, according to data from Ernst and Young.\nHelping drive a resurgence in new company listings were SPACs, which peaked in early 2021 after a surge last year. Altogether, companies have raised $453 billion in proceeds from their IPOs, representing a 67% increase relative to 2020 and a more than doubling from 2019 levels.\nFirms going public have predominately been in the technology sector, and the Nasdaq Exchange captured the most IPOs relative to other global stock exchanges.High profile IPOs this year include electric vehicle startups Rivian and Lucid Group, and direct-to-consumer brands Allbirds and Warby Parker.\nAnd with more than 900 IPOs this year on US exchanges alone, there have been plenty of big winners and losers.\nThese are the 10 best performing US IPOs of 2021 of companies with at least a $1 billion market capitalization. All performance data is as of December 15 and was sourced from Koyfin. (However, the chart action shown below reflects performance based on the opening price of a stock on its first day of trades, not its IPO price.)\n10. Prometheus Biosciences\nTicker:RXDX\nGain Since IPO Price: 72%\nMarket Capitalization: $1.3 billion\nMarkets Insider\n9. Verve Therapeutics\nTicker:VERV\nGain Since IPO Price: 75%\nMarket Capitalization: $1.6 billion\nMarkets Insider\n8. TaskUs\nTicker:TASK\nGain Since IPO Price: 91%\nMarket Capitalization: $4.3 billion\nMarkets Insider\n7. Kanzhun\nTicker:BZ\nGain Since IPO Price: 93%\nMarket Capitalization: $14.7 billion\nMarkets Insider\n6. Dutch Bros\nTicker:BROS\nGain Since IPO Price: 98%\nMarket Capitalization: $7.5 billion\nMarkets Insider\n5. Doximity\nTicker:DOCS\nGain Since IPO Price: 108%\nMarket Capitalization: $10.1 billion\nMarkets Insider\n4. Affirm\nTicker:AFRM\nGain Since IPO Price: 111%\nMarket Capitalization: $29.0 billion\nMarkets Insider\n3. Global-e Online\nTicker:GLBE\nGain Since IPO Price: 120%\nMarket Capitalization: $8.0 billion\nMarkets Insider\n2. ZIM Integrated Shipping Services\nTicker:ZIM\nGain Since IPO Price: 208%\nMarket Capitalization: $5.8 billion\nMarkets Insider\n1. Digital World Acquisition\nTicker:DWAC\nGain Since IPO Price: 508%\nMarket Capitalization: $1.9 billion\nMarkets Insider","news_type":1,"symbols_score_info":{"DWAC":0.9,"BROS":0.9,"ZIM":0.9,"AFRM":0.9,"DOCS":0.9,"GLBE":0.9,".IXIC":0.9,"VERV":0.9,".SPX":0.9,"TASK":0.9,".DJI":0.9,"RXDX":0.9,"BZ":0.9}},"isVote":1,"tweetType":1,"viewCount":2689,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607976936,"gmtCreate":1639482461681,"gmtModify":1639482461900,"author":{"id":"4087514122562540","authorId":"4087514122562540","name":"74809e5c","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087514122562540","authorIdStr":"4087514122562540"},"themes":[],"htmlText":"👌","listText":"👌","text":"👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607976936","repostId":"1174676939","repostType":4,"isVote":1,"tweetType":1,"viewCount":2394,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604200128,"gmtCreate":1639396162155,"gmtModify":1639396162391,"author":{"id":"4087514122562540","authorId":"4087514122562540","name":"74809e5c","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087514122562540","authorIdStr":"4087514122562540"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604200128","repostId":"1177848501","repostType":4,"repost":{"id":"1177848501","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639394512,"share":"https://www.laohu8.com/m/news/1177848501?lang=zh_CN&edition=full","pubTime":"2021-12-13 19:21","market":"us","language":"en","title":"Arena Pharmaceuticals soared nearly 90% in premarket trading as it entered into an Agreement and Plan of Merger with Pfizer<blockquote>Arena Pharmaceuticals与辉瑞达成协议和合并计划，盘前交易飙升近90%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1177848501","media":"Tiger Newspress","summary":"Arena Pharmaceuticals soared nearly 90% in premarket trading as it entered into an Agreement and Pla","content":"<p>Arena Pharmaceuticals soared nearly 90% in premarket trading as it entered into an Agreement and Plan of Merger with Pfizer.<img src=\"https://static.tigerbbs.com/12e0ce077a31825d9a0cad97f44f47f3\" tg-width=\"773\" tg-height=\"563\" width=\"100%\" height=\"auto\">On&nbsp;December 12, 2021, Arena entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Pfizer Inc., a&nbsp;Delaware&nbsp;corporation (\"Parent\"), and&nbsp;Antioch Merger Sub, Inc., a&nbsp;Delaware&nbsp;corporation and wholly owned subsidiary of Parent (\"Merger Sub\"), providing for, among other things, the merger of Merger Sub with and into Arena (the \"Merger\"), with Arena surviving the Merger.</p><p><blockquote>随着与辉瑞达成协议和合并计划，Arena Pharmaceuticals在盘前交易中飙升近90%。2021年12月12日，Arena与特拉华州公司（“母公司”）辉瑞公司和特拉华州公司及母公司的全资子公司Antioch Merger Sub，Inc.（“Merger Sub”）签订了合并协议和计划（“合并协议”），规定Merger Sub与Arena合并（“合并”），Arena在合并后幸存。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Arena Pharmaceuticals soared nearly 90% in premarket trading as it entered into an Agreement and Plan of Merger with Pfizer<blockquote>Arena Pharmaceuticals与辉瑞达成协议和合并计划，盘前交易飙升近90%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nArena Pharmaceuticals soared nearly 90% in premarket trading as it entered into an Agreement and Plan of Merger with Pfizer<blockquote>Arena Pharmaceuticals与辉瑞达成协议和合并计划，盘前交易飙升近90%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-13 19:21</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Arena Pharmaceuticals soared nearly 90% in premarket trading as it entered into an Agreement and Plan of Merger with Pfizer.<img src=\"https://static.tigerbbs.com/12e0ce077a31825d9a0cad97f44f47f3\" tg-width=\"773\" tg-height=\"563\" width=\"100%\" height=\"auto\">On&nbsp;December 12, 2021, Arena entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Pfizer Inc., a&nbsp;Delaware&nbsp;corporation (\"Parent\"), and&nbsp;Antioch Merger Sub, Inc., a&nbsp;Delaware&nbsp;corporation and wholly owned subsidiary of Parent (\"Merger Sub\"), providing for, among other things, the merger of Merger Sub with and into Arena (the \"Merger\"), with Arena surviving the Merger.</p><p><blockquote>随着与辉瑞达成协议和合并计划，Arena Pharmaceuticals在盘前交易中飙升近90%。2021年12月12日，Arena与特拉华州公司（“母公司”）辉瑞公司和特拉华州公司及母公司的全资子公司Antioch Merger Sub，Inc.（“Merger Sub”）签订了合并协议和计划（“合并协议”），规定Merger Sub与Arena合并（“合并”），Arena在合并后幸存。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARNA":"阿里那","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1177848501","content_text":"Arena Pharmaceuticals soared nearly 90% in premarket trading as it entered into an Agreement and Plan of Merger with Pfizer.On December 12, 2021, Arena entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Pfizer Inc., a Delaware corporation (\"Parent\"), and Antioch Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (\"Merger Sub\"), providing for, among other things, the merger of Merger Sub with and into Arena (the \"Merger\"), with Arena surviving the Merger.","news_type":1,"symbols_score_info":{"PFE":0.9,"ARNA":0.9}},"isVote":1,"tweetType":1,"viewCount":2633,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605781039,"gmtCreate":1639264173189,"gmtModify":1639264173440,"author":{"id":"4087514122562540","authorId":"4087514122562540","name":"74809e5c","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087514122562540","authorIdStr":"4087514122562540"},"themes":[],"htmlText":"👌","listText":"👌","text":"👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/605781039","repostId":"2190484675","repostType":4,"isVote":1,"tweetType":1,"viewCount":3240,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602482243,"gmtCreate":1639057772213,"gmtModify":1639058893489,"author":{"id":"4087514122562540","authorId":"4087514122562540","name":"74809e5c","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087514122562540","authorIdStr":"4087514122562540"},"themes":[],"htmlText":"👌","listText":"👌","text":"👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602482243","repostId":"1178942550","repostType":4,"repost":{"id":"1178942550","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639052194,"share":"https://www.laohu8.com/m/news/1178942550?lang=zh_CN&edition=full","pubTime":"2021-12-09 20:16","market":"us","language":"en","title":"JPMorgan Sees 41% Upside In FuboTV<blockquote>摩根大通认为FuboTV上涨41%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1178942550","media":"Tiger Newspress","summary":"FuboTV stock jumped more than 3% in premarket trading after JPMorgan analyst Anna Lizzul initiated c","content":"<p>FuboTV stock jumped more&nbsp;than&nbsp;3% in premarket trading&nbsp;after&nbsp;<b>JPMorgan</b>&nbsp;analyst Anna Lizzul&nbsp;initiated coverage of&nbsp;<b>FuboTV Inc</b>&nbsp;with an Overweight rating and a $28 price target.</p><p><blockquote>FuboTV股价在盘前交易中上涨超过3%<b>摩根大通</b>分析师Anna Lizzul开始报道<b>富波电视公司</b>给予跑赢大盘评级，目标价28美元。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/cce07fd0309d1a6c9deeb09df9a3078d\" tg-width=\"850\" tg-height=\"615\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <b>JPMorgan</b>&nbsp;analyst Anna Lizzul&nbsp;initiated coverage of&nbsp;<b>FuboTV Inc</b>&nbsp;with an Overweight rating and a $28 price target, implying a 41.63% upside.</p><p><blockquote><b>摩根大通</b>分析师Anna Lizzul开始报道<b>富波电视公司</b>给予跑赢大盘评级，目标价28美元，意味着上涨空间为41.63%。</blockquote></p><p> FuboTV launched in 2015 and is a live TV streaming platform, providing subscribers access to live sports, entertainment, and news, Lizzul tells investors in a research note.</p><p><blockquote>Lizzul在一份研究报告中告诉投资者，FuboTV于2015年推出，是一个直播电视流媒体平台，为订阅者提供直播体育、娱乐和新闻。</blockquote></p><p> The analyst sees value in the platform as a sports-centric virtual multichannel video programming distributor service but notes the company operates in a \"highly competitive environment.\"</p><p><blockquote>该分析师认为该平台作为以体育为中心的虚拟多渠道视频节目分销商服务的价值，但指出该公司在“竞争激烈的环境”中运营。</blockquote></p><p> While she sees some long-term risks to the business model, Lizzul believes FuboTV shares present an attractive entry point given the 40% decline since the Q3 earnings report.</p><p><blockquote>虽然她认为商业模式存在一些长期风险，但Lizzul认为，鉴于自第三季度收益报告以来FuboTV股价下跌了40%，FuboTV股价是一个有吸引力的切入点。</blockquote></p><p> FuboTV&nbsp;reported third-quarter&nbsp;revenue of $156.7 million, up 156% year-over-year, beating the consensus of $143.6 million. Advertising revenue was up 147% Y/Y to $18.6 million.</p><p><blockquote>FuboTV公布第三季度营收为1.567亿美元，同比增长156%，超出市场预期的1.436亿美元。广告收入同比增长147%至1860万美元。</blockquote></p><p> FuboTV raised its full-year revenue guidance from $560 million – $570 million to $612 million – $617 million, above the consensus of $577.7 million.</p><p><blockquote>FuboTV将全年营收指引从5.6亿至5.7亿美元上调至6.12亿至6.17亿美元，高于市场普遍预期的5.777亿美元。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JPMorgan Sees 41% Upside In FuboTV<blockquote>摩根大通认为FuboTV上涨41%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJPMorgan Sees 41% Upside In FuboTV<blockquote>摩根大通认为FuboTV上涨41%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-09 20:16</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>FuboTV stock jumped more&nbsp;than&nbsp;3% in premarket trading&nbsp;after&nbsp;<b>JPMorgan</b>&nbsp;analyst Anna Lizzul&nbsp;initiated coverage of&nbsp;<b>FuboTV Inc</b>&nbsp;with an Overweight rating and a $28 price target.</p><p><blockquote>FuboTV股价在盘前交易中上涨超过3%<b>摩根大通</b>分析师Anna Lizzul开始报道<b>富波电视公司</b>给予跑赢大盘评级，目标价28美元。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/cce07fd0309d1a6c9deeb09df9a3078d\" tg-width=\"850\" tg-height=\"615\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <b>JPMorgan</b>&nbsp;analyst Anna Lizzul&nbsp;initiated coverage of&nbsp;<b>FuboTV Inc</b>&nbsp;with an Overweight rating and a $28 price target, implying a 41.63% upside.</p><p><blockquote><b>摩根大通</b>分析师Anna Lizzul开始报道<b>富波电视公司</b>给予跑赢大盘评级，目标价28美元，意味着上涨空间为41.63%。</blockquote></p><p> FuboTV launched in 2015 and is a live TV streaming platform, providing subscribers access to live sports, entertainment, and news, Lizzul tells investors in a research note.</p><p><blockquote>Lizzul在一份研究报告中告诉投资者，FuboTV于2015年推出，是一个直播电视流媒体平台，为订阅者提供直播体育、娱乐和新闻。</blockquote></p><p> The analyst sees value in the platform as a sports-centric virtual multichannel video programming distributor service but notes the company operates in a \"highly competitive environment.\"</p><p><blockquote>该分析师认为该平台作为以体育为中心的虚拟多渠道视频节目分销商服务的价值，但指出该公司在“竞争激烈的环境”中运营。</blockquote></p><p> While she sees some long-term risks to the business model, Lizzul believes FuboTV shares present an attractive entry point given the 40% decline since the Q3 earnings report.</p><p><blockquote>虽然她认为商业模式存在一些长期风险，但Lizzul认为，鉴于自第三季度收益报告以来FuboTV股价下跌了40%，FuboTV股价是一个有吸引力的切入点。</blockquote></p><p> FuboTV&nbsp;reported third-quarter&nbsp;revenue of $156.7 million, up 156% year-over-year, beating the consensus of $143.6 million. Advertising revenue was up 147% Y/Y to $18.6 million.</p><p><blockquote>FuboTV公布第三季度营收为1.567亿美元，同比增长156%，超出市场预期的1.436亿美元。广告收入同比增长147%至1860万美元。</blockquote></p><p> FuboTV raised its full-year revenue guidance from $560 million – $570 million to $612 million – $617 million, above the consensus of $577.7 million.</p><p><blockquote>FuboTV将全年营收指引从5.6亿至5.7亿美元上调至6.12亿至6.17亿美元，高于市场普遍预期的5.777亿美元。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FUBO":"fuboTV Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1178942550","content_text":"FuboTV stock jumped more than 3% in premarket trading after JPMorgan analyst Anna Lizzul initiated coverage of FuboTV Inc with an Overweight rating and a $28 price target.\n\nJPMorgan analyst Anna Lizzul initiated coverage of FuboTV Inc with an Overweight rating and a $28 price target, implying a 41.63% upside.\nFuboTV launched in 2015 and is a live TV streaming platform, providing subscribers access to live sports, entertainment, and news, Lizzul tells investors in a research note.\nThe analyst sees value in the platform as a sports-centric virtual multichannel video programming distributor service but notes the company operates in a \"highly competitive environment.\"\nWhile she sees some long-term risks to the business model, Lizzul believes FuboTV shares present an attractive entry point given the 40% decline since the Q3 earnings report.\nFuboTV reported third-quarter revenue of $156.7 million, up 156% year-over-year, beating the consensus of $143.6 million. Advertising revenue was up 147% Y/Y to $18.6 million.\nFuboTV raised its full-year revenue guidance from $560 million – $570 million to $612 million – $617 million, above the consensus of $577.7 million.","news_type":1,"symbols_score_info":{"FUBO":0.9}},"isVote":1,"tweetType":1,"viewCount":2765,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606643246,"gmtCreate":1638877389678,"gmtModify":1638877425806,"author":{"id":"4087514122562540","authorId":"4087514122562540","name":"74809e5c","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087514122562540","authorIdStr":"4087514122562540"},"themes":[],"htmlText":"👌&nbsp;","listText":"👌&nbsp;","text":"👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606643246","repostId":"1187427850","repostType":4,"repost":{"id":"1187427850","kind":"news","pubTimestamp":1638871605,"share":"https://www.laohu8.com/m/news/1187427850?lang=zh_CN&edition=full","pubTime":"2021-12-07 18:06","market":"us","language":"en","title":"5 Stocks To Watch For December 7, 2021<blockquote>2021年12月7日值得关注的5只股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1187427850","media":"Benzinga","summary":"Wall Street expects AutoZone, Inc. to report quarterly earnings at $20.87 per share on revenue of $3","content":"<p><div> Wall Street expects AutoZone, Inc. to report quarterly earnings at $20.87 per share on revenue of $3.37 billion before the opening bell. AutoZone shares rose 0.3% to $1,885.00 in after-hours trading. ...</p><p><blockquote><div>华尔街预计AutoZone，Inc.将在开盘前公布季度收益为每股20.87美元，营收为33.7亿美元。AutoZone股价在盘后交易中上涨0.3%，至1,885.00美元。...</div></blockquote></p><p>  <a href=\"https://www.benzinga.com/news/earnings/21/12/24473988/5-stocks-to-watch-for-december-7-2021\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://www.benzinga.com/news/earnings/21/12/24473988/5-stocks-to-watch-for-december-7-2021\">网页连接</a></blockquote></p><p></p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks To Watch For December 7, 2021<blockquote>2021年12月7日值得关注的5只股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks To Watch For December 7, 2021<blockquote>2021年12月7日值得关注的5只股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Benzinga</strong><span class=\"h-time small\">2021-12-07 18:06</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> Wall Street expects AutoZone, Inc. to report quarterly earnings at $20.87 per share on revenue of $3.37 billion before the opening bell. AutoZone shares rose 0.3% to $1,885.00 in after-hours trading. ...</p><p><blockquote><div>华尔街预计AutoZone，Inc.将在开盘前公布季度收益为每股20.87美元，营收为33.7亿美元。AutoZone股价在盘后交易中上涨0.3%，至1,885.00美元。...</div></blockquote></p><p>  <a href=\"https://www.benzinga.com/news/earnings/21/12/24473988/5-stocks-to-watch-for-december-7-2021\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://www.benzinga.com/news/earnings/21/12/24473988/5-stocks-to-watch-for-december-7-2021\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.benzinga.com/news/earnings/21/12/24473988/5-stocks-to-watch-for-december-7-2021\">Benzinga</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AZO":"汽车地带","TOL":"托尔兄弟","DBI":"Designer Brands Inc","GLPI":"Gaming and Leisure Properties I","COUP":"Coupa Software Inc"},"source_url":"https://www.benzinga.com/news/earnings/21/12/24473988/5-stocks-to-watch-for-december-7-2021","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1187427850","content_text":"Wall Street expects AutoZone, Inc. to report quarterly earnings at $20.87 per share on revenue of $3.37 billion before the opening bell. AutoZone shares rose 0.3% to $1,885.00 in after-hours trading.\nCoupa Software Incorporated reported adjusted earnings of $0.31 per share for its third fiscal quarter ended October 31, 2021, up from $0.18 per share in the year-ago period. Total revenues climbed 40% to $185.8 million. The company also said it sees FY22 adjusted earnings of $0.66 to $0.69 per share on revenue of $717.0 to $718.0 million. Coupa Software shares dipped 10.4% to $156.00 in the after-hours trading session.\nAnalysts are expecting Toll Brothers, Inc. to have earned $2.49 per share on revenue of $2.88 billion for the latest quarter. The company will release earnings after the markets close. Toll Brothers shares slipped 0.5% to $70.50 in after-hours trading.\nGaming and Leisure Properties, Inc. priced its underwritten public offering of 7,700,000 shares of common stock for total gross proceeds of around $344.6 million. Gaming and Leisure Properties shares dropped 2.4% to $45.32 in the after-hours trading session.\nAnalysts expect Designer Brands Inc. to report quarterly earnings at $0.56 per share on revenue of $897.50 million before the opening bell. Designer Brands shares gained 1.5% to $13.70 in after-hours trading.","news_type":1,"symbols_score_info":{"COUP":0.9,"TOL":0.9,"DBI":0.9,"AZO":0.9,"GLPI":0.9}},"isVote":1,"tweetType":1,"viewCount":3101,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608225753,"gmtCreate":1638751204172,"gmtModify":1638751204287,"author":{"id":"4087514122562540","authorId":"4087514122562540","name":"74809e5c","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087514122562540","authorIdStr":"4087514122562540"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608225753","repostId":"1179313612","repostType":4,"repost":{"id":"1179313612","kind":"news","pubTimestamp":1638745398,"share":"https://www.laohu8.com/m/news/1179313612?lang=zh_CN&edition=full","pubTime":"2021-12-06 07:03","market":"us","language":"en","title":"Game Stop, Toll Brothers, Costco, CVS, and Other Stocks to Watch This Week<blockquote>Game Stop、Toll Brothers、Costco、CVS和其他本周值得关注的股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1179313612","media":"Barrons","summary":"Meme stock darling GameStop headlines this week’s earnings report lineup. The videogame retailer rep","content":"<p>Meme stock darling <a href=\"https://laohu8.com/S/GME\">GameStop</a> headlines this week’s earnings report lineup. The videogame retailer reports results after the market closes on Wednesday. <a href=\"https://laohu8.com/S/AZO\">AutoZone</a>, Casey’s <a href=\"https://laohu8.com/S/BGC\">General</a> Stores, and <a href=\"https://laohu8.com/S/TOL\">Toll Brothers</a> report earnings on Tuesday, followed by <a href=\"https://laohu8.com/S/BF.A\">Brown-Forman</a> and <a href=\"https://laohu8.com/S/CPB\">Campbell Soup</a> on Wednesday. <a href=\"https://laohu8.com/S/AVGO\">Broadcom</a>, <a href=\"https://laohu8.com/S/COST\">Costco</a> Wholesale, and <a href=\"https://laohu8.com/S/HRL\">Hormel</a> Foods round things out on Thursday.</p><p><blockquote>模因股票宠儿<a href=\"https://laohu8.com/S/GME\">游戏驿站</a>本周财报阵容头条。这家视频游戏零售商将在周三收盘后公布业绩。<a href=\"https://laohu8.com/S/AZO\">AutoZone</a>，凯西的<a href=\"https://laohu8.com/S/BGC\">一般的</a>商店，以及<a href=\"https://laohu8.com/S/TOL\">托尔兄弟</a>周二公布收益，随后<a href=\"https://laohu8.com/S/BF.A\">布朗-福尔曼</a>和<a href=\"https://laohu8.com/S/CPB\">金宝汤</a>星期三。<a href=\"https://laohu8.com/S/AVGO\">Broadcom</a>,<a href=\"https://laohu8.com/S/COST\">Costco</a>批发，及<a href=\"https://laohu8.com/S/HRL\">荷美尔</a>周四的食物使事情更加圆满。</blockquote></p><p> On Monday, <a href=\"https://laohu8.com/S/UNP\">Union Pacific</a> will hold a conference call to discuss its climate action plan. <a href=\"https://laohu8.com/S/MCK\">McKesson</a> and <a href=\"https://laohu8.com/S/LUV\">Southwest Airlines</a> host their 2021 investor days on Wednesday, followed by <a href=\"https://laohu8.com/S/CVS\">CVS Health</a> and <a href=\"https://laohu8.com/S/TSN\">Tyson</a> Foods on Thursday.</p><p><blockquote>周一，<a href=\"https://laohu8.com/S/UNP\">联合太平洋</a>将召开电话会议讨论其气候行动计划。<a href=\"https://laohu8.com/S/MCK\">麦克森</a>和<a href=\"https://laohu8.com/S/LUV\">西南航空</a>周三举办2021年投资者日，随后<a href=\"https://laohu8.com/S/CVS\">CVS健康</a>和<a href=\"https://laohu8.com/S/TSN\">泰森</a>周四的食物。</blockquote></p><p> The Federal Reserve’s report on consumer credit data for October will be released on Tuesday. On Thursday, the U.S. Labor Department reports initial jobless claims for the week ending on Dec. 4.</p><p><blockquote>美联储10月消费者信贷数据报告将于周二公布。周四，美国劳工部公布了截至12月4日当周的首次申请失业救济人数。</blockquote></p><p> The Bureau of Labor Statistics releases the consumer price index for November on Friday. The consensus estimate is for a 6.7% year-over-year jump, half a percentage point more than in October. The core CPI, which excludes volatile food and energy prices, is expected to rise 4.8% versus 4.6% previously.</p><p><blockquote>美国劳工统计局周五发布11月份消费者价格指数。市场普遍预期同比增长6.7%，比10月份高出半个百分点。排除波动较大的食品和能源价格的核心CPI预计将上涨4.8%，而此前为4.6%。</blockquote></p><p> <b>Monday 12/6</b></p><p><blockquote><b>星期一12/6</b></blockquote></p><p> Union Pacific holds a conference call to discuss its climate action plan.</p><p><blockquote>联合太平洋公司召开电话会议讨论其气候行动计划。</blockquote></p><p> <b>Tuesday 12/7</b></p><p><blockquote><b>星期二12/7</b></blockquote></p><p> AutoZone, Casey’s General Stores, and Toll Brothers announce quarterly results.</p><p><blockquote>AutoZone、Casey’s General Stores和Toll Brothers公布季度业绩。</blockquote></p><p> The Federal Reserve reports on consumer credit data for October. After falling slightly last year, total outstanding consumer debt has risen an average of $20 billion a month through September, and stands at a record $4.37 trillion.</p><p><blockquote>美联储报告10月份消费者信贷数据。继去年小幅下降后，截至9月份，未偿消费者债务总额平均每月增加200亿美元，达到创纪录的4.37万亿美元。</blockquote></p><p> <b>Wednesday 12/8</b></p><p><blockquote><b>星期三12/8</b></blockquote></p><p> The BLS releases the Job Openings and Labor Turnover Survey. Economists forecast 10.5 million job openings on the last business day of October, only 600,000 less than the record high of 11.1 million in July.</p><p><blockquote>BLS发布职位空缺和劳动力流动调查。经济学家预测10月最后一个工作日将有1050万个职位空缺，仅比7月1110万的历史新高少60万个。</blockquote></p><p> <a href=\"https://laohu8.com/S/BF.B\">Brown-Forman</a>, Campbell Soup, and GameStop report earnings.</p><p><blockquote><a href=\"https://laohu8.com/S/BF.B\">布朗-福尔曼</a>、金宝汤和游戏驿站公布财报。</blockquote></p><p> McKesson and <a href=\"https://laohu8.com/S/OKSB\">Southwest</a> Airlines host their 2021 investor days.</p><p><blockquote>麦克森和<a href=\"https://laohu8.com/S/OKSB\">西南</a>航空公司举办2021年投资者日。</blockquote></p><p> <a href=\"https://laohu8.com/S/EW\">Edwards Lifesciences</a> holds an investor conference in Irvine, Calif. The company will discuss its product pipeline as well as its financial outlook for 2022.</p><p><blockquote><a href=\"https://laohu8.com/S/EW\">爱德华兹生命科学公司</a>在加州尔湾举行投资者会议。该公司将讨论其产品线以及2022年的财务前景。</blockquote></p><p> The Bank of Canada announces its monetary-policy decision. The central bank is expected to keep its key short-term interest rate unchanged at 0.25%. At its late-October meeting, the bank ended its quantitative-easing program and signaled that its first interest-rate hike would be earlier in 2022 than had been expected.</p><p><blockquote>加拿大央行宣布货币政策决定。预计央行将维持关键短期利率在0.25%不变。在10月底的会议上，央行结束了量化宽松计划，并表示首次加息将于2022年早于预期。</blockquote></p><p> <b>Thursday 12/9</b></p><p><blockquote><b>星期四12/9</b></blockquote></p><p> Broadcom, Costco Wholesale, and Hormel Foods hold conference calls to discuss quarterly results.</p><p><blockquote>Broadcom、Costco Wholesale和Hormel Foods在评级召开会议讨论季度业绩。</blockquote></p><p> CVS Health and Tyson Foods host their annual investor days.</p><p><blockquote>CVS Health和泰森食品举办年度投资者日。</blockquote></p><p> The Department of Labor reports initial jobless claims for the week ending on Dec. 4. Jobless claims averaged 238,750 in November, the lowest since the beginning of the pandemic, and just 24,750 more than in February of 2020.</p><p><blockquote>劳工部报告了截至12月4日当周的首次申请失业救济人数。11月份平均申请失业救济人数为238,750人，为大流行开始以来的最低水平，仅比2020年2月增加24,750人。</blockquote></p><p> <b>Friday 12/10</b></p><p><blockquote><b>星期五12/10</b></blockquote></p><p> Archer-Daniels-Midland holds its global investor day.</p><p><blockquote>阿彻-丹尼尔斯-米德兰举办全球投资者日。</blockquote></p><p> <a href=\"https://laohu8.com/S/CNC\">Centene</a> holds an investor meeting and will provide financial guidance for 2022.</p><p><blockquote><a href=\"https://laohu8.com/S/CNC\">Centene</a>召开投资者会议，并将提供2022年的财务指导。</blockquote></p><p> The Bureau of Labor Statistics releases the consumer price index for November. Consensus estimate is for a 6.7% year-over-year jump, half a percentage point more than in October. The core CPI, which excludes volatile food and energy prices, is expected to rise 4.8% versus 4.6% previously. October’s 6.2% increase was the hottest the CPI has run in more than 30 years, and this past week Federal Reserve Chairman Jerome <a href=\"https://laohu8.com/S/POWL\">Powell</a> finally ditched “transitory” when discussing inflation before the Senate Banking Committee.</p><p><blockquote>美国劳工统计局发布11月份消费者价格指数。市场普遍预计同比增长6.7%，比10月份高出半个百分点。排除波动较大的食品和能源价格的核心CPI预计将上涨4.8%，而此前为4.6%。10月份6.2%的涨幅是CPI 30多年来最热的一次，上周美联储主席杰罗姆<a href=\"https://laohu8.com/S/POWL\">鲍威尔</a>在参议院银行委员会讨论通货膨胀时，最终放弃了“暂时性”。</blockquote></p><p> The University of Michigan releases its Consumer Sentiment index for December. Economists forecast a 66 reading, slightly less than the November data.</p><p><blockquote>密歇根大学发布12月份消费者信心指数。经济学家预测为66，略低于11月份的数据。</blockquote></p><p></p>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Game Stop, Toll Brothers, Costco, CVS, and Other Stocks to Watch This Week<blockquote>Game Stop、Toll Brothers、Costco、CVS和其他本周值得关注的股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGame Stop, Toll Brothers, Costco, CVS, and Other Stocks to Watch This Week<blockquote>Game Stop、Toll Brothers、Costco、CVS和其他本周值得关注的股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Barrons</strong><span class=\"h-time small\">2021-12-06 07:03</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Meme stock darling <a href=\"https://laohu8.com/S/GME\">GameStop</a> headlines this week’s earnings report lineup. The videogame retailer reports results after the market closes on Wednesday. <a href=\"https://laohu8.com/S/AZO\">AutoZone</a>, Casey’s <a href=\"https://laohu8.com/S/BGC\">General</a> Stores, and <a href=\"https://laohu8.com/S/TOL\">Toll Brothers</a> report earnings on Tuesday, followed by <a href=\"https://laohu8.com/S/BF.A\">Brown-Forman</a> and <a href=\"https://laohu8.com/S/CPB\">Campbell Soup</a> on Wednesday. <a href=\"https://laohu8.com/S/AVGO\">Broadcom</a>, <a href=\"https://laohu8.com/S/COST\">Costco</a> Wholesale, and <a href=\"https://laohu8.com/S/HRL\">Hormel</a> Foods round things out on Thursday.</p><p><blockquote>模因股票宠儿<a href=\"https://laohu8.com/S/GME\">游戏驿站</a>本周财报阵容头条。这家视频游戏零售商将在周三收盘后公布业绩。<a href=\"https://laohu8.com/S/AZO\">AutoZone</a>，凯西的<a href=\"https://laohu8.com/S/BGC\">一般的</a>商店，以及<a href=\"https://laohu8.com/S/TOL\">托尔兄弟</a>周二公布收益，随后<a href=\"https://laohu8.com/S/BF.A\">布朗-福尔曼</a>和<a href=\"https://laohu8.com/S/CPB\">金宝汤</a>星期三。<a href=\"https://laohu8.com/S/AVGO\">Broadcom</a>,<a href=\"https://laohu8.com/S/COST\">Costco</a>批发，及<a href=\"https://laohu8.com/S/HRL\">荷美尔</a>周四的食物使事情更加圆满。</blockquote></p><p> On Monday, <a href=\"https://laohu8.com/S/UNP\">Union Pacific</a> will hold a conference call to discuss its climate action plan. <a href=\"https://laohu8.com/S/MCK\">McKesson</a> and <a href=\"https://laohu8.com/S/LUV\">Southwest Airlines</a> host their 2021 investor days on Wednesday, followed by <a href=\"https://laohu8.com/S/CVS\">CVS Health</a> and <a href=\"https://laohu8.com/S/TSN\">Tyson</a> Foods on Thursday.</p><p><blockquote>周一，<a href=\"https://laohu8.com/S/UNP\">联合太平洋</a>将召开电话会议讨论其气候行动计划。<a href=\"https://laohu8.com/S/MCK\">麦克森</a>和<a href=\"https://laohu8.com/S/LUV\">西南航空</a>周三举办2021年投资者日，随后<a href=\"https://laohu8.com/S/CVS\">CVS健康</a>和<a href=\"https://laohu8.com/S/TSN\">泰森</a>周四的食物。</blockquote></p><p> The Federal Reserve’s report on consumer credit data for October will be released on Tuesday. On Thursday, the U.S. Labor Department reports initial jobless claims for the week ending on Dec. 4.</p><p><blockquote>美联储10月消费者信贷数据报告将于周二公布。周四，美国劳工部公布了截至12月4日当周的首次申请失业救济人数。</blockquote></p><p> The Bureau of Labor Statistics releases the consumer price index for November on Friday. The consensus estimate is for a 6.7% year-over-year jump, half a percentage point more than in October. The core CPI, which excludes volatile food and energy prices, is expected to rise 4.8% versus 4.6% previously.</p><p><blockquote>美国劳工统计局周五发布11月份消费者价格指数。市场普遍预期同比增长6.7%，比10月份高出半个百分点。排除波动较大的食品和能源价格的核心CPI预计将上涨4.8%，而此前为4.6%。</blockquote></p><p> <b>Monday 12/6</b></p><p><blockquote><b>星期一12/6</b></blockquote></p><p> Union Pacific holds a conference call to discuss its climate action plan.</p><p><blockquote>联合太平洋公司召开电话会议讨论其气候行动计划。</blockquote></p><p> <b>Tuesday 12/7</b></p><p><blockquote><b>星期二12/7</b></blockquote></p><p> AutoZone, Casey’s General Stores, and Toll Brothers announce quarterly results.</p><p><blockquote>AutoZone、Casey’s General Stores和Toll Brothers公布季度业绩。</blockquote></p><p> The Federal Reserve reports on consumer credit data for October. After falling slightly last year, total outstanding consumer debt has risen an average of $20 billion a month through September, and stands at a record $4.37 trillion.</p><p><blockquote>美联储报告10月份消费者信贷数据。继去年小幅下降后，截至9月份，未偿消费者债务总额平均每月增加200亿美元，达到创纪录的4.37万亿美元。</blockquote></p><p> <b>Wednesday 12/8</b></p><p><blockquote><b>星期三12/8</b></blockquote></p><p> The BLS releases the Job Openings and Labor Turnover Survey. Economists forecast 10.5 million job openings on the last business day of October, only 600,000 less than the record high of 11.1 million in July.</p><p><blockquote>BLS发布职位空缺和劳动力流动调查。经济学家预测10月最后一个工作日将有1050万个职位空缺，仅比7月1110万的历史新高少60万个。</blockquote></p><p> <a href=\"https://laohu8.com/S/BF.B\">Brown-Forman</a>, Campbell Soup, and GameStop report earnings.</p><p><blockquote><a href=\"https://laohu8.com/S/BF.B\">布朗-福尔曼</a>、金宝汤和游戏驿站公布财报。</blockquote></p><p> McKesson and <a href=\"https://laohu8.com/S/OKSB\">Southwest</a> Airlines host their 2021 investor days.</p><p><blockquote>麦克森和<a href=\"https://laohu8.com/S/OKSB\">西南</a>航空公司举办2021年投资者日。</blockquote></p><p> <a href=\"https://laohu8.com/S/EW\">Edwards Lifesciences</a> holds an investor conference in Irvine, Calif. The company will discuss its product pipeline as well as its financial outlook for 2022.</p><p><blockquote><a href=\"https://laohu8.com/S/EW\">爱德华兹生命科学公司</a>在加州尔湾举行投资者会议。该公司将讨论其产品线以及2022年的财务前景。</blockquote></p><p> The Bank of Canada announces its monetary-policy decision. The central bank is expected to keep its key short-term interest rate unchanged at 0.25%. At its late-October meeting, the bank ended its quantitative-easing program and signaled that its first interest-rate hike would be earlier in 2022 than had been expected.</p><p><blockquote>加拿大央行宣布货币政策决定。预计央行将维持关键短期利率在0.25%不变。在10月底的会议上，央行结束了量化宽松计划，并表示首次加息将于2022年早于预期。</blockquote></p><p> <b>Thursday 12/9</b></p><p><blockquote><b>星期四12/9</b></blockquote></p><p> Broadcom, Costco Wholesale, and Hormel Foods hold conference calls to discuss quarterly results.</p><p><blockquote>Broadcom、Costco Wholesale和Hormel Foods在评级召开会议讨论季度业绩。</blockquote></p><p> CVS Health and Tyson Foods host their annual investor days.</p><p><blockquote>CVS Health和泰森食品举办年度投资者日。</blockquote></p><p> The Department of Labor reports initial jobless claims for the week ending on Dec. 4. Jobless claims averaged 238,750 in November, the lowest since the beginning of the pandemic, and just 24,750 more than in February of 2020.</p><p><blockquote>劳工部报告了截至12月4日当周的首次申请失业救济人数。11月份平均申请失业救济人数为238,750人，为大流行开始以来的最低水平，仅比2020年2月增加24,750人。</blockquote></p><p> <b>Friday 12/10</b></p><p><blockquote><b>星期五12/10</b></blockquote></p><p> Archer-Daniels-Midland holds its global investor day.</p><p><blockquote>阿彻-丹尼尔斯-米德兰举办全球投资者日。</blockquote></p><p> <a href=\"https://laohu8.com/S/CNC\">Centene</a> holds an investor meeting and will provide financial guidance for 2022.</p><p><blockquote><a href=\"https://laohu8.com/S/CNC\">Centene</a>召开投资者会议，并将提供2022年的财务指导。</blockquote></p><p> The Bureau of Labor Statistics releases the consumer price index for November. Consensus estimate is for a 6.7% year-over-year jump, half a percentage point more than in October. The core CPI, which excludes volatile food and energy prices, is expected to rise 4.8% versus 4.6% previously. October’s 6.2% increase was the hottest the CPI has run in more than 30 years, and this past week Federal Reserve Chairman Jerome <a href=\"https://laohu8.com/S/POWL\">Powell</a> finally ditched “transitory” when discussing inflation before the Senate Banking Committee.</p><p><blockquote>美国劳工统计局发布11月份消费者价格指数。市场普遍预计同比增长6.7%，比10月份高出半个百分点。排除波动较大的食品和能源价格的核心CPI预计将上涨4.8%，而此前为4.6%。10月份6.2%的涨幅是CPI 30多年来最热的一次，上周美联储主席杰罗姆<a href=\"https://laohu8.com/S/POWL\">鲍威尔</a>在参议院银行委员会讨论通货膨胀时，最终放弃了“暂时性”。</blockquote></p><p> The University of Michigan releases its Consumer Sentiment index for December. Economists forecast a 66 reading, slightly less than the November data.</p><p><blockquote>密歇根大学发布12月份消费者信心指数。经济学家预测为66，略低于11月份的数据。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.marketwatch.com/articles/game-stop-toll-brothers-costco-cvs-and-other-stocks-to-watch-this-week-51638734413?mod=barrons-on-marketwatch\">Barrons</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GME":"游戏驿站","TOL":"托尔兄弟","COST":"好市多","CVS":"西维斯健康","BK4088":"住宅建筑"},"source_url":"https://www.marketwatch.com/articles/game-stop-toll-brothers-costco-cvs-and-other-stocks-to-watch-this-week-51638734413?mod=barrons-on-marketwatch","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1179313612","content_text":"Meme stock darling GameStop headlines this week’s earnings report lineup. The videogame retailer reports results after the market closes on Wednesday. AutoZone, Casey’s General Stores, and Toll Brothers report earnings on Tuesday, followed by Brown-Forman and Campbell Soup on Wednesday. Broadcom, Costco Wholesale, and Hormel Foods round things out on Thursday.\nOn Monday, Union Pacific will hold a conference call to discuss its climate action plan. McKesson and Southwest Airlines host their 2021 investor days on Wednesday, followed by CVS Health and Tyson Foods on Thursday.\nThe Federal Reserve’s report on consumer credit data for October will be released on Tuesday. On Thursday, the U.S. Labor Department reports initial jobless claims for the week ending on Dec. 4.\nThe Bureau of Labor Statistics releases the consumer price index for November on Friday. The consensus estimate is for a 6.7% year-over-year jump, half a percentage point more than in October. The core CPI, which excludes volatile food and energy prices, is expected to rise 4.8% versus 4.6% previously.\nMonday 12/6\nUnion Pacific holds a conference call to discuss its climate action plan.\nTuesday 12/7\nAutoZone, Casey’s General Stores, and Toll Brothers announce quarterly results.\nThe Federal Reserve reports on consumer credit data for October. After falling slightly last year, total outstanding consumer debt has risen an average of $20 billion a month through September, and stands at a record $4.37 trillion.\nWednesday 12/8\nThe BLS releases the Job Openings and Labor Turnover Survey. Economists forecast 10.5 million job openings on the last business day of October, only 600,000 less than the record high of 11.1 million in July.\nBrown-Forman, Campbell Soup, and GameStop report earnings.\nMcKesson and Southwest Airlines host their 2021 investor days.\nEdwards Lifesciences holds an investor conference in Irvine, Calif. The company will discuss its product pipeline as well as its financial outlook for 2022.\nThe Bank of Canada announces its monetary-policy decision. The central bank is expected to keep its key short-term interest rate unchanged at 0.25%. At its late-October meeting, the bank ended its quantitative-easing program and signaled that its first interest-rate hike would be earlier in 2022 than had been expected.\nThursday 12/9\nBroadcom, Costco Wholesale, and Hormel Foods hold conference calls to discuss quarterly results.\nCVS Health and Tyson Foods host their annual investor days.\nThe Department of Labor reports initial jobless claims for the week ending on Dec. 4. Jobless claims averaged 238,750 in November, the lowest since the beginning of the pandemic, and just 24,750 more than in February of 2020.\nFriday 12/10\nArcher-Daniels-Midland holds its global investor day.\nCentene holds an investor meeting and will provide financial guidance for 2022.\nThe Bureau of Labor Statistics releases the consumer price index for November. Consensus estimate is for a 6.7% year-over-year jump, half a percentage point more than in October. The core CPI, which excludes volatile food and energy prices, is expected to rise 4.8% versus 4.6% previously. October’s 6.2% increase was the hottest the CPI has run in more than 30 years, and this past week Federal Reserve Chairman Jerome Powell finally ditched “transitory” when discussing inflation before the Senate Banking Committee.\nThe University of Michigan releases its Consumer Sentiment index for December. Economists forecast a 66 reading, slightly less than the November data.","news_type":1,"symbols_score_info":{"COST":0.9,"GME":0.9,"TOL":0.9,"CVS":0.9}},"isVote":1,"tweetType":1,"viewCount":935,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608958733,"gmtCreate":1638603255325,"gmtModify":1638603255494,"author":{"id":"4087514122562540","authorId":"4087514122562540","name":"74809e5c","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087514122562540","authorIdStr":"4087514122562540"},"themes":[],"htmlText":"👌","listText":"👌","text":"👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608958733","repostId":"1115344844","repostType":4,"repost":{"id":"1115344844","kind":"news","pubTimestamp":1638544099,"share":"https://www.laohu8.com/m/news/1115344844?lang=zh_CN&edition=full","pubTime":"2021-12-03 23:08","market":"us","language":"en","title":"3 High Growth Stocks To Buy In The Pullback<blockquote>回调中值得买入的3只高增长股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1115344844","media":"Seeking Alpha","summary":"Summary\n\nUpstart has fallen more than 50% from its highs. But its last earnings report wasn't that b","content":"<p><b>Summary</b></p><p><blockquote><b>总结</b></blockquote></p><p> <ul>  <li>Upstart has fallen more than 50% from its highs. But its last earnings report wasn't that bad. The story is still intact and shares have derisked considerably.</li>  <li>Zscaler continues to impress with recent results showing accelerated growth again. The shares went up immediately after the report but reversed down in the general wash out.</li>  <li>Monday.com is a fairly new company and it also got hit by the market. Its high growth profile, rapidly improving profitability, and reasonable valuation makes it an interesting stock pick.</li> </ul> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2aac50f1e4e4115b0d38a5ec6c15c267\" tg-width=\"1536\" tg-height=\"1139\" width=\"100%\" height=\"auto\"><span>Galeanu Mihai/iStock via Getty Images</span></p><p><blockquote><ul><li>Upstart已较高点下跌超过50%。但其上一份收益报告并没有那么糟糕。故事仍然完好无损，股价已大幅下降。</li><li>Zscaler继续给人留下深刻印象，最近的业绩再次显示加速增长。报告发布后，该股立即上涨，但在普遍下跌中逆转下跌。</li><li>Monday.com是一家相当新的公司，它也受到了市场的冲击。其高增长、快速提高的盈利能力和合理的估值使其成为一个有趣的股票选择。</li></ul><p class=\"t-img-caption\"><span>Galeanu Mihai/iStock来自Getty Images</span></p></blockquote></p><p> I started writing this article one week ago with the goal to review Upstart's recent quarterly results. Since in my&nbsp;last article, I argued that Upstart (UPST) might still be an attractive buying opportunity at $390 a share, I wanted to check on the company (currently trading around $180 –<i>yikes!</i>).</p><p><blockquote>我一周前开始写这篇文章，目的是回顾Upstart最近的季度业绩。由于在我的上一篇文章中，我认为Upstart(UPST)可能仍然是每股390美元的有吸引力的买入机会，因此我想检查一下该公司（目前交易价格约为180美元-<i>呀！</i>).</blockquote></p><p> However, the recent market sell-off, especially in high-growth names, made me reconsider the direction of the article. I think it is much more interesting right now to write about some high-growth names in my portfolio that I am considering adding during this little downturn.</p><p><blockquote>然而，最近的市场抛售，尤其是高增长股票的抛售，让我重新考虑了文章的方向。我认为现在写一些我的投资组合中的高增长股票更有趣，我正在考虑在这次小衰退期间添加这些股票。</blockquote></p><p> A little caveat upfront, though. I am really bad at short-term calls (as evidenced by my recent Upstart article). I have no idea what the Omicron variant will do to our economy, what the Fed's monetary policy will be in the future and how far this sell-off will go eventually. By the time this article is published, the sell-off might already have reversed. Or it might have gotten much worse. I simply don't know.</p><p><blockquote>不过，提前有一点警告。我真的不擅长短期评级（正如我最近的新贵文章所证明的那样）。我不知道奥密克戎变体会对我们的经济产生什么影响，美联储未来的货币政策会是什么，也不知道这次抛售最终会走多远。当本文发表时，抛售可能已经逆转。或者情况可能会变得更糟。我就是不知道。</blockquote></p><p> What I do know is that there are companies in the public markets with exceptional business fundamentals that&nbsp;<b>will do very well regardless of the macro environment</b>. These are businesses with high growth rates, high margins, and long runways of growth. They also have high valuation multiples which lead to increased risk and high volatility. Taking advantage of that volatility is a great way to increase your returns. Here are some stocks that I consider buying right now:</p><p><blockquote>我所知道的是，公开市场上有些公司拥有出色的业务基本面<b>无论宏观环境如何，都会做得很好</b>这些业务具有高增长率、高利润率和长期增长。它们的估值倍数也很高，这导致风险增加和波动性高。利用这种波动性是增加回报的好方法。以下是我现在考虑购买的一些股票：</blockquote></p><p> <b>Upstart</b></p><p><blockquote><b>暴发户</b></blockquote></p><p> Let's start with the one I originally wanted to write about: To summarize shortly, I think that if you liked Upstart at $390, you should like it much more at $180. The earnings release for Q3 2021 was not as bad as the market's reaction might suggest. Yes, expectations were lofty based on an exceptional Q2 report, and yes, these expectations were not entirely met in Q3. But that does not mean that the fundamental picture has deteriorated. What the wild price swings of the past prove, and I have written about in the past, is that this young company is difficult to value. Growth is high, but also hard to predict. And while the disruption of the FICO score through AI technology is enticing and seems inevitable, Upstart's role in that story is not set in stone.</p><p><blockquote>让我们从我最初想写的一个开始：简单总结一下，我认为如果你喜欢390美元的Upstart，你应该更喜欢180美元的Upstart。2021年第三季度的财报发布并不像市场反应所暗示的那么糟糕。是的，基于出色的第二季度报告，人们的期望很高，是的，这些期望在第三季度并没有完全实现。但这并不意味着基本面已经恶化。过去的剧烈价格波动证明，我过去也写过，这家年轻的公司很难估值。增长很高，但也很难预测。虽然人工智能技术对FICO分数的破坏很诱人，而且似乎不可避免，但Upstart在这个故事中的角色并不是一成不变的。</blockquote></p><p> Let's look at some numbers:</p><p><blockquote>我们来看一些数字：</blockquote></p><p> <img src=\"https://static.tigerbbs.com/7b085c5134a9e376f177da8f5fa2674e\" tg-width=\"640\" tg-height=\"309\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b826680751b139c569c90d0d3be483cf\" tg-width=\"640\" tg-height=\"163\" width=\"100%\" height=\"auto\"><span>Source: Author</span></p><p><blockquote><p class=\"t-img-caption\"><span>来源：作者</span></p></blockquote></p><p> As you can see, revenue growth is still explosive, and with a normal beat should accelerate again into Q4 on a sequential basis. And while most key performance indicators (loans transacted, conversion rate, percentage of automated loans) together with&nbsp;margins&nbsp;all decelerated or went down slightly, I don't think that this means the fundamentals have changed with this company. There were many details mentioned in the&nbsp;earnings call&nbsp;that I won't discuss in this article format. But the key takeaway for me was that management seemed very upbeat about the future of the company.</p><p><blockquote>正如您所看到的，收入增长仍然是爆炸性的，按照正常的节奏，第四季度应该会再次加速。虽然大多数关键绩效指标（交易贷款、转化率、自动贷款百分比）以及利润率都减速或略有下降，但我不认为这意味着这家公司的基本面发生了变化。收益看涨期权中提到了许多细节，我不会在本文中讨论。但对我来说，关键的收获是管理层似乎对公司的未来非常乐观。</blockquote></p><p> I think there are two key mistakes that investors should avoid here:</p><p><blockquote>我认为投资者在这里应该避免两个关键错误：</blockquote></p><p></p><p> <ol>  <li>Let the disappointment of a \"not-so-blowout\" quarter and a devastating price action make you blind to this investment opportunity. This was still a very good quarter and now that the shares have fallen off a cliff the stock is much more attractive.</li>  <li>Do not look at Upstart through the lens of SaaS businesses. As I wrote in&nbsp;May:<i>Upstart might be a high-promising cloud software company but it does not have a SaaS business model. There is</i>&nbsp;<i><b>no recurring revenue</b></i>&nbsp;<i>to fall back on in tough times, no sticky subscription customers, no backlog, no land and expand. Every quarter Upstart has to sell new loans, and revenue basically starts from zero.</i></li> </ol> Upstart's financials are lumpier and less reliable and as a result, the company deserves much more investor attention and a lower valuation multiple than high growth companies with recurring revenues. However, if growth stays very high, it could more than make up for that fact. Currently, the company is trading at a 17.76 forward EV/S, which I think is a relative bargain for a company with this growth and margin profile.</p><p><blockquote><ol><li>让“不那么井喷”的季度的失望和毁灭性的价格走势让你对这个投资机会视而不见。这仍然是一个非常好的季度，现在股价已经断崖式下跌，该股更具吸引力。</li><li>不要通过SaaS企业的视角来看待Upstart。正如我在五月份所写的：<i>Upstart可能是一家很有前途的云软件公司，但它没有SaaS商业模式。有</i> <i><b>无经常性收入</b></i> <i>在困难时期可以依靠，没有粘性订阅客户，没有积压，没有土地和扩张。每个季度Upstart都要出售新贷款，营收基本从零开始。</i></li></ol>Upstart的财务状况更加不稳定且不太可靠，因此，与具有经常性收入的高增长公司相比，该公司值得投资者更多关注，估值倍数也更低。然而，如果增长保持在很高的水平，它就足以弥补这一事实。目前，该公司的远期EV/S交易价格为17.76，我认为对于具有这种增长和利润率的公司来说，这是相对便宜的。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/15592919228dec8ee2403898d69ef228\" tg-width=\"635\" tg-height=\"417\" width=\"100%\" height=\"auto\"><span>Data by YCharts</span></p><p><blockquote><p class=\"t-img-caption\"><span>数据来自YCharts</span></p></blockquote></p><p> <b>Zscaler</b></p><p><blockquote><b>Zscaler</b></blockquote></p><p> Sometimes the market gives you a gift that you should not refuse. This is what happened with Zscaler (ZS) yesterday. The&nbsp;stock initially was up&nbsp;in the postmarket after the company reported another&nbsp;blow-out quarter&nbsp;on Tuesday. But on Wednesday it all didn't matter anymore and thanks to the little correction, sector rotation, or whatever you want to call it, the stock actually went&nbsp;<b>down by more than 8%</b>. This is really a time when you want to buy: You just got confirmation that your company is doing incredibly well with growth accelerating and the stock sells off for macro concerns. The stock is definitely not cheap at a forward EV/S of 43.51 and, of course, this \"pull-back\" is laughable (<i>\"oh my god, the stock is back to where it was...one month ago\"</i>).</p><p><blockquote>有时候市场会给你一份你不应该拒绝的礼物。这就是Zscaler(ZS)昨天发生的情况。在该公司周二公布另一个井喷季度后，该股最初在盘后市场上涨。但到了周三，这一切都不再重要了，由于小幅调整、行业轮换或任何你想看涨期权的东西，该股实际上上涨了<b>跌幅超过8%</b>.这确实是你想买入的时候：你刚刚得到确认，你的公司表现非常好，增长加速，股票因宏观担忧而遭到抛售。该股的远期EV/S为43.51，绝对不便宜，当然，这种“回调”是可笑的（<i>“天哪，股票又回到了……一个月前”</i>).</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e79ff3fce3101896f17b65ced143c037\" tg-width=\"635\" tg-height=\"433\" width=\"100%\" height=\"auto\"><span>Data by YCharts</span></p><p><blockquote><p class=\"t-img-caption\"><span>数据来自YCharts</span></p></blockquote></p><p> But I like to own companies that are doing exceptional things and I don't mind paying up for them, especially in a turbulent market.</p><p><blockquote>但我喜欢拥有那些做着非凡事情的公司，我不介意为它们买单，尤其是在动荡的市场中。</blockquote></p><p> How exceptional is Zscaler? Just look at those revenue growth numbers:</p><p><blockquote>Zscaler有多特别？看看这些收入增长数字就知道了：</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3def4410c8c903a03041a2cd51b36979\" tg-width=\"640\" tg-height=\"386\" width=\"100%\" height=\"auto\"><span>Source: Author.</span></p><p><blockquote><p class=\"t-img-caption\"><span>来源：作者。</span></p></blockquote></p><p> I&nbsp;thought&nbsp;in May that growth acceleration might end soon, but it has continued to accelerate in Q1 2022. If the company beats its guidance in Q2 in a similar fashion to the past (usually more than 5%), it should accelerate year-on-year growth again in Q2 (or at least maintain the current 60%+ growth rate). On top of that, this quarter saw&nbsp;<b>RPO growing 98%, a dollar-based net retention rate of 125%, and FCF margins of 36%</b>. In other words, this business is firing on all cylinders. If you don't know what Zscaler does,read my article from December 2018&nbsp;– the stock is up 710% since then, and I think it can go even higher.</p><p><blockquote>我在5月份认为增长加速可能很快就会结束，但在2022年第一季度继续加速。如果该公司在第二季度的表现与过去类似（通常超过5%），那么它应该会在第二季度再次加速同比增长（或至少保持目前60%以上的增长率）。最重要的是，本季度<b>RPO增长98%，以美元计算的净保留率为125%，FCF利润率为36%</b>换句话说，这项业务正在全速运转。如果您不知道Zscaler是做什么的，请阅读我2018年12月的文章——自那时以来，该股已上涨710%，我认为它还可以走得更高。</blockquote></p><p> <b>Monday.com</b></p><p><blockquote><b>周一网</b></blockquote></p><p> Monday.com (MNDY) is a company that is a relatively new stock in the public markets (it IPOed in June this year) and a completely new stock in my portfolio (I just bought my first position). In a nutshell, the reason why I bought Monday.com is their hyper-growth and rapidly improving profitability. Just look at these two slides from the most recent earnings call presentation:</p><p><blockquote>Monday.com(MNDY)是一家在公开市场上相对较新的股票（今年6月首次公开募股），也是我投资组合中的一只全新股票（我刚刚购买了我的第一个头寸）。简而言之，我购买Monday.com的原因是他们的高速增长和盈利能力的快速提高。看看看涨期权最新财报演示中的这两张幻灯片即可：</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/c5b07658237c02685eb3d049a537ba61\" tg-width=\"640\" tg-height=\"727\" width=\"100%\" height=\"auto\"><span>Source: Earnings call presentation Q3 2021.</span></p><p><blockquote><p class=\"t-img-caption\"><span>资料来源：看涨期权2021年第三季度收益演示。</span></p></blockquote></p><p> Revenue was&nbsp;<b>up 95%</b>(up from 94% in the last quarter). This is quite astounding growth which indicates that this company is winning in the market (but also consider that the company is at a small annual revenue run rate, which makes it a bit easier). The number of enterprise customerswith more than $50K ARRwas&nbsp;<b>up 231%</b>(at 613, up from 185 a year ago). Monday was also&nbsp;<b>cash flow positive</b>&nbsp;for the first time this quarter.</p><p><blockquote>收入为<b>上涨95%</b>（高于上季度的94%）。这是相当惊人的增长，表明该公司正在市场上获胜（但也考虑到该公司的年收入运行率很小，这使得它变得更容易）。ARRs超过5万美元的企业客户数量为<b>上涨231%</b>（为613，高于一年前的185）。星期一也是<b>现金流为正</b>本季度首次。</blockquote></p><p> On top of that, it is also cheap relative to other cloud stocks:</p><p><blockquote>最重要的是，相对于其他云股票，它也很便宜：</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/80e6afbf54bdde4ad31dd3aaa06d0073\" tg-width=\"640\" tg-height=\"368\" width=\"100%\" height=\"auto\"><span>Source: Clouded Judgement 11.26.21.</span></p><p><blockquote><p class=\"t-img-caption\"><span>资料来源：阴云密布的判断11.26.21。</span></p></blockquote></p><p></p><p> The company currently has a TTM EV/S of 57, and a 2022 EV/S of 38.7, based on analysts' expectation of 47% growth in 2022. That seems rich but not terribly so relative to other cloud names. The growth expectation of 47% in 2022, however, seems quite low if you consider the current growth of 95% year-on-year and 17% sequentially, plus the current momentum in larger customers. Actually, anything below 70% growth in FY 2022 would come as a surprise to me, and then we are looking at a maximum forward EV/S of 33.</p><p><blockquote>根据分析师对2022年增长47%的预期，该公司目前的TTM EV/S为57，2022年EV/S为38.7。这看起来很丰富，但相对于其他云的名称来说并不那么丰富。然而，如果考虑到目前95%的同比增长和17%的环比增长，再加上目前较大客户的势头，2022年47%的增长预期似乎相当低。事实上，2022财年任何低于70%的增长都会让我感到惊讶，然后我们预计最大远期EV/S为33。</blockquote></p><p> The big question going forward – in terms of if Monday.com will be a good long-term investment – is to which extent Monday.com can maintain its high growth rate beyond FY 2022. Here I do have some doubts still. The company is operating in a very dynamic and competitive field and I am not yet sure where Monday differentiates itself meaningfully from companies like Asana (ASAN) or Atlassian (TEAM). Still, the market for cloud-based work management solutions is big and there can be many winners in the space. For the moment I'm happy to follow the numbers (which look fantastic) and hope that the relatively cheap valuation will result in substantial alpha and is not an indication of a lower quality company.</p><p><blockquote>未来的大问题——就Monday.com是否会成为一项良好的长期投资而言——是Monday.com能够在2022财年之后在多大程度上保持其高增长率。在这里，我仍然有一些疑问。该公司在一个充满活力和竞争激烈的领域运营，我还不确定Monday与Asana(ASAN)或Atlassian(TEAM)等公司有何显著区别。尽管如此，基于云的工作管理解决方案的市场很大，这个领域可能会有许多赢家。目前，我很高兴关注这些数字（看起来很棒），并希望相对便宜的估值将带来可观的阿尔法，而不是表明公司质量较低。</blockquote></p><p> <b>Closing Thoughts And Honorary Mentions</b></p><p><blockquote><b>结束语和荣誉奖</b></blockquote></p><p> On days like these, there are many companies worth considering. For example, I haven't mentioned Datadog (DDOG) which&nbsp;reported another fantastic quarter&nbsp;at the beginning of November. Like Zscaler, this is also a company with accelerating growth that you can buy at a lower price than it was before it reported its blowout results.</p><p><blockquote>在这样的日子里，有很多公司值得考虑。例如，我没有提到Datadog(DDOG)，它在11月初报告了另一个出色的季度业绩。与Zscaler一样，这也是一家正在加速增长的公司，您可以以比报告井喷业绩之前更低的价格购买。</blockquote></p><p> Remember that the stocks mentioned, even though they may look attractive from a relative perspective, are still very expensive in absolute terms and from a historical perspective. However, sustainable growth is a beautiful form of downside protection for investors and the best antidote to \"overvaluation\" that I know. If I learned one thing in the last four years investing in high-growth SaaS/cloud stocks, it is to stay invested in the companies that sustain (or preferably accelerate) their top-line growth and get out of the stocks that see slowdowns. That sounds terribly simplistic and of course, many other factors play a role in a stock's long-term gains, but revenue growth and its&nbsp;endurance&nbsp;have been the predominant factors in the past.</p><p><blockquote>请记住，所提到的股票，尽管从相对角度来看它们可能看起来很有吸引力，但从绝对值和历史角度来看仍然非常昂贵。然而，可持续增长对投资者来说是一种美丽的下行保护形式，也是我所知道的“高估”的最佳解毒剂。如果说我在过去四年投资高增长SaaS/云股票中学到了一件事，那就是继续投资于那些维持（或者最好是加速）营收增长的公司，并退出那些放缓的股票。这听起来非常简单，当然，许多其他因素在股票的长期收益中发挥着作用，但收入增长及其耐力在过去一直是主要因素。</blockquote></p><p> This pull-back is far from the worst I have seen in recent years. But it is still painful – and when it starts to hurt, it is usually a good time to buy some quality companies.</p><p><blockquote>这次回调远不是我近年来见过的最糟糕的。但它仍然是痛苦的——当它开始痛苦时，通常是购买一些优质公司的好时机。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 High Growth Stocks To Buy In The Pullback<blockquote>回调中值得买入的3只高增长股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 High Growth Stocks To Buy In The Pullback<blockquote>回调中值得买入的3只高增长股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Seeking Alpha</strong><span class=\"h-time small\">2021-12-03 23:08</span>\n</p>\n</h4>\n</header>\n<article>\n<p><b>Summary</b></p><p><blockquote><b>总结</b></blockquote></p><p> <ul>  <li>Upstart has fallen more than 50% from its highs. But its last earnings report wasn't that bad. The story is still intact and shares have derisked considerably.</li>  <li>Zscaler continues to impress with recent results showing accelerated growth again. The shares went up immediately after the report but reversed down in the general wash out.</li>  <li>Monday.com is a fairly new company and it also got hit by the market. Its high growth profile, rapidly improving profitability, and reasonable valuation makes it an interesting stock pick.</li> </ul> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2aac50f1e4e4115b0d38a5ec6c15c267\" tg-width=\"1536\" tg-height=\"1139\" width=\"100%\" height=\"auto\"><span>Galeanu Mihai/iStock via Getty Images</span></p><p><blockquote><ul><li>Upstart已较高点下跌超过50%。但其上一份收益报告并没有那么糟糕。故事仍然完好无损，股价已大幅下降。</li><li>Zscaler继续给人留下深刻印象，最近的业绩再次显示加速增长。报告发布后，该股立即上涨，但在普遍下跌中逆转下跌。</li><li>Monday.com是一家相当新的公司，它也受到了市场的冲击。其高增长、快速提高的盈利能力和合理的估值使其成为一个有趣的股票选择。</li></ul><p class=\"t-img-caption\"><span>Galeanu Mihai/iStock来自Getty Images</span></p></blockquote></p><p> I started writing this article one week ago with the goal to review Upstart's recent quarterly results. Since in my&nbsp;last article, I argued that Upstart (UPST) might still be an attractive buying opportunity at $390 a share, I wanted to check on the company (currently trading around $180 –<i>yikes!</i>).</p><p><blockquote>我一周前开始写这篇文章，目的是回顾Upstart最近的季度业绩。由于在我的上一篇文章中，我认为Upstart(UPST)可能仍然是每股390美元的有吸引力的买入机会，因此我想检查一下该公司（目前交易价格约为180美元-<i>呀！</i>).</blockquote></p><p> However, the recent market sell-off, especially in high-growth names, made me reconsider the direction of the article. I think it is much more interesting right now to write about some high-growth names in my portfolio that I am considering adding during this little downturn.</p><p><blockquote>然而，最近的市场抛售，尤其是高增长股票的抛售，让我重新考虑了文章的方向。我认为现在写一些我的投资组合中的高增长股票更有趣，我正在考虑在这次小衰退期间添加这些股票。</blockquote></p><p> A little caveat upfront, though. I am really bad at short-term calls (as evidenced by my recent Upstart article). I have no idea what the Omicron variant will do to our economy, what the Fed's monetary policy will be in the future and how far this sell-off will go eventually. By the time this article is published, the sell-off might already have reversed. Or it might have gotten much worse. I simply don't know.</p><p><blockquote>不过，提前有一点警告。我真的不擅长短期评级（正如我最近的新贵文章所证明的那样）。我不知道奥密克戎变体会对我们的经济产生什么影响，美联储未来的货币政策会是什么，也不知道这次抛售最终会走多远。当本文发表时，抛售可能已经逆转。或者情况可能会变得更糟。我就是不知道。</blockquote></p><p> What I do know is that there are companies in the public markets with exceptional business fundamentals that&nbsp;<b>will do very well regardless of the macro environment</b>. These are businesses with high growth rates, high margins, and long runways of growth. They also have high valuation multiples which lead to increased risk and high volatility. Taking advantage of that volatility is a great way to increase your returns. Here are some stocks that I consider buying right now:</p><p><blockquote>我所知道的是，公开市场上有些公司拥有出色的业务基本面<b>无论宏观环境如何，都会做得很好</b>这些业务具有高增长率、高利润率和长期增长。它们的估值倍数也很高，这导致风险增加和波动性高。利用这种波动性是增加回报的好方法。以下是我现在考虑购买的一些股票：</blockquote></p><p> <b>Upstart</b></p><p><blockquote><b>暴发户</b></blockquote></p><p> Let's start with the one I originally wanted to write about: To summarize shortly, I think that if you liked Upstart at $390, you should like it much more at $180. The earnings release for Q3 2021 was not as bad as the market's reaction might suggest. Yes, expectations were lofty based on an exceptional Q2 report, and yes, these expectations were not entirely met in Q3. But that does not mean that the fundamental picture has deteriorated. What the wild price swings of the past prove, and I have written about in the past, is that this young company is difficult to value. Growth is high, but also hard to predict. And while the disruption of the FICO score through AI technology is enticing and seems inevitable, Upstart's role in that story is not set in stone.</p><p><blockquote>让我们从我最初想写的一个开始：简单总结一下，我认为如果你喜欢390美元的Upstart，你应该更喜欢180美元的Upstart。2021年第三季度的财报发布并不像市场反应所暗示的那么糟糕。是的，基于出色的第二季度报告，人们的期望很高，是的，这些期望在第三季度并没有完全实现。但这并不意味着基本面已经恶化。过去的剧烈价格波动证明，我过去也写过，这家年轻的公司很难估值。增长很高，但也很难预测。虽然人工智能技术对FICO分数的破坏很诱人，而且似乎不可避免，但Upstart在这个故事中的角色并不是一成不变的。</blockquote></p><p> Let's look at some numbers:</p><p><blockquote>我们来看一些数字：</blockquote></p><p> <img src=\"https://static.tigerbbs.com/7b085c5134a9e376f177da8f5fa2674e\" tg-width=\"640\" tg-height=\"309\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b826680751b139c569c90d0d3be483cf\" tg-width=\"640\" tg-height=\"163\" width=\"100%\" height=\"auto\"><span>Source: Author</span></p><p><blockquote><p class=\"t-img-caption\"><span>来源：作者</span></p></blockquote></p><p> As you can see, revenue growth is still explosive, and with a normal beat should accelerate again into Q4 on a sequential basis. And while most key performance indicators (loans transacted, conversion rate, percentage of automated loans) together with&nbsp;margins&nbsp;all decelerated or went down slightly, I don't think that this means the fundamentals have changed with this company. There were many details mentioned in the&nbsp;earnings call&nbsp;that I won't discuss in this article format. But the key takeaway for me was that management seemed very upbeat about the future of the company.</p><p><blockquote>正如您所看到的，收入增长仍然是爆炸性的，按照正常的节奏，第四季度应该会再次加速。虽然大多数关键绩效指标（交易贷款、转化率、自动贷款百分比）以及利润率都减速或略有下降，但我不认为这意味着这家公司的基本面发生了变化。收益看涨期权中提到了许多细节，我不会在本文中讨论。但对我来说，关键的收获是管理层似乎对公司的未来非常乐观。</blockquote></p><p> I think there are two key mistakes that investors should avoid here:</p><p><blockquote>我认为投资者在这里应该避免两个关键错误：</blockquote></p><p></p><p> <ol>  <li>Let the disappointment of a \"not-so-blowout\" quarter and a devastating price action make you blind to this investment opportunity. This was still a very good quarter and now that the shares have fallen off a cliff the stock is much more attractive.</li>  <li>Do not look at Upstart through the lens of SaaS businesses. As I wrote in&nbsp;May:<i>Upstart might be a high-promising cloud software company but it does not have a SaaS business model. There is</i>&nbsp;<i><b>no recurring revenue</b></i>&nbsp;<i>to fall back on in tough times, no sticky subscription customers, no backlog, no land and expand. Every quarter Upstart has to sell new loans, and revenue basically starts from zero.</i></li> </ol> Upstart's financials are lumpier and less reliable and as a result, the company deserves much more investor attention and a lower valuation multiple than high growth companies with recurring revenues. However, if growth stays very high, it could more than make up for that fact. Currently, the company is trading at a 17.76 forward EV/S, which I think is a relative bargain for a company with this growth and margin profile.</p><p><blockquote><ol><li>让“不那么井喷”的季度的失望和毁灭性的价格走势让你对这个投资机会视而不见。这仍然是一个非常好的季度，现在股价已经断崖式下跌，该股更具吸引力。</li><li>不要通过SaaS企业的视角来看待Upstart。正如我在五月份所写的：<i>Upstart可能是一家很有前途的云软件公司，但它没有SaaS商业模式。有</i> <i><b>无经常性收入</b></i> <i>在困难时期可以依靠，没有粘性订阅客户，没有积压，没有土地和扩张。每个季度Upstart都要出售新贷款，营收基本从零开始。</i></li></ol>Upstart的财务状况更加不稳定且不太可靠，因此，与具有经常性收入的高增长公司相比，该公司值得投资者更多关注，估值倍数也更低。然而，如果增长保持在很高的水平，它就足以弥补这一事实。目前，该公司的远期EV/S交易价格为17.76，我认为对于具有这种增长和利润率的公司来说，这是相对便宜的。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/15592919228dec8ee2403898d69ef228\" tg-width=\"635\" tg-height=\"417\" width=\"100%\" height=\"auto\"><span>Data by YCharts</span></p><p><blockquote><p class=\"t-img-caption\"><span>数据来自YCharts</span></p></blockquote></p><p> <b>Zscaler</b></p><p><blockquote><b>Zscaler</b></blockquote></p><p> Sometimes the market gives you a gift that you should not refuse. This is what happened with Zscaler (ZS) yesterday. The&nbsp;stock initially was up&nbsp;in the postmarket after the company reported another&nbsp;blow-out quarter&nbsp;on Tuesday. But on Wednesday it all didn't matter anymore and thanks to the little correction, sector rotation, or whatever you want to call it, the stock actually went&nbsp;<b>down by more than 8%</b>. This is really a time when you want to buy: You just got confirmation that your company is doing incredibly well with growth accelerating and the stock sells off for macro concerns. The stock is definitely not cheap at a forward EV/S of 43.51 and, of course, this \"pull-back\" is laughable (<i>\"oh my god, the stock is back to where it was...one month ago\"</i>).</p><p><blockquote>有时候市场会给你一份你不应该拒绝的礼物。这就是Zscaler(ZS)昨天发生的情况。在该公司周二公布另一个井喷季度后，该股最初在盘后市场上涨。但到了周三，这一切都不再重要了，由于小幅调整、行业轮换或任何你想看涨期权的东西，该股实际上上涨了<b>跌幅超过8%</b>.这确实是你想买入的时候：你刚刚得到确认，你的公司表现非常好，增长加速，股票因宏观担忧而遭到抛售。该股的远期EV/S为43.51，绝对不便宜，当然，这种“回调”是可笑的（<i>“天哪，股票又回到了……一个月前”</i>).</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e79ff3fce3101896f17b65ced143c037\" tg-width=\"635\" tg-height=\"433\" width=\"100%\" height=\"auto\"><span>Data by YCharts</span></p><p><blockquote><p class=\"t-img-caption\"><span>数据来自YCharts</span></p></blockquote></p><p> But I like to own companies that are doing exceptional things and I don't mind paying up for them, especially in a turbulent market.</p><p><blockquote>但我喜欢拥有那些做着非凡事情的公司，我不介意为它们买单，尤其是在动荡的市场中。</blockquote></p><p> How exceptional is Zscaler? Just look at those revenue growth numbers:</p><p><blockquote>Zscaler有多特别？看看这些收入增长数字就知道了：</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3def4410c8c903a03041a2cd51b36979\" tg-width=\"640\" tg-height=\"386\" width=\"100%\" height=\"auto\"><span>Source: Author.</span></p><p><blockquote><p class=\"t-img-caption\"><span>来源：作者。</span></p></blockquote></p><p> I&nbsp;thought&nbsp;in May that growth acceleration might end soon, but it has continued to accelerate in Q1 2022. If the company beats its guidance in Q2 in a similar fashion to the past (usually more than 5%), it should accelerate year-on-year growth again in Q2 (or at least maintain the current 60%+ growth rate). On top of that, this quarter saw&nbsp;<b>RPO growing 98%, a dollar-based net retention rate of 125%, and FCF margins of 36%</b>. In other words, this business is firing on all cylinders. If you don't know what Zscaler does,read my article from December 2018&nbsp;– the stock is up 710% since then, and I think it can go even higher.</p><p><blockquote>我在5月份认为增长加速可能很快就会结束，但在2022年第一季度继续加速。如果该公司在第二季度的表现与过去类似（通常超过5%），那么它应该会在第二季度再次加速同比增长（或至少保持目前60%以上的增长率）。最重要的是，本季度<b>RPO增长98%，以美元计算的净保留率为125%，FCF利润率为36%</b>换句话说，这项业务正在全速运转。如果您不知道Zscaler是做什么的，请阅读我2018年12月的文章——自那时以来，该股已上涨710%，我认为它还可以走得更高。</blockquote></p><p> <b>Monday.com</b></p><p><blockquote><b>周一网</b></blockquote></p><p> Monday.com (MNDY) is a company that is a relatively new stock in the public markets (it IPOed in June this year) and a completely new stock in my portfolio (I just bought my first position). In a nutshell, the reason why I bought Monday.com is their hyper-growth and rapidly improving profitability. Just look at these two slides from the most recent earnings call presentation:</p><p><blockquote>Monday.com(MNDY)是一家在公开市场上相对较新的股票（今年6月首次公开募股），也是我投资组合中的一只全新股票（我刚刚购买了我的第一个头寸）。简而言之，我购买Monday.com的原因是他们的高速增长和盈利能力的快速提高。看看看涨期权最新财报演示中的这两张幻灯片即可：</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/c5b07658237c02685eb3d049a537ba61\" tg-width=\"640\" tg-height=\"727\" width=\"100%\" height=\"auto\"><span>Source: Earnings call presentation Q3 2021.</span></p><p><blockquote><p class=\"t-img-caption\"><span>资料来源：看涨期权2021年第三季度收益演示。</span></p></blockquote></p><p> Revenue was&nbsp;<b>up 95%</b>(up from 94% in the last quarter). This is quite astounding growth which indicates that this company is winning in the market (but also consider that the company is at a small annual revenue run rate, which makes it a bit easier). The number of enterprise customerswith more than $50K ARRwas&nbsp;<b>up 231%</b>(at 613, up from 185 a year ago). Monday was also&nbsp;<b>cash flow positive</b>&nbsp;for the first time this quarter.</p><p><blockquote>收入为<b>上涨95%</b>（高于上季度的94%）。这是相当惊人的增长，表明该公司正在市场上获胜（但也考虑到该公司的年收入运行率很小，这使得它变得更容易）。ARRs超过5万美元的企业客户数量为<b>上涨231%</b>（为613，高于一年前的185）。星期一也是<b>现金流为正</b>本季度首次。</blockquote></p><p> On top of that, it is also cheap relative to other cloud stocks:</p><p><blockquote>最重要的是，相对于其他云股票，它也很便宜：</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/80e6afbf54bdde4ad31dd3aaa06d0073\" tg-width=\"640\" tg-height=\"368\" width=\"100%\" height=\"auto\"><span>Source: Clouded Judgement 11.26.21.</span></p><p><blockquote><p class=\"t-img-caption\"><span>资料来源：阴云密布的判断11.26.21。</span></p></blockquote></p><p></p><p> The company currently has a TTM EV/S of 57, and a 2022 EV/S of 38.7, based on analysts' expectation of 47% growth in 2022. That seems rich but not terribly so relative to other cloud names. The growth expectation of 47% in 2022, however, seems quite low if you consider the current growth of 95% year-on-year and 17% sequentially, plus the current momentum in larger customers. Actually, anything below 70% growth in FY 2022 would come as a surprise to me, and then we are looking at a maximum forward EV/S of 33.</p><p><blockquote>根据分析师对2022年增长47%的预期，该公司目前的TTM EV/S为57，2022年EV/S为38.7。这看起来很丰富，但相对于其他云的名称来说并不那么丰富。然而，如果考虑到目前95%的同比增长和17%的环比增长，再加上目前较大客户的势头，2022年47%的增长预期似乎相当低。事实上，2022财年任何低于70%的增长都会让我感到惊讶，然后我们预计最大远期EV/S为33。</blockquote></p><p> The big question going forward – in terms of if Monday.com will be a good long-term investment – is to which extent Monday.com can maintain its high growth rate beyond FY 2022. Here I do have some doubts still. The company is operating in a very dynamic and competitive field and I am not yet sure where Monday differentiates itself meaningfully from companies like Asana (ASAN) or Atlassian (TEAM). Still, the market for cloud-based work management solutions is big and there can be many winners in the space. For the moment I'm happy to follow the numbers (which look fantastic) and hope that the relatively cheap valuation will result in substantial alpha and is not an indication of a lower quality company.</p><p><blockquote>未来的大问题——就Monday.com是否会成为一项良好的长期投资而言——是Monday.com能够在2022财年之后在多大程度上保持其高增长率。在这里，我仍然有一些疑问。该公司在一个充满活力和竞争激烈的领域运营，我还不确定Monday与Asana(ASAN)或Atlassian(TEAM)等公司有何显著区别。尽管如此，基于云的工作管理解决方案的市场很大，这个领域可能会有许多赢家。目前，我很高兴关注这些数字（看起来很棒），并希望相对便宜的估值将带来可观的阿尔法，而不是表明公司质量较低。</blockquote></p><p> <b>Closing Thoughts And Honorary Mentions</b></p><p><blockquote><b>结束语和荣誉奖</b></blockquote></p><p> On days like these, there are many companies worth considering. For example, I haven't mentioned Datadog (DDOG) which&nbsp;reported another fantastic quarter&nbsp;at the beginning of November. Like Zscaler, this is also a company with accelerating growth that you can buy at a lower price than it was before it reported its blowout results.</p><p><blockquote>在这样的日子里，有很多公司值得考虑。例如，我没有提到Datadog(DDOG)，它在11月初报告了另一个出色的季度业绩。与Zscaler一样，这也是一家正在加速增长的公司，您可以以比报告井喷业绩之前更低的价格购买。</blockquote></p><p> Remember that the stocks mentioned, even though they may look attractive from a relative perspective, are still very expensive in absolute terms and from a historical perspective. However, sustainable growth is a beautiful form of downside protection for investors and the best antidote to \"overvaluation\" that I know. If I learned one thing in the last four years investing in high-growth SaaS/cloud stocks, it is to stay invested in the companies that sustain (or preferably accelerate) their top-line growth and get out of the stocks that see slowdowns. That sounds terribly simplistic and of course, many other factors play a role in a stock's long-term gains, but revenue growth and its&nbsp;endurance&nbsp;have been the predominant factors in the past.</p><p><blockquote>请记住，所提到的股票，尽管从相对角度来看它们可能看起来很有吸引力，但从绝对值和历史角度来看仍然非常昂贵。然而，可持续增长对投资者来说是一种美丽的下行保护形式，也是我所知道的“高估”的最佳解毒剂。如果说我在过去四年投资高增长SaaS/云股票中学到了一件事，那就是继续投资于那些维持（或者最好是加速）营收增长的公司，并退出那些放缓的股票。这听起来非常简单，当然，许多其他因素在股票的长期收益中发挥着作用，但收入增长及其耐力在过去一直是主要因素。</blockquote></p><p> This pull-back is far from the worst I have seen in recent years. But it is still painful – and when it starts to hurt, it is usually a good time to buy some quality companies.</p><p><blockquote>这次回调远不是我近年来见过的最糟糕的。但它仍然是痛苦的——当它开始痛苦时，通常是购买一些优质公司的好时机。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://seekingalpha.com/article/4473014-3-high-growth-stocks-to-buy-in-the-pullback\">Seeking Alpha</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UPST":"Upstart Holdings, Inc.","ZS":"Zscaler Inc.","MNDY":"Monday.com Ltd."},"source_url":"https://seekingalpha.com/article/4473014-3-high-growth-stocks-to-buy-in-the-pullback","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1115344844","content_text":"Summary\n\nUpstart has fallen more than 50% from its highs. But its last earnings report wasn't that bad. The story is still intact and shares have derisked considerably.\nZscaler continues to impress with recent results showing accelerated growth again. The shares went up immediately after the report but reversed down in the general wash out.\nMonday.com is a fairly new company and it also got hit by the market. Its high growth profile, rapidly improving profitability, and reasonable valuation makes it an interesting stock pick.\n\nGaleanu Mihai/iStock via Getty Images\nI started writing this article one week ago with the goal to review Upstart's recent quarterly results. Since in my last article, I argued that Upstart (UPST) might still be an attractive buying opportunity at $390 a share, I wanted to check on the company (currently trading around $180 –yikes!).\nHowever, the recent market sell-off, especially in high-growth names, made me reconsider the direction of the article. I think it is much more interesting right now to write about some high-growth names in my portfolio that I am considering adding during this little downturn.\nA little caveat upfront, though. I am really bad at short-term calls (as evidenced by my recent Upstart article). I have no idea what the Omicron variant will do to our economy, what the Fed's monetary policy will be in the future and how far this sell-off will go eventually. By the time this article is published, the sell-off might already have reversed. Or it might have gotten much worse. I simply don't know.\nWhat I do know is that there are companies in the public markets with exceptional business fundamentals that will do very well regardless of the macro environment. These are businesses with high growth rates, high margins, and long runways of growth. They also have high valuation multiples which lead to increased risk and high volatility. Taking advantage of that volatility is a great way to increase your returns. Here are some stocks that I consider buying right now:\nUpstart\nLet's start with the one I originally wanted to write about: To summarize shortly, I think that if you liked Upstart at $390, you should like it much more at $180. The earnings release for Q3 2021 was not as bad as the market's reaction might suggest. Yes, expectations were lofty based on an exceptional Q2 report, and yes, these expectations were not entirely met in Q3. But that does not mean that the fundamental picture has deteriorated. What the wild price swings of the past prove, and I have written about in the past, is that this young company is difficult to value. Growth is high, but also hard to predict. And while the disruption of the FICO score through AI technology is enticing and seems inevitable, Upstart's role in that story is not set in stone.\nLet's look at some numbers:\n\nSource: Author\nAs you can see, revenue growth is still explosive, and with a normal beat should accelerate again into Q4 on a sequential basis. And while most key performance indicators (loans transacted, conversion rate, percentage of automated loans) together with margins all decelerated or went down slightly, I don't think that this means the fundamentals have changed with this company. There were many details mentioned in the earnings call that I won't discuss in this article format. But the key takeaway for me was that management seemed very upbeat about the future of the company.\nI think there are two key mistakes that investors should avoid here:\n\nLet the disappointment of a \"not-so-blowout\" quarter and a devastating price action make you blind to this investment opportunity. This was still a very good quarter and now that the shares have fallen off a cliff the stock is much more attractive.\nDo not look at Upstart through the lens of SaaS businesses. As I wrote in May:Upstart might be a high-promising cloud software company but it does not have a SaaS business model. There is no recurring revenue to fall back on in tough times, no sticky subscription customers, no backlog, no land and expand. Every quarter Upstart has to sell new loans, and revenue basically starts from zero.\n\nUpstart's financials are lumpier and less reliable and as a result, the company deserves much more investor attention and a lower valuation multiple than high growth companies with recurring revenues. However, if growth stays very high, it could more than make up for that fact. Currently, the company is trading at a 17.76 forward EV/S, which I think is a relative bargain for a company with this growth and margin profile.\nData by YCharts\nZscaler\nSometimes the market gives you a gift that you should not refuse. This is what happened with Zscaler (ZS) yesterday. The stock initially was up in the postmarket after the company reported another blow-out quarter on Tuesday. But on Wednesday it all didn't matter anymore and thanks to the little correction, sector rotation, or whatever you want to call it, the stock actually went down by more than 8%. This is really a time when you want to buy: You just got confirmation that your company is doing incredibly well with growth accelerating and the stock sells off for macro concerns. The stock is definitely not cheap at a forward EV/S of 43.51 and, of course, this \"pull-back\" is laughable (\"oh my god, the stock is back to where it was...one month ago\").\nData by YCharts\nBut I like to own companies that are doing exceptional things and I don't mind paying up for them, especially in a turbulent market.\nHow exceptional is Zscaler? Just look at those revenue growth numbers:\nSource: Author.\nI thought in May that growth acceleration might end soon, but it has continued to accelerate in Q1 2022. If the company beats its guidance in Q2 in a similar fashion to the past (usually more than 5%), it should accelerate year-on-year growth again in Q2 (or at least maintain the current 60%+ growth rate). On top of that, this quarter saw RPO growing 98%, a dollar-based net retention rate of 125%, and FCF margins of 36%. In other words, this business is firing on all cylinders. If you don't know what Zscaler does,read my article from December 2018 – the stock is up 710% since then, and I think it can go even higher.\nMonday.com\nMonday.com (MNDY) is a company that is a relatively new stock in the public markets (it IPOed in June this year) and a completely new stock in my portfolio (I just bought my first position). In a nutshell, the reason why I bought Monday.com is their hyper-growth and rapidly improving profitability. Just look at these two slides from the most recent earnings call presentation:\nSource: Earnings call presentation Q3 2021.\nRevenue was up 95%(up from 94% in the last quarter). This is quite astounding growth which indicates that this company is winning in the market (but also consider that the company is at a small annual revenue run rate, which makes it a bit easier). The number of enterprise customerswith more than $50K ARRwas up 231%(at 613, up from 185 a year ago). Monday was also cash flow positive for the first time this quarter.\nOn top of that, it is also cheap relative to other cloud stocks:\nSource: Clouded Judgement 11.26.21.\nThe company currently has a TTM EV/S of 57, and a 2022 EV/S of 38.7, based on analysts' expectation of 47% growth in 2022. That seems rich but not terribly so relative to other cloud names. The growth expectation of 47% in 2022, however, seems quite low if you consider the current growth of 95% year-on-year and 17% sequentially, plus the current momentum in larger customers. Actually, anything below 70% growth in FY 2022 would come as a surprise to me, and then we are looking at a maximum forward EV/S of 33.\nThe big question going forward – in terms of if Monday.com will be a good long-term investment – is to which extent Monday.com can maintain its high growth rate beyond FY 2022. Here I do have some doubts still. The company is operating in a very dynamic and competitive field and I am not yet sure where Monday differentiates itself meaningfully from companies like Asana (ASAN) or Atlassian (TEAM). Still, the market for cloud-based work management solutions is big and there can be many winners in the space. For the moment I'm happy to follow the numbers (which look fantastic) and hope that the relatively cheap valuation will result in substantial alpha and is not an indication of a lower quality company.\nClosing Thoughts And Honorary Mentions\nOn days like these, there are many companies worth considering. For example, I haven't mentioned Datadog (DDOG) which reported another fantastic quarter at the beginning of November. Like Zscaler, this is also a company with accelerating growth that you can buy at a lower price than it was before it reported its blowout results.\nRemember that the stocks mentioned, even though they may look attractive from a relative perspective, are still very expensive in absolute terms and from a historical perspective. However, sustainable growth is a beautiful form of downside protection for investors and the best antidote to \"overvaluation\" that I know. If I learned one thing in the last four years investing in high-growth SaaS/cloud stocks, it is to stay invested in the companies that sustain (or preferably accelerate) their top-line growth and get out of the stocks that see slowdowns. That sounds terribly simplistic and of course, many other factors play a role in a stock's long-term gains, but revenue growth and its endurance have been the predominant factors in the past.\nThis pull-back is far from the worst I have seen in recent years. But it is still painful – and when it starts to hurt, it is usually a good time to buy some quality companies.","news_type":1,"symbols_score_info":{"UPST":0.9,"MNDY":0.9,"ZS":0.9}},"isVote":1,"tweetType":1,"viewCount":783,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601112905,"gmtCreate":1638497389584,"gmtModify":1638497389701,"author":{"id":"4087514122562540","authorId":"4087514122562540","name":"74809e5c","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087514122562540","authorIdStr":"4087514122562540"},"themes":[],"htmlText":"👌","listText":"👌","text":"👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/601112905","repostId":"1119529609","repostType":4,"isVote":1,"tweetType":1,"viewCount":791,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603527612,"gmtCreate":1638430998605,"gmtModify":1638430998995,"author":{"id":"4087514122562540","authorId":"4087514122562540","name":"74809e5c","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087514122562540","authorIdStr":"4087514122562540"},"themes":[],"htmlText":"👌","listText":"👌","text":"👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603527612","repostId":"1187737792","repostType":4,"repost":{"id":"1187737792","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1638429050,"share":"https://www.laohu8.com/m/news/1187737792?lang=zh_CN&edition=full","pubTime":"2021-12-02 15:10","market":"us","language":"en","title":"What Happened To AMC Entertainment's Stock And When Will It Recover? A Technical Analysis<blockquote>AMC院线的股票怎么了，什么时候才能恢复？技术分析</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1187737792","media":"Benzinga","summary":"AMC Entertainment Holdings Inc. shares are trading lower Wednesday, as concerns over COVID-19 varian","content":"<p><b>AMC Entertainment Holdings Inc.</b>&nbsp;shares are trading lower Wednesday, as concerns over COVID-19 variant omicron weighs on the outlook for theater traffic in the future. Shutdowns in theaters in the beginning of 2020 could continue if the omicron variant extends the pandemic.</p><p><blockquote><b>AMC院线控股公司。</b>由于对COVID-19变种奥密克戎的担忧影响了未来影院客流量的前景，周三股价走低。如果奥密克戎变种延长疫情，2020年初影院的关闭可能会继续。</blockquote></p><p> AMC Entertainment closed down 15.8% at $28.57.</p><p><blockquote>AMC院线收跌15.8%，报28.57美元。</blockquote></p><p> <b>AMC Entertainment Daily Chart Analysis</b></p><p><blockquote><b>AMC院线日线图分析</b></blockquote></p><p> <ul>  <li>The stock has fallen below support in what technical traders call a pennant pattern.</li>  <li>The stock was seeing condensed highs and lows and neared the end of the pennant pattern looking for a breakout, but fell below pattern support seeing a strong bearish move.</li>  <li>The stock trades below the 50-day moving average (green) and fell below the 200-day moving average (blue) Wednesday, indicating the sentiment in the stock looks to be turning more bearish.</li>  <li>Each of these moving averages may hold as an area of resistance in the future.</li>  <li>The Relative Strength Index (RSI) saw a steep drop off and pushed down to 25 on the level Wednesday. This shows the stock is now in the oversold range and is seeing much more selling pressure than buying pressure.</li> </ul> <img src=\"https://static.tigerbbs.com/e5dad36850a74a6c9fbdda0d9c7d68f4\" tg-width=\"2400\" tg-height=\"1236\" width=\"100%\" height=\"auto\"></p><p><blockquote><ul><li>该股已跌破技术交易员看涨期权三角旗形态的支撑位。</li><li>该股出现了浓缩的高点和低点，并接近三角旗形态的末端寻求突破，但跌破形态支撑，出现了强劲的看跌走势。</li><li>该股周三交易价格低于50日移动平均线（绿色），并跌破200日移动平均线（蓝色），表明该股的情绪似乎变得更加看跌。</li><li>这些移动平均线中的每一条都可能在未来成为阻力区域。</li><li>相对强弱指数（RSI）大幅下跌，周三跌至25。这表明该股目前处于超卖区间，抛售压力远大于买入压力。</li></ul></blockquote></p><p> <b>What’s Next For AMC Entertainment?</b></p><p><blockquote><b>AMC院线的下一步是什么？</b></blockquote></p><p> Bullish traders want AMC to bounce and start to head higher while being able to form higher lows. Higher lows are key in showing the stock is ready to turnaround and start to move higher once again. Bulls also want to see the price cross back above the moving averages for the sentiment to turn bullish once again.</p><p><blockquote>看涨交易者希望AMC反弹并开始走高，同时能够形成更高的低点。较高的低点是表明该股已准备好扭亏为盈并开始再次走高的关键。多头还希望看到价格回到移动平均线上方，以便情绪再次转向看涨。</blockquote></p><p> Bearish traders look to have taken control of the stock after the drop below the pattern support and the moving averages. The drop below the moving averages shows a bearish sentiment beginning in the stock. If the stock can hold below the pattern support and the moving averages, bears can maintain a hold on the stock.</p><p><blockquote>在跌破形态支撑位和移动平均线后，看跌交易者似乎已经控制了该股。跌破移动平均线表明该股开始出现看跌情绪。如果该股能够保持在形态支撑和移动平均线以下，空头可以持有该股。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What Happened To AMC Entertainment's Stock And When Will It Recover? A Technical Analysis<blockquote>AMC院线的股票怎么了，什么时候才能恢复？技术分析</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat Happened To AMC Entertainment's Stock And When Will It Recover? A Technical Analysis<blockquote>AMC院线的股票怎么了，什么时候才能恢复？技术分析</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time smaller\">2021-12-02 15:10</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p><b>AMC Entertainment Holdings Inc.</b>&nbsp;shares are trading lower Wednesday, as concerns over COVID-19 variant omicron weighs on the outlook for theater traffic in the future. Shutdowns in theaters in the beginning of 2020 could continue if the omicron variant extends the pandemic.</p><p><blockquote><b>AMC院线控股公司。</b>由于对COVID-19变种奥密克戎的担忧影响了未来影院客流量的前景，周三股价走低。如果奥密克戎变种延长疫情，2020年初影院的关闭可能会继续。</blockquote></p><p> AMC Entertainment closed down 15.8% at $28.57.</p><p><blockquote>AMC院线收跌15.8%，报28.57美元。</blockquote></p><p> <b>AMC Entertainment Daily Chart Analysis</b></p><p><blockquote><b>AMC院线日线图分析</b></blockquote></p><p> <ul>  <li>The stock has fallen below support in what technical traders call a pennant pattern.</li>  <li>The stock was seeing condensed highs and lows and neared the end of the pennant pattern looking for a breakout, but fell below pattern support seeing a strong bearish move.</li>  <li>The stock trades below the 50-day moving average (green) and fell below the 200-day moving average (blue) Wednesday, indicating the sentiment in the stock looks to be turning more bearish.</li>  <li>Each of these moving averages may hold as an area of resistance in the future.</li>  <li>The Relative Strength Index (RSI) saw a steep drop off and pushed down to 25 on the level Wednesday. This shows the stock is now in the oversold range and is seeing much more selling pressure than buying pressure.</li> </ul> <img src=\"https://static.tigerbbs.com/e5dad36850a74a6c9fbdda0d9c7d68f4\" tg-width=\"2400\" tg-height=\"1236\" width=\"100%\" height=\"auto\"></p><p><blockquote><ul><li>该股已跌破技术交易员看涨期权三角旗形态的支撑位。</li><li>该股出现了浓缩的高点和低点，并接近三角旗形态的末端寻求突破，但跌破形态支撑，出现了强劲的看跌走势。</li><li>该股周三交易价格低于50日移动平均线（绿色），并跌破200日移动平均线（蓝色），表明该股的情绪似乎变得更加看跌。</li><li>这些移动平均线中的每一条都可能在未来成为阻力区域。</li><li>相对强弱指数（RSI）大幅下跌，周三跌至25。这表明该股目前处于超卖区间，抛售压力远大于买入压力。</li></ul></blockquote></p><p> <b>What’s Next For AMC Entertainment?</b></p><p><blockquote><b>AMC院线的下一步是什么？</b></blockquote></p><p> Bullish traders want AMC to bounce and start to head higher while being able to form higher lows. Higher lows are key in showing the stock is ready to turnaround and start to move higher once again. Bulls also want to see the price cross back above the moving averages for the sentiment to turn bullish once again.</p><p><blockquote>看涨交易者希望AMC反弹并开始走高，同时能够形成更高的低点。较高的低点是表明该股已准备好扭亏为盈并开始再次走高的关键。多头还希望看到价格回到移动平均线上方，以便情绪再次转向看涨。</blockquote></p><p> Bearish traders look to have taken control of the stock after the drop below the pattern support and the moving averages. The drop below the moving averages shows a bearish sentiment beginning in the stock. If the stock can hold below the pattern support and the moving averages, bears can maintain a hold on the stock.</p><p><blockquote>在跌破形态支撑位和移动平均线后，看跌交易者似乎已经控制了该股。跌破移动平均线表明该股开始出现看跌情绪。如果该股能够保持在形态支撑和移动平均线以下，空头可以持有该股。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1187737792","content_text":"AMC Entertainment Holdings Inc. shares are trading lower Wednesday, as concerns over COVID-19 variant omicron weighs on the outlook for theater traffic in the future. Shutdowns in theaters in the beginning of 2020 could continue if the omicron variant extends the pandemic.\nAMC Entertainment closed down 15.8% at $28.57.\nAMC Entertainment Daily Chart Analysis\n\nThe stock has fallen below support in what technical traders call a pennant pattern.\nThe stock was seeing condensed highs and lows and neared the end of the pennant pattern looking for a breakout, but fell below pattern support seeing a strong bearish move.\nThe stock trades below the 50-day moving average (green) and fell below the 200-day moving average (blue) Wednesday, indicating the sentiment in the stock looks to be turning more bearish.\nEach of these moving averages may hold as an area of resistance in the future.\nThe Relative Strength Index (RSI) saw a steep drop off and pushed down to 25 on the level Wednesday. This shows the stock is now in the oversold range and is seeing much more selling pressure than buying pressure.\n\n\nWhat’s Next For AMC Entertainment?\nBullish traders want AMC to bounce and start to head higher while being able to form higher lows. Higher lows are key in showing the stock is ready to turnaround and start to move higher once again. Bulls also want to see the price cross back above the moving averages for the sentiment to turn bullish once again.\nBearish traders look to have taken control of the stock after the drop below the pattern support and the moving averages. The drop below the moving averages shows a bearish sentiment beginning in the stock. If the stock can hold below the pattern support and the moving averages, bears can maintain a hold on the stock.","news_type":1,"symbols_score_info":{"AMC":0.9}},"isVote":1,"tweetType":1,"viewCount":701,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609607987,"gmtCreate":1638274104460,"gmtModify":1638274104603,"author":{"id":"4087514122562540","authorId":"4087514122562540","name":"74809e5c","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087514122562540","authorIdStr":"4087514122562540"},"themes":[],"htmlText":"👌","listText":"👌","text":"👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609607987","repostId":"1192203085","repostType":4,"repost":{"id":"1192203085","kind":"news","pubTimestamp":1638273550,"share":"https://www.laohu8.com/m/news/1192203085?lang=zh_CN&edition=full","pubTime":"2021-11-30 19:59","market":"us","language":"en","title":"Covid-19 Antibody Drugs Are Challenged by Omicron, Preliminary Testing Indicates<blockquote>新冠抗体药物受奥密克戎挑战初步检测显示</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1192203085","media":"The Wall Street Journal","summary":"Regeneron said its antibody drug cocktail was found to lose effectiveness against the new variant\nA ","content":"<p>Regeneron said its antibody drug cocktail was found to lose effectiveness against the new variant</p><p><blockquote>再生元表示，其抗体药物鸡尾酒被发现对新变种失去效力</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ed6086131617e6933fe07f3e46cd5c26\" tg-width=\"1290\" tg-height=\"859\" referrerpolicy=\"no-referrer\"><span>A monoclonal antibody treatment site in Pembroke Pines, Fla., earlier this year.</span></p><p><blockquote><p class=\"t-img-caption\"><span>今年早些时候，佛罗里达州彭布罗克派恩斯的一个单克隆抗体治疗点。</span></p></blockquote></p><p> Preliminary tests indicate the Covid-19 antibody drug cocktail from Regeneron Pharmaceuticals Inc. loses effectiveness against Omicron, the company said Tuesday, a sign that some products in an important class of therapies might need modifying if the new strain becomes widespread.</p><p><blockquote>再生元制药公司周二表示，初步测试表明，该公司的Covid-19抗体药物鸡尾酒对奥密克戎病毒失去了效力，这表明，如果新毒株广泛传播，一类重要疗法中的一些产品可能需要修改。</blockquote></p><p> Separate testing of another authorized Covid-19 antibody drug cocktail, from&nbsp;Eli Lilly&amp; Co., indicates it also isn’t as effective against Omicron, outside scientists said. Lilly said it is testing the new variant against its antibody treatment and wouldn’t speculate on what the results will be.</p><p><blockquote>外部科学家表示，对礼来公司(Eli Lilly&amp;Co.)的另一种授权的Covid-19抗体药物混合物进行的单独测试表明，它对奥密克戎病也没有那么有效。礼来公司表示，正在针对其抗体治疗测试新变种，但不愿猜测结果会是什么。</blockquote></p><p> The findings are the early results of researchers’ race to assess the impact of the&nbsp;new Omicron variant&nbsp;on Covid-19 treatments that patients, doctors and hospitals have been relying on, as well as pills in development that have promised to keep people out of the hospital.</p><p><blockquote>这些发现是研究人员竞相评估新的奥密克戎病毒变种对患者、医生和医院一直依赖的Covid-19治疗的影响的早期结果，以及正在开发的有望让人们远离医院的药物。</blockquote></p><p> Researchers say some antibody therapies are likely to be especially vulnerable to Omicron because it contains mutations to the spike protein that the Regeneron and Lilly drugs target, while other drugs should hold up well because they attack elements of the virus unchanged in the variant.</p><p><blockquote>研究人员表示，一些抗体疗法可能特别容易受到奥密克戎病毒的影响，因为它含有再生元和礼来药物所针对的刺突蛋白的突变，而其他药物应该表现良好，因为它们攻击的是变种中未改变的病毒元素。</blockquote></p><p> Monoclonal antibodies are lab-made molecules derived from survivors of Covid-19 or mice engineered to have human immune systems. When given soon after infection, the drugs attach to the surface of the coronavirus and prevent it from replicating itself in new cells.</p><p><blockquote>单克隆抗体是实验室制造的分子，来自新冠肺炎幸存者或被改造成具有人类免疫系统的小鼠。当感染后不久给药时，这些药物会附着在冠状病毒的表面，阻止它在新细胞中自我复制。</blockquote></p><p> They are the only drugs authorized to treat patients, before they require hospitalization, who are at high risk of developing severe cases.</p><p><blockquote>它们是唯一被授权在需要住院治疗患者之前治疗这些患者的药物，这些患者具有发展为严重病例的高风险。</blockquote></p><p> The drugs differ from vaccines, which train the immune system how to defend against the virus, including with the production of antibodies. Last year, former&nbsp;President Donald Trump credited Regeneron’s drug&nbsp;with his speedy recovery from Covid-19.</p><p><blockquote>这些药物不同于疫苗，疫苗训练免疫系统如何防御病毒，包括产生抗体。去年，前总统唐纳德·特朗普将他从Covid-19中迅速康复归功于再生元的药物。</blockquote></p><p> Regeneron said it would be able to quantify the impact of the variant in coming weeks, after further testing is done.</p><p><blockquote>再生元表示，在进行进一步测试后，它将能够在未来几周内量化该变体的影响。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6e7fac5c4630025e6c5ad28d2c3efbfa\" tg-width=\"1050\" tg-height=\"700\" referrerpolicy=\"no-referrer\"><span>Antiviral pills such as Pfizer’s Paxlovid appear to be unaffected by the variant.</span></p><p><blockquote><p class=\"t-img-caption\"><span>辉瑞公司的Paxlovid等抗病毒药物似乎不受该变种的影响。</span></p></blockquote></p><p> If final testing shows that its antibody drugs are less effective against Omicron, Regeneron has developed alternative antibodies that it can push into clinical testing and that it thinks will retain effectiveness against the variant, said George Yancopoulos, the company’s president and chief scientific officer.</p><p><blockquote>该公司总裁兼首席科学官George Yancopoulos表示，如果最终测试表明其抗体药物对奥密克戎病毒的效果较差，再生元已经开发出替代抗体，可以将其推向临床测试，并且认为这些抗体将保留对该变种的有效性。</blockquote></p><p> One of Regeneron’s alternative antibodies is already in clinical testing, which the company began in anticipation of new variants emerging over time.</p><p><blockquote>再生元的一种替代抗体已经处于临床测试阶段，该公司预计随着时间的推移会出现新的变种。</blockquote></p><p> The Omicron variant was identified last week by scientists in South Africa, prompting drug researchers to scramble to see if the relatively small medicine chest of Covid-19 treatments would still work against the new strain if it ends up spreading widely.</p><p><blockquote>南非科学家上周发现了奥密克戎病毒变种，促使药物研究人员争先恐后地看看，如果新冠肺炎病毒最终广泛传播，相对较小的新冠肺炎治疗药箱是否仍能对抗新毒株。</blockquote></p><p> “What we have to admit is, in the course of the past six days, our urgency has increased,” Dr. Yancopoulos said in an interview. “What started out as a backup plan has now been made a lot more urgent.”</p><p><blockquote>“我们必须承认的是，在过去的六天里，我们的紧迫性有所增加，”扬科普洛斯博士在接受采访时说。“最初的备用计划现在变得更加紧迫。”</blockquote></p><p> Scientists at the Fred Hutchinson Cancer Research Center in Seattle found that individual mutations from Omicron reduced or eliminated the ability of Regeneron’s and Lilly’s drugs to attach to the virus, said Allie Greaney, a Ph.D. candidate at the center and the University of Washington in Seattle.</p><p><blockquote>西雅图Fred Hutchinson癌症研究中心的科学家发现，奥密克戎病毒的个体突变降低或消除了再生元和礼来公司的药物附着在病毒上的能力。该中心和西雅图华盛顿大学的候选人。</blockquote></p><p> More comprehensive tests of the drugs against the entire variant are needed to fully understand the impact, she said. “I’m not certain what the exact magnitude of effect would be, but probably less effective,” said Ms. Greaney.</p><p><blockquote>她说，需要对针对整个变种的药物进行更全面的测试，以充分了解其影响。“我不确定效果的确切程度，但效果可能会较差，”格雷尼女士说。</blockquote></p><p> Lilly is in the process of testing the new variant against its drug, a combination of&nbsp;two antibodies called bamlanivimab and etesevimab,said Nicole Kallewaard, a Lilly virologist and research adviser.</p><p><blockquote>礼来公司病毒学家兼研究顾问Nicole Kallewaard表示，礼来公司正在针对其药物测试新变种，该药物是两种抗体的组合，称为bamlanivimab和etesevimab。</blockquote></p><p> She declined to comment on the results showing reduced effectiveness against individual Omicron mutations, because the results may differ when all of the mutations are combined.</p><p><blockquote>她拒绝对显示针对单个奥密克戎突变的有效性降低的结果发表评论，因为当所有突变结合在一起时，结果可能会有所不同。</blockquote></p><p> “I think that we need to wait for confirmation of the whole virus,” said Dr. Kallewaard. “Hopefully, the data will come in the next few weeks.”</p><p><blockquote>“我认为我们需要等待整个病毒的确认，”Kallewaard博士说。“希望数据能在未来几周内公布。”</blockquote></p><p> A rise in the prevalence of Omicron could present an opportunity for competitors who say their drugs don’t appear in preliminary testing to be affected by the variant, including&nbsp;Vir Biotechnology&nbsp;Inc.&nbsp;and GlaxoSmithKline PLC, whose drug&nbsp;sotrovimab was authorized for emergency use&nbsp;earlier this year.</p><p><blockquote>奥密克戎病毒患病率的上升可能会给那些表示其药物在初步测试中没有出现的竞争对手带来受到该变种影响的机会，其中包括Vir Biotechnology Inc.和葛兰素史克PLC，其药物sotrovimab早些时候被授权紧急使用今年。</blockquote></p><p></p><p> Fred Hutchinson researchers also said their initial testing indicated the Vir-GSK antibody drug retained its effectiveness.</p><p><blockquote>Fred Hutchinson研究人员还表示，他们的初步测试表明Vir-GSK抗体药物保留了其有效性。</blockquote></p><p> Adagio Therapeutics&nbsp;Inc.,a biotech with a Covid-19 antibody drug in clinical trials, said its antibody also appears to be unaffected by the new variant.</p><p><blockquote>Adagio Therapeutics Inc.是一家正在进行临床试验的新冠肺炎抗体药物的生物技术公司，该公司表示，其抗体似乎也不受新变种的影响。</blockquote></p><p> Vir, Glaxo and Adagio said they are conducting further tests to confirm that their drugs aren’t affected by Omicron.</p><p><blockquote>Vir、葛兰素史克和Adagio表示，他们正在进行进一步测试，以确认他们的药物不受奥密克戎病的影响。</blockquote></p><p> Omicron poses a threat to lab-made antibody drugs as well as antibodies generated by vaccines, because the new variant has mutations on the spike protein part of the virus where antibodies are known to frequently attach themselves, scientists say.</p><p><blockquote>科学家说，奥密克戎病毒对实验室制造的抗体药物以及疫苗产生的抗体构成威胁，因为这种新变种在病毒的刺突蛋白部分发生了突变，已知抗体经常附着在该部分。</blockquote></p><p> Vir and Adagio officials said the companies designed their antibodies with the aim of targeting spots on the virus that are common across different coronaviruses that remained stable even after numerous mutations over many years.</p><p><blockquote>Vir和Adagio官员表示，两家公司设计抗体的目的是针对病毒上不同冠状病毒中常见的点，这些点即使在多年多次突变后仍保持稳定。</blockquote></p><p> “They bind to a region of the virus that through decades of evolution has not changed a lot,” Adagio Chief Executive Tillman Gerngross said in an interview. “Those conserved areas make the virus much more vulnerable” to antibodies.</p><p><blockquote>Adagio首席执行官蒂尔曼·格恩格罗斯(Tillman Gerngross)在接受采访时表示：“它们与病毒的一个区域结合，该区域经过数十年的进化并没有发生太大变化。”“这些保守区域使病毒更容易受到抗体的攻击”。</blockquote></p><p> It will take at least two weeks to create a version of the full Omicron virus variant and test antibody drugs against it, company officials said. Still, scientists say they are concerned by what they know already about the variant’s ability to evade antibodies produced by vaccines, prior infection or from drug treatment.</p><p><blockquote>公司官员表示，至少需要两周时间才能创建完整的奥密克戎病毒变种版本并测试针对其的抗体药物。尽管如此，科学家们表示，他们对这种变异逃避疫苗、先前感染或药物治疗产生的抗体的能力感到担忧。</blockquote></p><p> “Omicron hasn’t become the next Delta,” Vir Chief Scientific Officer Skip Virgin said in an interview. But “we think the extent of the mutations, the number of them, means that the world needs to take Omicron very seriously.”</p><p><blockquote>“奥密克戎还没有成为下一个三角洲，”Vir首席科学官Skip Virgin在接受采访时表示。但“我们认为突变的程度和数量意味着世界需要非常认真地对待奥密克戎。”</blockquote></p><p> Antiviral drugs, including pills from&nbsp;Merck&amp; Co. and partner Ridgeback Biotherapeutics LP and from&nbsp;Pfizer&nbsp;Inc.&nbsp;that are being&nbsp;evaluated for authorization,appear to be unaffected by the variant because they target a different site on the virus, said Michel Nussenzweig, an immunologist at Rockefeller University.</p><p><blockquote>洛克菲勒大学免疫学家米歇尔·努森茨威格(Michel Nussenzweig)表示，抗病毒药物，包括默克公司(Merck&amp;Co.)和合作伙伴Ridgeback Biotherapeutics LP以及辉瑞公司(Pfizer Inc.)正在接受授权评估的药物，似乎不受该变种的影响，因为它们针对病毒上的不同位点。</blockquote></p><p> Doctors and patients have been looking forward to authorization of the pills, which in clinical trials have&nbsp;reduced the risk of hospitalization&nbsp;if taken early enough.</p><p><blockquote>医生和患者一直在期待这种药物的批准，在临床试验中，如果尽早服用，这种药物可以降低住院风险。</blockquote></p><p> “The targets of the pills appear to be under less pressure and may be OK, but this too needs to be tested,” said Dr. Nussenzweig.</p><p><blockquote>“药物的目标似乎压力较小，可能没问题，但这也需要测试，”努森茨威格博士说。</blockquote></p><p> Pfizer and Merck said they expect their drugs to be effective against Omicron.</p><p><blockquote>辉瑞和默克表示，他们预计他们的药物将有效对抗奥密克戎病。</blockquote></p><p> Gilead SciencesInc.&nbsp;also said it expects&nbsp;Veklury, its antiviral drug&nbsp;used to treat hospitalized patients, to retain effectiveness against Omicron as it has against other variants of concern.</p><p><blockquote>吉利德科学公司还表示，预计其用于治疗住院患者的抗病毒药物Veklury将保持对奥密克戎病毒的有效性，就像它对其他令人担忧的变种一样。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Covid-19 Antibody Drugs Are Challenged by Omicron, Preliminary Testing Indicates<blockquote>新冠抗体药物受奥密克戎挑战初步检测显示</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCovid-19 Antibody Drugs Are Challenged by Omicron, Preliminary Testing Indicates<blockquote>新冠抗体药物受奥密克戎挑战初步检测显示</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">The Wall Street Journal</strong><span class=\"h-time small\">2021-11-30 19:59</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Regeneron said its antibody drug cocktail was found to lose effectiveness against the new variant</p><p><blockquote>再生元表示，其抗体药物鸡尾酒被发现对新变种失去效力</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ed6086131617e6933fe07f3e46cd5c26\" tg-width=\"1290\" tg-height=\"859\" referrerpolicy=\"no-referrer\"><span>A monoclonal antibody treatment site in Pembroke Pines, Fla., earlier this year.</span></p><p><blockquote><p class=\"t-img-caption\"><span>今年早些时候，佛罗里达州彭布罗克派恩斯的一个单克隆抗体治疗点。</span></p></blockquote></p><p> Preliminary tests indicate the Covid-19 antibody drug cocktail from Regeneron Pharmaceuticals Inc. loses effectiveness against Omicron, the company said Tuesday, a sign that some products in an important class of therapies might need modifying if the new strain becomes widespread.</p><p><blockquote>再生元制药公司周二表示，初步测试表明，该公司的Covid-19抗体药物鸡尾酒对奥密克戎病毒失去了效力，这表明，如果新毒株广泛传播，一类重要疗法中的一些产品可能需要修改。</blockquote></p><p> Separate testing of another authorized Covid-19 antibody drug cocktail, from&nbsp;Eli Lilly&amp; Co., indicates it also isn’t as effective against Omicron, outside scientists said. Lilly said it is testing the new variant against its antibody treatment and wouldn’t speculate on what the results will be.</p><p><blockquote>外部科学家表示，对礼来公司(Eli Lilly&amp;Co.)的另一种授权的Covid-19抗体药物混合物进行的单独测试表明，它对奥密克戎病也没有那么有效。礼来公司表示，正在针对其抗体治疗测试新变种，但不愿猜测结果会是什么。</blockquote></p><p> The findings are the early results of researchers’ race to assess the impact of the&nbsp;new Omicron variant&nbsp;on Covid-19 treatments that patients, doctors and hospitals have been relying on, as well as pills in development that have promised to keep people out of the hospital.</p><p><blockquote>这些发现是研究人员竞相评估新的奥密克戎病毒变种对患者、医生和医院一直依赖的Covid-19治疗的影响的早期结果，以及正在开发的有望让人们远离医院的药物。</blockquote></p><p> Researchers say some antibody therapies are likely to be especially vulnerable to Omicron because it contains mutations to the spike protein that the Regeneron and Lilly drugs target, while other drugs should hold up well because they attack elements of the virus unchanged in the variant.</p><p><blockquote>研究人员表示，一些抗体疗法可能特别容易受到奥密克戎病毒的影响，因为它含有再生元和礼来药物所针对的刺突蛋白的突变，而其他药物应该表现良好，因为它们攻击的是变种中未改变的病毒元素。</blockquote></p><p> Monoclonal antibodies are lab-made molecules derived from survivors of Covid-19 or mice engineered to have human immune systems. When given soon after infection, the drugs attach to the surface of the coronavirus and prevent it from replicating itself in new cells.</p><p><blockquote>单克隆抗体是实验室制造的分子，来自新冠肺炎幸存者或被改造成具有人类免疫系统的小鼠。当感染后不久给药时，这些药物会附着在冠状病毒的表面，阻止它在新细胞中自我复制。</blockquote></p><p> They are the only drugs authorized to treat patients, before they require hospitalization, who are at high risk of developing severe cases.</p><p><blockquote>它们是唯一被授权在需要住院治疗患者之前治疗这些患者的药物，这些患者具有发展为严重病例的高风险。</blockquote></p><p> The drugs differ from vaccines, which train the immune system how to defend against the virus, including with the production of antibodies. Last year, former&nbsp;President Donald Trump credited Regeneron’s drug&nbsp;with his speedy recovery from Covid-19.</p><p><blockquote>这些药物不同于疫苗，疫苗训练免疫系统如何防御病毒，包括产生抗体。去年，前总统唐纳德·特朗普将他从Covid-19中迅速康复归功于再生元的药物。</blockquote></p><p> Regeneron said it would be able to quantify the impact of the variant in coming weeks, after further testing is done.</p><p><blockquote>再生元表示，在进行进一步测试后，它将能够在未来几周内量化该变体的影响。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6e7fac5c4630025e6c5ad28d2c3efbfa\" tg-width=\"1050\" tg-height=\"700\" referrerpolicy=\"no-referrer\"><span>Antiviral pills such as Pfizer’s Paxlovid appear to be unaffected by the variant.</span></p><p><blockquote><p class=\"t-img-caption\"><span>辉瑞公司的Paxlovid等抗病毒药物似乎不受该变种的影响。</span></p></blockquote></p><p> If final testing shows that its antibody drugs are less effective against Omicron, Regeneron has developed alternative antibodies that it can push into clinical testing and that it thinks will retain effectiveness against the variant, said George Yancopoulos, the company’s president and chief scientific officer.</p><p><blockquote>该公司总裁兼首席科学官George Yancopoulos表示，如果最终测试表明其抗体药物对奥密克戎病毒的效果较差，再生元已经开发出替代抗体，可以将其推向临床测试，并且认为这些抗体将保留对该变种的有效性。</blockquote></p><p> One of Regeneron’s alternative antibodies is already in clinical testing, which the company began in anticipation of new variants emerging over time.</p><p><blockquote>再生元的一种替代抗体已经处于临床测试阶段，该公司预计随着时间的推移会出现新的变种。</blockquote></p><p> The Omicron variant was identified last week by scientists in South Africa, prompting drug researchers to scramble to see if the relatively small medicine chest of Covid-19 treatments would still work against the new strain if it ends up spreading widely.</p><p><blockquote>南非科学家上周发现了奥密克戎病毒变种，促使药物研究人员争先恐后地看看，如果新冠肺炎病毒最终广泛传播，相对较小的新冠肺炎治疗药箱是否仍能对抗新毒株。</blockquote></p><p> “What we have to admit is, in the course of the past six days, our urgency has increased,” Dr. Yancopoulos said in an interview. “What started out as a backup plan has now been made a lot more urgent.”</p><p><blockquote>“我们必须承认的是，在过去的六天里，我们的紧迫性有所增加，”扬科普洛斯博士在接受采访时说。“最初的备用计划现在变得更加紧迫。”</blockquote></p><p> Scientists at the Fred Hutchinson Cancer Research Center in Seattle found that individual mutations from Omicron reduced or eliminated the ability of Regeneron’s and Lilly’s drugs to attach to the virus, said Allie Greaney, a Ph.D. candidate at the center and the University of Washington in Seattle.</p><p><blockquote>西雅图Fred Hutchinson癌症研究中心的科学家发现，奥密克戎病毒的个体突变降低或消除了再生元和礼来公司的药物附着在病毒上的能力。该中心和西雅图华盛顿大学的候选人。</blockquote></p><p> More comprehensive tests of the drugs against the entire variant are needed to fully understand the impact, she said. “I’m not certain what the exact magnitude of effect would be, but probably less effective,” said Ms. Greaney.</p><p><blockquote>她说，需要对针对整个变种的药物进行更全面的测试，以充分了解其影响。“我不确定效果的确切程度，但效果可能会较差，”格雷尼女士说。</blockquote></p><p> Lilly is in the process of testing the new variant against its drug, a combination of&nbsp;two antibodies called bamlanivimab and etesevimab,said Nicole Kallewaard, a Lilly virologist and research adviser.</p><p><blockquote>礼来公司病毒学家兼研究顾问Nicole Kallewaard表示，礼来公司正在针对其药物测试新变种，该药物是两种抗体的组合，称为bamlanivimab和etesevimab。</blockquote></p><p> She declined to comment on the results showing reduced effectiveness against individual Omicron mutations, because the results may differ when all of the mutations are combined.</p><p><blockquote>她拒绝对显示针对单个奥密克戎突变的有效性降低的结果发表评论，因为当所有突变结合在一起时，结果可能会有所不同。</blockquote></p><p> “I think that we need to wait for confirmation of the whole virus,” said Dr. Kallewaard. “Hopefully, the data will come in the next few weeks.”</p><p><blockquote>“我认为我们需要等待整个病毒的确认，”Kallewaard博士说。“希望数据能在未来几周内公布。”</blockquote></p><p> A rise in the prevalence of Omicron could present an opportunity for competitors who say their drugs don’t appear in preliminary testing to be affected by the variant, including&nbsp;Vir Biotechnology&nbsp;Inc.&nbsp;and GlaxoSmithKline PLC, whose drug&nbsp;sotrovimab was authorized for emergency use&nbsp;earlier this year.</p><p><blockquote>奥密克戎病毒患病率的上升可能会给那些表示其药物在初步测试中没有出现的竞争对手带来受到该变种影响的机会，其中包括Vir Biotechnology Inc.和葛兰素史克PLC，其药物sotrovimab早些时候被授权紧急使用今年。</blockquote></p><p></p><p> Fred Hutchinson researchers also said their initial testing indicated the Vir-GSK antibody drug retained its effectiveness.</p><p><blockquote>Fred Hutchinson研究人员还表示，他们的初步测试表明Vir-GSK抗体药物保留了其有效性。</blockquote></p><p> Adagio Therapeutics&nbsp;Inc.,a biotech with a Covid-19 antibody drug in clinical trials, said its antibody also appears to be unaffected by the new variant.</p><p><blockquote>Adagio Therapeutics Inc.是一家正在进行临床试验的新冠肺炎抗体药物的生物技术公司，该公司表示，其抗体似乎也不受新变种的影响。</blockquote></p><p> Vir, Glaxo and Adagio said they are conducting further tests to confirm that their drugs aren’t affected by Omicron.</p><p><blockquote>Vir、葛兰素史克和Adagio表示，他们正在进行进一步测试，以确认他们的药物不受奥密克戎病的影响。</blockquote></p><p> Omicron poses a threat to lab-made antibody drugs as well as antibodies generated by vaccines, because the new variant has mutations on the spike protein part of the virus where antibodies are known to frequently attach themselves, scientists say.</p><p><blockquote>科学家说，奥密克戎病毒对实验室制造的抗体药物以及疫苗产生的抗体构成威胁，因为这种新变种在病毒的刺突蛋白部分发生了突变，已知抗体经常附着在该部分。</blockquote></p><p> Vir and Adagio officials said the companies designed their antibodies with the aim of targeting spots on the virus that are common across different coronaviruses that remained stable even after numerous mutations over many years.</p><p><blockquote>Vir和Adagio官员表示，两家公司设计抗体的目的是针对病毒上不同冠状病毒中常见的点，这些点即使在多年多次突变后仍保持稳定。</blockquote></p><p> “They bind to a region of the virus that through decades of evolution has not changed a lot,” Adagio Chief Executive Tillman Gerngross said in an interview. “Those conserved areas make the virus much more vulnerable” to antibodies.</p><p><blockquote>Adagio首席执行官蒂尔曼·格恩格罗斯(Tillman Gerngross)在接受采访时表示：“它们与病毒的一个区域结合，该区域经过数十年的进化并没有发生太大变化。”“这些保守区域使病毒更容易受到抗体的攻击”。</blockquote></p><p> It will take at least two weeks to create a version of the full Omicron virus variant and test antibody drugs against it, company officials said. Still, scientists say they are concerned by what they know already about the variant’s ability to evade antibodies produced by vaccines, prior infection or from drug treatment.</p><p><blockquote>公司官员表示，至少需要两周时间才能创建完整的奥密克戎病毒变种版本并测试针对其的抗体药物。尽管如此，科学家们表示，他们对这种变异逃避疫苗、先前感染或药物治疗产生的抗体的能力感到担忧。</blockquote></p><p> “Omicron hasn’t become the next Delta,” Vir Chief Scientific Officer Skip Virgin said in an interview. But “we think the extent of the mutations, the number of them, means that the world needs to take Omicron very seriously.”</p><p><blockquote>“奥密克戎还没有成为下一个三角洲，”Vir首席科学官Skip Virgin在接受采访时表示。但“我们认为突变的程度和数量意味着世界需要非常认真地对待奥密克戎。”</blockquote></p><p> Antiviral drugs, including pills from&nbsp;Merck&amp; Co. and partner Ridgeback Biotherapeutics LP and from&nbsp;Pfizer&nbsp;Inc.&nbsp;that are being&nbsp;evaluated for authorization,appear to be unaffected by the variant because they target a different site on the virus, said Michel Nussenzweig, an immunologist at Rockefeller University.</p><p><blockquote>洛克菲勒大学免疫学家米歇尔·努森茨威格(Michel Nussenzweig)表示，抗病毒药物，包括默克公司(Merck&amp;Co.)和合作伙伴Ridgeback Biotherapeutics LP以及辉瑞公司(Pfizer Inc.)正在接受授权评估的药物，似乎不受该变种的影响，因为它们针对病毒上的不同位点。</blockquote></p><p> Doctors and patients have been looking forward to authorization of the pills, which in clinical trials have&nbsp;reduced the risk of hospitalization&nbsp;if taken early enough.</p><p><blockquote>医生和患者一直在期待这种药物的批准，在临床试验中，如果尽早服用，这种药物可以降低住院风险。</blockquote></p><p> “The targets of the pills appear to be under less pressure and may be OK, but this too needs to be tested,” said Dr. Nussenzweig.</p><p><blockquote>“药物的目标似乎压力较小，可能没问题，但这也需要测试，”努森茨威格博士说。</blockquote></p><p> Pfizer and Merck said they expect their drugs to be effective against Omicron.</p><p><blockquote>辉瑞和默克表示，他们预计他们的药物将有效对抗奥密克戎病。</blockquote></p><p> Gilead SciencesInc.&nbsp;also said it expects&nbsp;Veklury, its antiviral drug&nbsp;used to treat hospitalized patients, to retain effectiveness against Omicron as it has against other variants of concern.</p><p><blockquote>吉利德科学公司还表示，预计其用于治疗住院患者的抗病毒药物Veklury将保持对奥密克戎病毒的有效性，就像它对其他令人担忧的变种一样。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.wsj.com/articles/covid-19-antibody-drugs-are-challenged-by-omicron-preliminary-testing-indicates-11638270003?mod=Searchresults_pos1&page=1\">The Wall Street Journal</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LLY":"礼来","REGN":"再生元制药公司"},"source_url":"https://www.wsj.com/articles/covid-19-antibody-drugs-are-challenged-by-omicron-preliminary-testing-indicates-11638270003?mod=Searchresults_pos1&page=1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1192203085","content_text":"Regeneron said its antibody drug cocktail was found to lose effectiveness against the new variant\nA monoclonal antibody treatment site in Pembroke Pines, Fla., earlier this year.\nPreliminary tests indicate the Covid-19 antibody drug cocktail from Regeneron Pharmaceuticals Inc. loses effectiveness against Omicron, the company said Tuesday, a sign that some products in an important class of therapies might need modifying if the new strain becomes widespread.\nSeparate testing of another authorized Covid-19 antibody drug cocktail, from Eli Lilly& Co., indicates it also isn’t as effective against Omicron, outside scientists said. Lilly said it is testing the new variant against its antibody treatment and wouldn’t speculate on what the results will be.\nThe findings are the early results of researchers’ race to assess the impact of the new Omicron variant on Covid-19 treatments that patients, doctors and hospitals have been relying on, as well as pills in development that have promised to keep people out of the hospital.\nResearchers say some antibody therapies are likely to be especially vulnerable to Omicron because it contains mutations to the spike protein that the Regeneron and Lilly drugs target, while other drugs should hold up well because they attack elements of the virus unchanged in the variant.\nMonoclonal antibodies are lab-made molecules derived from survivors of Covid-19 or mice engineered to have human immune systems. When given soon after infection, the drugs attach to the surface of the coronavirus and prevent it from replicating itself in new cells.\nThey are the only drugs authorized to treat patients, before they require hospitalization, who are at high risk of developing severe cases.\nThe drugs differ from vaccines, which train the immune system how to defend against the virus, including with the production of antibodies. Last year, former President Donald Trump credited Regeneron’s drug with his speedy recovery from Covid-19.\nRegeneron said it would be able to quantify the impact of the variant in coming weeks, after further testing is done.\nAntiviral pills such as Pfizer’s Paxlovid appear to be unaffected by the variant.\nIf final testing shows that its antibody drugs are less effective against Omicron, Regeneron has developed alternative antibodies that it can push into clinical testing and that it thinks will retain effectiveness against the variant, said George Yancopoulos, the company’s president and chief scientific officer.\nOne of Regeneron’s alternative antibodies is already in clinical testing, which the company began in anticipation of new variants emerging over time.\nThe Omicron variant was identified last week by scientists in South Africa, prompting drug researchers to scramble to see if the relatively small medicine chest of Covid-19 treatments would still work against the new strain if it ends up spreading widely.\n“What we have to admit is, in the course of the past six days, our urgency has increased,” Dr. Yancopoulos said in an interview. “What started out as a backup plan has now been made a lot more urgent.”\nScientists at the Fred Hutchinson Cancer Research Center in Seattle found that individual mutations from Omicron reduced or eliminated the ability of Regeneron’s and Lilly’s drugs to attach to the virus, said Allie Greaney, a Ph.D. candidate at the center and the University of Washington in Seattle.\nMore comprehensive tests of the drugs against the entire variant are needed to fully understand the impact, she said. “I’m not certain what the exact magnitude of effect would be, but probably less effective,” said Ms. Greaney.\nLilly is in the process of testing the new variant against its drug, a combination of two antibodies called bamlanivimab and etesevimab,said Nicole Kallewaard, a Lilly virologist and research adviser.\nShe declined to comment on the results showing reduced effectiveness against individual Omicron mutations, because the results may differ when all of the mutations are combined.\n“I think that we need to wait for confirmation of the whole virus,” said Dr. Kallewaard. “Hopefully, the data will come in the next few weeks.”\nA rise in the prevalence of Omicron could present an opportunity for competitors who say their drugs don’t appear in preliminary testing to be affected by the variant, including Vir Biotechnology Inc. and GlaxoSmithKline PLC, whose drug sotrovimab was authorized for emergency use earlier this year.\nFred Hutchinson researchers also said their initial testing indicated the Vir-GSK antibody drug retained its effectiveness.\nAdagio Therapeutics Inc.,a biotech with a Covid-19 antibody drug in clinical trials, said its antibody also appears to be unaffected by the new variant.\nVir, Glaxo and Adagio said they are conducting further tests to confirm that their drugs aren’t affected by Omicron.\nOmicron poses a threat to lab-made antibody drugs as well as antibodies generated by vaccines, because the new variant has mutations on the spike protein part of the virus where antibodies are known to frequently attach themselves, scientists say.\nVir and Adagio officials said the companies designed their antibodies with the aim of targeting spots on the virus that are common across different coronaviruses that remained stable even after numerous mutations over many years.\n“They bind to a region of the virus that through decades of evolution has not changed a lot,” Adagio Chief Executive Tillman Gerngross said in an interview. “Those conserved areas make the virus much more vulnerable” to antibodies.\nIt will take at least two weeks to create a version of the full Omicron virus variant and test antibody drugs against it, company officials said. Still, scientists say they are concerned by what they know already about the variant’s ability to evade antibodies produced by vaccines, prior infection or from drug treatment.\n“Omicron hasn’t become the next Delta,” Vir Chief Scientific Officer Skip Virgin said in an interview. But “we think the extent of the mutations, the number of them, means that the world needs to take Omicron very seriously.”\nAntiviral drugs, including pills from Merck& Co. and partner Ridgeback Biotherapeutics LP and from Pfizer Inc. that are being evaluated for authorization,appear to be unaffected by the variant because they target a different site on the virus, said Michel Nussenzweig, an immunologist at Rockefeller University.\nDoctors and patients have been looking forward to authorization of the pills, which in clinical trials have reduced the risk of hospitalization if taken early enough.\n“The targets of the pills appear to be under less pressure and may be OK, but this too needs to be tested,” said Dr. Nussenzweig.\nPfizer and Merck said they expect their drugs to be effective against Omicron.\nGilead SciencesInc. also said it expects Veklury, its antiviral drug used to treat hospitalized patients, to retain effectiveness against Omicron as it has against other variants of concern.","news_type":1,"symbols_score_info":{"REGN":0.9,"LLY":0.9}},"isVote":1,"tweetType":1,"viewCount":671,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600480772,"gmtCreate":1638187250225,"gmtModify":1638187250609,"author":{"id":"4087514122562540","authorId":"4087514122562540","name":"74809e5c","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087514122562540","authorIdStr":"4087514122562540"},"themes":[],"htmlText":"👌","listText":"👌","text":"👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/600480772","repostId":"1177474272","repostType":4,"isVote":1,"tweetType":1,"viewCount":1519,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877763502,"gmtCreate":1637985304514,"gmtModify":1637985304625,"author":{"id":"4087514122562540","authorId":"4087514122562540","name":"74809e5c","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087514122562540","authorIdStr":"4087514122562540"},"themes":[],"htmlText":"👌","listText":"👌","text":"👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877763502","repostId":"2186344334","repostType":4,"isVote":1,"tweetType":1,"viewCount":981,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877629375,"gmtCreate":1637926837209,"gmtModify":1637926837316,"author":{"id":"4087514122562540","authorId":"4087514122562540","name":"74809e5c","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087514122562540","authorIdStr":"4087514122562540"},"themes":[],"htmlText":"👌","listText":"👌","text":"👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877629375","repostId":"1107826153","repostType":4,"repost":{"id":"1107826153","kind":"news","pubTimestamp":1637923523,"share":"https://www.laohu8.com/m/news/1107826153?lang=zh_CN&edition=full","pubTime":"2021-11-26 18:45","market":"us","language":"en","title":"5 Stocks To Watch For November 26, 2021<blockquote>2021年11月26日值得关注的5只股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1107826153","media":"Benzinga","summary":"Some of the stocks that may grab investor focus today are:\n\nWall Street expects Pinduoduo Inc. to re","content":"<p><div> Some of the stocks that may grab investor focus today are:  Wall Street expects Pinduoduo Inc. to report quarterly earnings at $0.02 per share on revenue of $4.16 billion before the opening bell. ...</p><p><blockquote><div>今天可能吸引投资者关注的一些股票包括：华尔街预计拼多多将在开盘前公布季度收益为每股0.02美元，营收为41.6亿美元。...</div></blockquote></p><p>  <a href=\"https://www.benzinga.com/news/earnings/21/11/24301733/5-stocks-to-watch-for-november-26-2021\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://www.benzinga.com/news/earnings/21/11/24301733/5-stocks-to-watch-for-november-26-2021\">网页连接</a></blockquote></p><p></p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks To Watch For November 26, 2021<blockquote>2021年11月26日值得关注的5只股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks To Watch For November 26, 2021<blockquote>2021年11月26日值得关注的5只股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Benzinga</strong><span class=\"h-time small\">2021-11-26 18:45</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> Some of the stocks that may grab investor focus today are:  Wall Street expects Pinduoduo Inc. to report quarterly earnings at $0.02 per share on revenue of $4.16 billion before the opening bell. ...</p><p><blockquote><div>今天可能吸引投资者关注的一些股票包括：华尔街预计拼多多将在开盘前公布季度收益为每股0.02美元，营收为41.6亿美元。...</div></blockquote></p><p>  <a href=\"https://www.benzinga.com/news/earnings/21/11/24301733/5-stocks-to-watch-for-november-26-2021\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://www.benzinga.com/news/earnings/21/11/24301733/5-stocks-to-watch-for-november-26-2021\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.benzinga.com/news/earnings/21/11/24301733/5-stocks-to-watch-for-november-26-2021\">Benzinga</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BLCT":"蓝城兄弟","CVBF":"CVB金融","PDD":"拼多多"},"source_url":"https://www.benzinga.com/news/earnings/21/11/24301733/5-stocks-to-watch-for-november-26-2021","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1107826153","content_text":"Some of the stocks that may grab investor focus today are:\n\nWall Street expects Pinduoduo Inc. to report quarterly earnings at $0.02 per share on revenue of $4.16 billion before the opening bell. Pinduoduo shares rose 0.8% to $82.00 in after-hours trading.\nGlobal Cord Blood Corporation reported that its revenue for the second quarter climbed 9.8% year-over-year to RMB313.7 million ($48.7 million). Net income attributable to shareholders, however, fell 4.3% to RMB125.7 million ($19.5 million) last quarter. Global Cord Blood shares fell 0.7% to $4.22 in the after-hours trading session.\nAnalysts expect BlueCity Holdings Limited to post a quarterly loss at $0.14 per share on revenue of $51.21 billion before the opening bell. BlueCity shares gained 2.5% to $2.48 in after-hours trading.\n\n\nSelecta Biosciences disclosed that the FDA has issued clinical hold on its Phase 1/2 clinical trial of SEL-302 due to CMC related questions. Selecta Biosciences shares dipped 14.8% to $2.71 in the after-hours trading session.\nCVB Financial Corp., the holding company for Citizens Business Bank, disclosed that Citizens received regulatory approvals to complete its merger with Suncrest Bank. CVB Financial shares fell 1.4% to close at $20.65 on Wednesday.","news_type":1,"symbols_score_info":{"BLCT":0.9,"SELB":0.9,"PDD":0.9,"CVBF":0.9,"CO":0.9}},"isVote":1,"tweetType":1,"viewCount":809,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877069678,"gmtCreate":1637843625047,"gmtModify":1637843625152,"author":{"id":"4087514122562540","authorId":"4087514122562540","name":"74809e5c","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087514122562540","authorIdStr":"4087514122562540"},"themes":[],"htmlText":"👌","listText":"👌","text":"👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877069678","repostId":"1146332317","repostType":4,"isVote":1,"tweetType":1,"viewCount":786,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875149515,"gmtCreate":1637627811521,"gmtModify":1637627811621,"author":{"id":"4087514122562540","authorId":"4087514122562540","name":"74809e5c","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087514122562540","authorIdStr":"4087514122562540"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875149515","repostId":"1107051557","repostType":4,"repost":{"id":"1107051557","kind":"news","pubTimestamp":1637625930,"share":"https://www.laohu8.com/m/news/1107051557?lang=zh_CN&edition=full","pubTime":"2021-11-23 08:05","market":"sg","language":"en","title":"Singapore Stock Market Expected To Be Rangebound On Tuesday<blockquote>新加坡股市预计周二将区间震荡</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1107051557","media":"RTTNews","summary":"The Singapore stock market has climbed higher in two of three trading days since the end of the two-","content":"<p>The Singapore stock market has climbed higher in two of three trading days since the end of the two-day slide in which it had fallen almost 10 points or 0.3 percent. The Straits Times Index now sits just above the 3,235-point plateau and it's likely to see renewed consolidation on Tuesday.</p><p><blockquote>新加坡股市在连续两天下跌近10点或0.3%后，在三个交易日中有两个交易日上涨。海峡时报指数目前略高于3,235点的高位，周二可能会出现新的盘整。</blockquote></p><p> The global forecast for the Asian&nbsp;markets&nbsp;is mixed to lower, with technology stocks expected to weigh - although support from crude oil prices should limit the downside. The European and U.S. markets were mixed and the Asian bourses figure to follow suit.</p><p><blockquote>全球对亚洲市场的预测好坏参半，预计科技股将承压——尽管原油价格的支撑应该会限制下行空间。欧洲和美国市场涨跌互现，亚洲股市也将效仿。</blockquote></p><p> The STI finished slightly higher on Monday following gains from the financial shares and industrial stocks.</p><p><blockquote>继金融股和工业股上涨后，海指周一小幅收高。</blockquote></p><p> For the day, the index added 4.74 points or 0.15 percent to finish at 3,237.08 after trading between 3,231.10 and 3,244.73. Volume was 1.7 billion shares worth 936.5 million Singapore dollars. There were 282 decliners and 190 gainers.</p><p><blockquote>当天，该指数在3,231.10点至3,244.73点之间交易后，上涨4.74点或0.15%，收于3,237.08点。成交量为17亿股，价值9.365亿新元。下跌股282家，上涨股190家。</blockquote></p><p> Among the actives, City Developments was up 0.14 percent, while Comfort DelGro tumbled 0.65 percent, Dairy Farm International plummeted 3.02 percent, DBS Group rose 0.15 percent, Genting Singapore advanced 0.60 percent, Keppel Corp and Wilmar International both spiked 0.94 percent, Mapletree Commercial Trust retreated 0.47 percent, Mapletree Logistics Trust skidded 0.51 percent, Oversea-Chinese Banking Corporation gained 0.17 percent, SembCorp Industries jumped 0.99 percent, Singapore Airlines dipped 0.19 percent, Singapore Exchange declined 0.43 percent, SingTel added 0.40 percent, Thai Beverage plunged 2.04 percent, United Overseas Bank collected 0.29 percent, Yangzijiang Shipbuilding surged 1.59 percent and CapitaLand Integrated Commercial Trust, Ascendas REIT, Singapore Technologies Engineering, Singapore Press Holdings and SATS were unchanged.</p><p><blockquote>活跃股中，City Developments上涨0.14%，Comfort DelGro下跌0.65%，Dairy Farm International暴跌3.02%，星展集团上涨0.15%，云顶新加坡上涨0.60%，吉宝企业和丰益国际均上涨0.94%，丰树商业信托下跌0.47%，丰树物流信托下跌0.51%，华侨银行上涨0.17%，胜科工业上涨0.99%，新加坡航空下跌0.19%，新加坡电信上涨0.40%，泰国饮料暴跌2.04%，大华银行上涨0.29%，扬子江造船飙升1.59%，凯德综合商业信托、腾飞房地产投资信托、新加坡技术工程、新加坡报业控股和新翔集团持平。</blockquote></p><p> The lead from Wall Street is not encouraging as the major averages opened higher on Monday but tumbled late in the day, with only the Dow managing to barely hang on to positive territory.</p><p><blockquote>华尔街的领先并不令人鼓舞，主要股指周一开盘走高，但尾盘暴跌，只有道琼斯指数勉强维持在正值区域。</blockquote></p><p> The Dow rose 17.27 points or 0.05 percent to finish at 35,619.25, while the NASDAQ plunged 202.68 points or 1.26 percent to close at 15,854.76 and the S&amp;P fell 15.02 points or 0.32 percent to end at 4,682.94.</p><p><blockquote>道琼斯指数上涨17.27点，涨幅0.05%，收于35,619.25点；纳斯达克下跌202.68点，跌幅1.26%，收于15,854.76点；标准普尔指数下跌15.02点，跌幅0.32%，收于4,682.94点。</blockquote></p><p> The mixed close on Wall Street came after President Joe Biden announced his intent to nominate Jerome Powell for a second term as Federal Reserve Chair. The White House also revealed that Biden intends to nominate current Fed Governor Lael Brainard as Vice Chair of the Federal Reserve System.</p><p><blockquote>在总统乔·拜登宣布打算提名杰罗姆·鲍威尔连任美联储主席后，华尔街收盘涨跌互现。白宫还透露，拜登有意提名现任美联储理事莱尔·布雷纳德为美联储系统副主席。</blockquote></p><p> While the re-nomination of Powell will give the Fed stability as it grapples with the economic recovery and elevated inflation, Brainard was seen as the more dovish choice.</p><p><blockquote>虽然鲍威尔的重新提名将使美联储在应对经济复苏和通胀上升时保持稳定，但布雷纳德被视为更鸽派的选择。</blockquote></p><p> Crude oil futures settled higher Monday despite rising concerns about the outlook for energy demand due to a surge in&nbsp;coronavirus&nbsp;cases in several countries. West Texas Intermediate Crude oil futures for December rose $0.81 or 1.1 percent at $76.75 a barrel.</p><p><blockquote>尽管由于多个国家的冠状病毒病例激增，人们对能源需求前景的担忧日益加剧，但原油期货周一收高。西德克萨斯中质原油12月期货上涨0.81美元或1.1%，报每桶76.75美元。</blockquote></p><p> Closer to home, Singapore will release October numbers for consumer prices later today, with forecasts suggesting an increase of 1.3 percent on year - accelerating from 1.2 percent in September. Core CPI is called higher by an annual 2.8 percent, up from 2.5 percent a month earlier.</p><p><blockquote>在国内，新加坡将于今天晚些时候发布10月份消费者价格数据，预测显示同比上涨1.3%，高于9月份的1.2%。核心CPI年率上涨2.8%，高于一个月前的2.5%。</blockquote></p><p></p>","source":"lsy1626938412129","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Singapore Stock Market Expected To Be Rangebound On Tuesday<blockquote>新加坡股市预计周二将区间震荡</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSingapore Stock Market Expected To Be Rangebound On Tuesday<blockquote>新加坡股市预计周二将区间震荡</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">RTTNews</strong><span class=\"h-time small\">2021-11-23 08:05</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The Singapore stock market has climbed higher in two of three trading days since the end of the two-day slide in which it had fallen almost 10 points or 0.3 percent. The Straits Times Index now sits just above the 3,235-point plateau and it's likely to see renewed consolidation on Tuesday.</p><p><blockquote>新加坡股市在连续两天下跌近10点或0.3%后，在三个交易日中有两个交易日上涨。海峡时报指数目前略高于3,235点的高位，周二可能会出现新的盘整。</blockquote></p><p> The global forecast for the Asian&nbsp;markets&nbsp;is mixed to lower, with technology stocks expected to weigh - although support from crude oil prices should limit the downside. The European and U.S. markets were mixed and the Asian bourses figure to follow suit.</p><p><blockquote>全球对亚洲市场的预测好坏参半，预计科技股将承压——尽管原油价格的支撑应该会限制下行空间。欧洲和美国市场涨跌互现，亚洲股市也将效仿。</blockquote></p><p> The STI finished slightly higher on Monday following gains from the financial shares and industrial stocks.</p><p><blockquote>继金融股和工业股上涨后，海指周一小幅收高。</blockquote></p><p> For the day, the index added 4.74 points or 0.15 percent to finish at 3,237.08 after trading between 3,231.10 and 3,244.73. Volume was 1.7 billion shares worth 936.5 million Singapore dollars. There were 282 decliners and 190 gainers.</p><p><blockquote>当天，该指数在3,231.10点至3,244.73点之间交易后，上涨4.74点或0.15%，收于3,237.08点。成交量为17亿股，价值9.365亿新元。下跌股282家，上涨股190家。</blockquote></p><p> Among the actives, City Developments was up 0.14 percent, while Comfort DelGro tumbled 0.65 percent, Dairy Farm International plummeted 3.02 percent, DBS Group rose 0.15 percent, Genting Singapore advanced 0.60 percent, Keppel Corp and Wilmar International both spiked 0.94 percent, Mapletree Commercial Trust retreated 0.47 percent, Mapletree Logistics Trust skidded 0.51 percent, Oversea-Chinese Banking Corporation gained 0.17 percent, SembCorp Industries jumped 0.99 percent, Singapore Airlines dipped 0.19 percent, Singapore Exchange declined 0.43 percent, SingTel added 0.40 percent, Thai Beverage plunged 2.04 percent, United Overseas Bank collected 0.29 percent, Yangzijiang Shipbuilding surged 1.59 percent and CapitaLand Integrated Commercial Trust, Ascendas REIT, Singapore Technologies Engineering, Singapore Press Holdings and SATS were unchanged.</p><p><blockquote>活跃股中，City Developments上涨0.14%，Comfort DelGro下跌0.65%，Dairy Farm International暴跌3.02%，星展集团上涨0.15%，云顶新加坡上涨0.60%，吉宝企业和丰益国际均上涨0.94%，丰树商业信托下跌0.47%，丰树物流信托下跌0.51%，华侨银行上涨0.17%，胜科工业上涨0.99%，新加坡航空下跌0.19%，新加坡电信上涨0.40%，泰国饮料暴跌2.04%，大华银行上涨0.29%，扬子江造船飙升1.59%，凯德综合商业信托、腾飞房地产投资信托、新加坡技术工程、新加坡报业控股和新翔集团持平。</blockquote></p><p> The lead from Wall Street is not encouraging as the major averages opened higher on Monday but tumbled late in the day, with only the Dow managing to barely hang on to positive territory.</p><p><blockquote>华尔街的领先并不令人鼓舞，主要股指周一开盘走高，但尾盘暴跌，只有道琼斯指数勉强维持在正值区域。</blockquote></p><p> The Dow rose 17.27 points or 0.05 percent to finish at 35,619.25, while the NASDAQ plunged 202.68 points or 1.26 percent to close at 15,854.76 and the S&amp;P fell 15.02 points or 0.32 percent to end at 4,682.94.</p><p><blockquote>道琼斯指数上涨17.27点，涨幅0.05%，收于35,619.25点；纳斯达克下跌202.68点，跌幅1.26%，收于15,854.76点；标准普尔指数下跌15.02点，跌幅0.32%，收于4,682.94点。</blockquote></p><p> The mixed close on Wall Street came after President Joe Biden announced his intent to nominate Jerome Powell for a second term as Federal Reserve Chair. The White House also revealed that Biden intends to nominate current Fed Governor Lael Brainard as Vice Chair of the Federal Reserve System.</p><p><blockquote>在总统乔·拜登宣布打算提名杰罗姆·鲍威尔连任美联储主席后，华尔街收盘涨跌互现。白宫还透露，拜登有意提名现任美联储理事莱尔·布雷纳德为美联储系统副主席。</blockquote></p><p> While the re-nomination of Powell will give the Fed stability as it grapples with the economic recovery and elevated inflation, Brainard was seen as the more dovish choice.</p><p><blockquote>虽然鲍威尔的重新提名将使美联储在应对经济复苏和通胀上升时保持稳定，但布雷纳德被视为更鸽派的选择。</blockquote></p><p> Crude oil futures settled higher Monday despite rising concerns about the outlook for energy demand due to a surge in&nbsp;coronavirus&nbsp;cases in several countries. West Texas Intermediate Crude oil futures for December rose $0.81 or 1.1 percent at $76.75 a barrel.</p><p><blockquote>尽管由于多个国家的冠状病毒病例激增，人们对能源需求前景的担忧日益加剧，但原油期货周一收高。西德克萨斯中质原油12月期货上涨0.81美元或1.1%，报每桶76.75美元。</blockquote></p><p> Closer to home, Singapore will release October numbers for consumer prices later today, with forecasts suggesting an increase of 1.3 percent on year - accelerating from 1.2 percent in September. Core CPI is called higher by an annual 2.8 percent, up from 2.5 percent a month earlier.</p><p><blockquote>在国内，新加坡将于今天晚些时候发布10月份消费者价格数据，预测显示同比上涨1.3%，高于9月份的1.2%。核心CPI年率上涨2.8%，高于一个月前的2.5%。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.rttnews.com/3244154/singapore-stock-market-expected-to-be-rangebound-on-tuesday.aspx\">RTTNews</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://www.rttnews.com/3244154/singapore-stock-market-expected-to-be-rangebound-on-tuesday.aspx","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1107051557","content_text":"The Singapore stock market has climbed higher in two of three trading days since the end of the two-day slide in which it had fallen almost 10 points or 0.3 percent. The Straits Times Index now sits just above the 3,235-point plateau and it's likely to see renewed consolidation on Tuesday.\nThe global forecast for the Asian markets is mixed to lower, with technology stocks expected to weigh - although support from crude oil prices should limit the downside. The European and U.S. markets were mixed and the Asian bourses figure to follow suit.\nThe STI finished slightly higher on Monday following gains from the financial shares and industrial stocks.\nFor the day, the index added 4.74 points or 0.15 percent to finish at 3,237.08 after trading between 3,231.10 and 3,244.73. Volume was 1.7 billion shares worth 936.5 million Singapore dollars. There were 282 decliners and 190 gainers.\nAmong the actives, City Developments was up 0.14 percent, while Comfort DelGro tumbled 0.65 percent, Dairy Farm International plummeted 3.02 percent, DBS Group rose 0.15 percent, Genting Singapore advanced 0.60 percent, Keppel Corp and Wilmar International both spiked 0.94 percent, Mapletree Commercial Trust retreated 0.47 percent, Mapletree Logistics Trust skidded 0.51 percent, Oversea-Chinese Banking Corporation gained 0.17 percent, SembCorp Industries jumped 0.99 percent, Singapore Airlines dipped 0.19 percent, Singapore Exchange declined 0.43 percent, SingTel added 0.40 percent, Thai Beverage plunged 2.04 percent, United Overseas Bank collected 0.29 percent, Yangzijiang Shipbuilding surged 1.59 percent and CapitaLand Integrated Commercial Trust, Ascendas REIT, Singapore Technologies Engineering, Singapore Press Holdings and SATS were unchanged.\nThe lead from Wall Street is not encouraging as the major averages opened higher on Monday but tumbled late in the day, with only the Dow managing to barely hang on to positive territory.\nThe Dow rose 17.27 points or 0.05 percent to finish at 35,619.25, while the NASDAQ plunged 202.68 points or 1.26 percent to close at 15,854.76 and the S&P fell 15.02 points or 0.32 percent to end at 4,682.94.\nThe mixed close on Wall Street came after President Joe Biden announced his intent to nominate Jerome Powell for a second term as Federal Reserve Chair. The White House also revealed that Biden intends to nominate current Fed Governor Lael Brainard as Vice Chair of the Federal Reserve System.\nWhile the re-nomination of Powell will give the Fed stability as it grapples with the economic recovery and elevated inflation, Brainard was seen as the more dovish choice.\nCrude oil futures settled higher Monday despite rising concerns about the outlook for energy demand due to a surge in coronavirus cases in several countries. West Texas Intermediate Crude oil futures for December rose $0.81 or 1.1 percent at $76.75 a barrel.\nCloser to home, Singapore will release October numbers for consumer prices later today, with forecasts suggesting an increase of 1.3 percent on year - accelerating from 1.2 percent in September. Core CPI is called higher by an annual 2.8 percent, up from 2.5 percent a month earlier.","news_type":1,"symbols_score_info":{"STI.SI":0.9}},"isVote":1,"tweetType":1,"viewCount":749,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":805951807,"gmtCreate":1627855899209,"gmtModify":1633756014900,"author":{"id":"4087514122562540","authorId":"4087514122562540","name":"74809e5c","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087514122562540","idStr":"4087514122562540"},"themes":[],"htmlText":"Yes yes&nbsp;","listText":"Yes yes&nbsp;","text":"Yes yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/805951807","repostId":"1147877145","repostType":4,"isVote":1,"tweetType":1,"viewCount":265,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":873823537,"gmtCreate":1636930852582,"gmtModify":1636930852681,"author":{"id":"4087514122562540","authorId":"4087514122562540","name":"74809e5c","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087514122562540","idStr":"4087514122562540"},"themes":[],"htmlText":"👌","listText":"👌","text":"👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/873823537","repostId":"1103944030","repostType":4,"isVote":1,"tweetType":1,"viewCount":635,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":823177955,"gmtCreate":1633608197225,"gmtModify":1633608197459,"author":{"id":"4087514122562540","authorId":"4087514122562540","name":"74809e5c","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087514122562540","idStr":"4087514122562540"},"themes":[],"htmlText":"👌","listText":"👌","text":"👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/823177955","repostId":"1184680135","repostType":4,"isVote":1,"tweetType":1,"viewCount":456,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":176512547,"gmtCreate":1626907073789,"gmtModify":1633769986333,"author":{"id":"4087514122562540","authorId":"4087514122562540","name":"74809e5c","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087514122562540","idStr":"4087514122562540"},"themes":[],"htmlText":"Go to the moon","listText":"Go to the moon","text":"Go to the moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/176512547","repostId":"1109551881","repostType":4,"repost":{"id":"1109551881","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1626878219,"share":"https://www.laohu8.com/m/news/1109551881?lang=zh_CN&edition=full","pubTime":"2021-07-21 22:36","market":"us","language":"en","title":"AMC Smokes Shorts Again: What's Next?<blockquote>AMC再次抽短裤：下一步是什么？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1109551881","media":"Benzinga","summary":"AMC Entertainment Holding Inc(NYSE:AMC) shot up 24.47% Tuesday amid returned interest in reopening s","content":"<p><b>AMC Entertainment Holding Inc</b>(NYSE:AMC) shot up 24.47% Tuesday&nbsp;amid returned interest in reopening stocks. The company also announced on Monday evening it hadmade a dealto reopen the Grove Theatre and The Americana at Brand Theatre in the Los Angeles area in August under the AMC Brand. The two theatres were formerly leased by Pacific Theatres and are two of the highest-grossing theatres in Los Angeles.</p><p><blockquote><b>AMC院线控股公司</b>由于人们对重新开放股票的兴趣恢复，(NYSE：AMC)周二上涨24.47%。该公司周一晚间还宣布，已达成协议，将于8月份以AMC品牌重新开放洛杉矶地区的Grove剧院和Americana at Brand剧院。这两家剧院以前由太平洋剧院租赁，是洛杉矶票房最高的两家剧院。</blockquote></p><p> Although presently not the toptrendingstock on r/WallStreetBets, AMC was still the 10th most mentioned stock on Tuesday. The subreddit often targets stocks with unusual characteristics such as bizarre levels of ownership and high short interest. AMC’s underlying statistics have been improving over the last few months, however, and of the company’s 448.74 million share float 75.48 million shares are held short; this is down from 102.3 million in May.</p><p><blockquote>尽管AMC目前不是r/WallStreetBets上的热门股票，但它仍然是周二被提及次数第十多的股票。subreddit通常针对具有不寻常特征的股票，例如奇怪的所有权水平和高空头利息。然而，AMC的基本统计数据在过去几个月中一直在改善，该公司4.4874亿股流通股中，有7548万股被卖空；这比5月份的1.023亿有所下降。</blockquote></p><p> Despite short interest decreasing, AMC is still volatile and able to make big swings.</p><p><blockquote>尽管空头兴趣下降，AMC仍然不稳定，并且能够大幅波动。</blockquote></p><p> <b>The AMC Chart:</b>On Monday, during a big bear day in the general markets, AMC&nbsp;put in a bottom at $31.15 and managed to print a bullish hammer candlestick indicating higher prices would come on Tuesday. AMC then printed a bullish Marubozu candlestick on Tuesday. This Marubozu candle has a very small upper wick, indicating AMC had buyers at every price level it traded at intraday.</p><p><blockquote><b>AMC图表：</b>周一，在大盘大熊市期间，AMC触底31.15美元，并成功打印出看涨锤子烛台，表明周二价格将上涨。AMC随后在周二打印了看涨的Marubozu烛台。这根Marubozu蜡烛的上部灯芯非常小，表明AMC在盘中交易的每个价格水平都有买家。</blockquote></p><p> AMC broke into a downtrend on July 1 and made a series of lower highs and lower lows until Tuesday when the price closed at $43.08, above its lower high of $37.73, which indicates a bullish trend change. Bulls won’t want the stock to drop below $31.15 for the trend to be confirmed.</p><p><blockquote>AMC于7月1日进入下跌趋势，并创下一系列较低的高点和较低的低点，直到周二价格收于43.08美元，高于37.73美元的较低高点，这表明看涨趋势发生了变化。多头不希望该股跌破31.15美元以确认趋势。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/61ba2be17dcfd5bd5f6a00ab4398a5a6\" tg-width=\"651\" tg-height=\"256\" width=\"100%\" height=\"auto\">AMC&nbsp;was able to recapture the eight-day exponential moving average (EMA) as support but rejected, and wicked from, the 21-day EMA. Bulls will want to see AMC regain support of the level in the near term. AMC is trading well above the 200-day simple moving average, indicating overall sentiment in the stock remains bullish.</p><p><blockquote>AMC能够重新获得8日指数移动平均线(EMA)作为支撑，但拒绝并远离21日EMA。多头希望看到AMC在短期内重新获得该水平的支撑。AMC的交易价格远高于200日简单移动平均线，表明该股的整体情绪仍然看涨。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/afbe29a91b623abe465464f45c8889b6\" tg-width=\"1366\" tg-height=\"768\" width=\"100%\" height=\"auto\">Bulls want to see continued bullish volume push AMC over the 21-day EMA and up towards the $47.91 area. If it can regain the level as support, it could trade up toward $52.97.</p><p><blockquote>多头希望看到持续的看涨成交量推动AMC突破21日均线并升至47.91美元区域。如果它能够重新获得该水平作为支撑，它可能会上涨至52.97美元。</blockquote></p><p> Bears want to see AMC’s stock continue to reject the 21-day EMA and for it to drop down and lose support of the eight-day EMA which aligns with a support level at $39.71. If the stock were to lose the level, it could fall toward the $31.81 mark.</p><p><blockquote>空头希望看到AMC的股票继续拒绝21日均线，并下跌并失去8日均线的支撑，该支撑位与39.71美元的支撑位一致。如果该股跌破该水平，可能会跌至31.81美元大关。</blockquote></p><p> <b>AMC Price Action:</b>Shares of AMC Entertainment traded up 4.2% to $44.78 at publication time.</p><p><blockquote><b>AMC价格走势：</b>截至发稿时，AMC院线股价上涨4.2%，至44.78美元。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AMC Smokes Shorts Again: What's Next?<blockquote>AMC再次抽短裤：下一步是什么？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAMC Smokes Shorts Again: What's Next?<blockquote>AMC再次抽短裤：下一步是什么？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time smaller\">2021-07-21 22:36</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p><b>AMC Entertainment Holding Inc</b>(NYSE:AMC) shot up 24.47% Tuesday&nbsp;amid returned interest in reopening stocks. The company also announced on Monday evening it hadmade a dealto reopen the Grove Theatre and The Americana at Brand Theatre in the Los Angeles area in August under the AMC Brand. The two theatres were formerly leased by Pacific Theatres and are two of the highest-grossing theatres in Los Angeles.</p><p><blockquote><b>AMC院线控股公司</b>由于人们对重新开放股票的兴趣恢复，(NYSE：AMC)周二上涨24.47%。该公司周一晚间还宣布，已达成协议，将于8月份以AMC品牌重新开放洛杉矶地区的Grove剧院和Americana at Brand剧院。这两家剧院以前由太平洋剧院租赁，是洛杉矶票房最高的两家剧院。</blockquote></p><p> Although presently not the toptrendingstock on r/WallStreetBets, AMC was still the 10th most mentioned stock on Tuesday. The subreddit often targets stocks with unusual characteristics such as bizarre levels of ownership and high short interest. AMC’s underlying statistics have been improving over the last few months, however, and of the company’s 448.74 million share float 75.48 million shares are held short; this is down from 102.3 million in May.</p><p><blockquote>尽管AMC目前不是r/WallStreetBets上的热门股票，但它仍然是周二被提及次数第十多的股票。subreddit通常针对具有不寻常特征的股票，例如奇怪的所有权水平和高空头利息。然而，AMC的基本统计数据在过去几个月中一直在改善，该公司4.4874亿股流通股中，有7548万股被卖空；这比5月份的1.023亿有所下降。</blockquote></p><p> Despite short interest decreasing, AMC is still volatile and able to make big swings.</p><p><blockquote>尽管空头兴趣下降，AMC仍然不稳定，并且能够大幅波动。</blockquote></p><p> <b>The AMC Chart:</b>On Monday, during a big bear day in the general markets, AMC&nbsp;put in a bottom at $31.15 and managed to print a bullish hammer candlestick indicating higher prices would come on Tuesday. AMC then printed a bullish Marubozu candlestick on Tuesday. This Marubozu candle has a very small upper wick, indicating AMC had buyers at every price level it traded at intraday.</p><p><blockquote><b>AMC图表：</b>周一，在大盘大熊市期间，AMC触底31.15美元，并成功打印出看涨锤子烛台，表明周二价格将上涨。AMC随后在周二打印了看涨的Marubozu烛台。这根Marubozu蜡烛的上部灯芯非常小，表明AMC在盘中交易的每个价格水平都有买家。</blockquote></p><p> AMC broke into a downtrend on July 1 and made a series of lower highs and lower lows until Tuesday when the price closed at $43.08, above its lower high of $37.73, which indicates a bullish trend change. Bulls won’t want the stock to drop below $31.15 for the trend to be confirmed.</p><p><blockquote>AMC于7月1日进入下跌趋势，并创下一系列较低的高点和较低的低点，直到周二价格收于43.08美元，高于37.73美元的较低高点，这表明看涨趋势发生了变化。多头不希望该股跌破31.15美元以确认趋势。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/61ba2be17dcfd5bd5f6a00ab4398a5a6\" tg-width=\"651\" tg-height=\"256\" width=\"100%\" height=\"auto\">AMC&nbsp;was able to recapture the eight-day exponential moving average (EMA) as support but rejected, and wicked from, the 21-day EMA. Bulls will want to see AMC regain support of the level in the near term. AMC is trading well above the 200-day simple moving average, indicating overall sentiment in the stock remains bullish.</p><p><blockquote>AMC能够重新获得8日指数移动平均线(EMA)作为支撑，但拒绝并远离21日EMA。多头希望看到AMC在短期内重新获得该水平的支撑。AMC的交易价格远高于200日简单移动平均线，表明该股的整体情绪仍然看涨。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/afbe29a91b623abe465464f45c8889b6\" tg-width=\"1366\" tg-height=\"768\" width=\"100%\" height=\"auto\">Bulls want to see continued bullish volume push AMC over the 21-day EMA and up towards the $47.91 area. If it can regain the level as support, it could trade up toward $52.97.</p><p><blockquote>多头希望看到持续的看涨成交量推动AMC突破21日均线并升至47.91美元区域。如果它能够重新获得该水平作为支撑，它可能会上涨至52.97美元。</blockquote></p><p> Bears want to see AMC’s stock continue to reject the 21-day EMA and for it to drop down and lose support of the eight-day EMA which aligns with a support level at $39.71. If the stock were to lose the level, it could fall toward the $31.81 mark.</p><p><blockquote>空头希望看到AMC的股票继续拒绝21日均线，并下跌并失去8日均线的支撑，该支撑位与39.71美元的支撑位一致。如果该股跌破该水平，可能会跌至31.81美元大关。</blockquote></p><p> <b>AMC Price Action:</b>Shares of AMC Entertainment traded up 4.2% to $44.78 at publication time.</p><p><blockquote><b>AMC价格走势：</b>截至发稿时，AMC院线股价上涨4.2%，至44.78美元。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1109551881","content_text":"AMC Entertainment Holding Inc(NYSE:AMC) shot up 24.47% Tuesday amid returned interest in reopening stocks. The company also announced on Monday evening it hadmade a dealto reopen the Grove Theatre and The Americana at Brand Theatre in the Los Angeles area in August under the AMC Brand. The two theatres were formerly leased by Pacific Theatres and are two of the highest-grossing theatres in Los Angeles.\nAlthough presently not the toptrendingstock on r/WallStreetBets, AMC was still the 10th most mentioned stock on Tuesday. The subreddit often targets stocks with unusual characteristics such as bizarre levels of ownership and high short interest. AMC’s underlying statistics have been improving over the last few months, however, and of the company’s 448.74 million share float 75.48 million shares are held short; this is down from 102.3 million in May.\nDespite short interest decreasing, AMC is still volatile and able to make big swings.\nThe AMC Chart:On Monday, during a big bear day in the general markets, AMC put in a bottom at $31.15 and managed to print a bullish hammer candlestick indicating higher prices would come on Tuesday. AMC then printed a bullish Marubozu candlestick on Tuesday. This Marubozu candle has a very small upper wick, indicating AMC had buyers at every price level it traded at intraday.\nAMC broke into a downtrend on July 1 and made a series of lower highs and lower lows until Tuesday when the price closed at $43.08, above its lower high of $37.73, which indicates a bullish trend change. Bulls won’t want the stock to drop below $31.15 for the trend to be confirmed.\nAMC was able to recapture the eight-day exponential moving average (EMA) as support but rejected, and wicked from, the 21-day EMA. Bulls will want to see AMC regain support of the level in the near term. AMC is trading well above the 200-day simple moving average, indicating overall sentiment in the stock remains bullish.\nBulls want to see continued bullish volume push AMC over the 21-day EMA and up towards the $47.91 area. If it can regain the level as support, it could trade up toward $52.97.\nBears want to see AMC’s stock continue to reject the 21-day EMA and for it to drop down and lose support of the eight-day EMA which aligns with a support level at $39.71. If the stock were to lose the level, it could fall toward the $31.81 mark.\nAMC Price Action:Shares of AMC Entertainment traded up 4.2% to $44.78 at publication time.","news_type":1,"symbols_score_info":{"AMC":0.9}},"isVote":1,"tweetType":1,"viewCount":417,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":809027053,"gmtCreate":1627341274072,"gmtModify":1633766051975,"author":{"id":"4087514122562540","authorId":"4087514122562540","name":"74809e5c","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087514122562540","idStr":"4087514122562540"},"themes":[],"htmlText":"🍎👍","listText":"🍎👍","text":"🍎👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/809027053","repostId":"1100647798","repostType":4,"repost":{"id":"1100647798","kind":"news","pubTimestamp":1627313442,"share":"https://www.laohu8.com/m/news/1100647798?lang=zh_CN&edition=full","pubTime":"2021-07-26 23:30","market":"us","language":"en","title":"Apple Earnings Face High Expectations<blockquote>苹果盈利面临高预期</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1100647798","media":"seekingalpha","summary":"After the bell on Tuesday, we'll receive fiscal third quarter results from technology giant Apple  for its June ending period. With the company's previous two quarterly earnings reports smashing street estimates, it's not really a surprise that expectations have continued to rise. With shares rallying in recent weeks to new all-time highs, another strong report will likely be needed to keep things going.I'm sure analysts will also be looking to see how Apple has navigated the chip shortage as we","content":"<p><b>Summary</b></p><p><blockquote><b>总结</b></blockquote></p><p> <ul>  <li>Shares go into report near all-time high.</li>  <li>Estimates surge after two massive beats.</li>  <li>Timing of product launches will shift revenue picture.</li> </ul> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/bdd5b8fd99a0523d96bf052afd8c1b37\" tg-width=\"1536\" tg-height=\"988\" width=\"100%\" height=\"auto\"><span>Nikada/iStock Unreleased via Getty Images</span></p><p><blockquote><ul><li>股价接近历史新高。</li><li>两次大幅上涨后，预估值飙升。</li><li>产品发布的时间将改变收入状况。</li></ul><p class=\"t-img-caption\"><span>Nikada/iStock未通过Getty Images发布</span></p></blockquote></p><p> After the bell on Tuesday, we'll receive fiscal third quarter results from technology giant Apple (AAPL) for its June ending period. With the company's previous two quarterly earnings reports smashing street estimates, it's not really a surprise that expectations have continued to rise. With shares rallying in recent weeks to new all-time highs, another strong report will likely be needed to keep things going.</p><p><blockquote>周二盘后，我们将收到科技巨头苹果(AAPL)截至6月底的第三财季业绩。由于该公司前两个季度的收益报告超出了华尔街的预期，预期持续上升也就不足为奇了。随着最近几周股价上涨至历史新高，可能需要另一份强劲的报告来维持局面。</blockquote></p><p> For the first half of fiscal 2021, Apple's revenues have beaten street estimates by an average of $10.25 billion per quarter. The fiscal Q3&nbsp;current average estimate&nbsp;is $73.44 billion, which would represent growth of more than 23% from the year-ago period. It's quite impressive that the current average is up more than $13 billion over the past year. On the bottom line, the street is looking for $1.01, growth of more than 56%. In the table below, you can see some Q3 key financial items for the past two years, with the current estimates for this year's period in yellow. Dollar values are millions except per share amounts.</p><p><blockquote>2021财年上半年，苹果的收入平均每季度超出华尔街预期102.5亿美元。第三财季目前的平均预期为734.4亿美元，比去年同期增长23%以上。令人印象深刻的是，目前的平均水平在过去一年中增长了超过130亿美元。从底线来看，华尔街的目标是1.01美元，增长超过56%。在下表中，您可以看到过去两年第三季度的一些关键财务项目，今年同期的当前估计为黄色。除每股金额外，美元价值为数百万。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/df8630a7ef0be70113aeac0d50265a57\" tg-width=\"476\" tg-height=\"361\" width=\"100%\" height=\"auto\"><span>(*Numbers estimated based on last year's split. Actual numbers to come from the company. Source: Fiscal Q3 2020 report)</span></p><p><blockquote><p class=\"t-img-caption\"><span>（*根据去年的拆分估算的数字。实际数字来自公司。资料来源：2020财年第三季度报告）</span></p></blockquote></p><p> Apple is comingoff arguably&nbsp;its best quarter ever. Revenues for the iPhone were up more than 65.5% over the prior-year period, with the Mac up more than 70% and iPad up nearly 79%. Fiscal Q2 overall revenue growth was nearly 54%, so this time around we're looking for about 40% of that figure. Don't forget, on the&nbsp;Q2 conference call, management talked about a $3 billion to $4 billion revenue hit in the June period from supply constraints.</p><p><blockquote>苹果可以说是有史以来最好的季度。iPhone的收入同比增长超过65.5%，Mac增长超过70%，iPad增长近79%。第二财季整体收入增长近54%，因此这次我们预计这一数字的40%左右。别忘了，在第二季度电话会议上，管理层谈到6月份期间供应限制导致收入损失30亿至40亿美元。</blockquote></p><p> I'm most curious to see how the iPhone does this time around, as it appears that the 5G supercycle seems to be going pretty well. This year, however, most expectations are that the smartphone will return to its usual September launch period, meaning new phone revenues would be generated in fiscal Q4 again. Last year's coronavirus delayed launch meant sales didn't start until well into October and even November for some models, completely changing the sales trajectory for Apple's current fiscal year. This year's launch isn't expected to see a major upgrade to the phone line itself, so demand trends will probably be more dependent on how many consumers are upgrading to 5G rather than switching to iPhones.</p><p><blockquote>我最好奇的是这一次iPhone的表现如何，因为5G超级周期似乎进展顺利。然而，今年，大多数人预计智能手机将回到通常的9月发布期，这意味着新手机收入将在第四财季再次产生。去年的冠状病毒推迟了上市，这意味着某些车型直到10月甚至11月才开始销售，这完全改变了苹果本财年的销售轨迹。今年的发布预计不会对电话线本身进行重大升级，因此需求趋势可能更多地取决于有多少消费者升级到5G，而不是转向iPhone。</blockquote></p><p> I'm sure analysts will also be looking to see how Apple has navigated the chip shortage as well as soaring commodity prices. I don't think we will see a repeat of the 575 basis point increase in product gross margins that Q2 saw this time around, but the iPhone 12 line should still provide a nice year-over-year boost. In the long run, investors will look at growing services margins helping the gross margin percentage overall, but don't forget that the services side of the business has a lot of its expenses on the operating line.</p><p><blockquote>我相信分析师也将关注苹果如何应对芯片短缺和大宗商品价格飙升的问题。我认为我们不会看到第二季度产品毛利率增长575个基点的重演，但iPhone 12系列仍然应该会带来不错的同比增长。从长远来看，投资者将关注不断增长的服务利润率，以帮助提高整体毛利率，但不要忘记，业务的服务方面在运营方面有大量费用。</blockquote></p><p> For the stock to stay elevated, management is going to need to show that work from home and stimulus money tailwinds are still ongoing. As I discussed in&nbsp;a previous article, estimates call for Apple to see quarterly revenues decline for its March 2022 fiscal period, as the company laps very high previous year bars. While that might bring out some of the bears again, the long-term trajectory still seems positive. Current estimates call for $355 billion in total revenue during this fiscal year with Apple adding another $50 billion to that total over the next three years.</p><p><blockquote>为了使股价保持高位，管理层需要证明在家工作和刺激资金的顺风仍在持续。正如我在上一篇文章中讨论的那样，看涨期权预计苹果2022年3月财年的季度收入将下降，因为该公司去年的收入水平非常高。虽然这可能会再次引发一些空头，但长期轨迹似乎仍然是积极的。目前估计看涨期权本财年的总收入为3550亿美元，苹果将在未来三年内再增加500亿美元。</blockquote></p><p> I hope that management took advantage of the weakness in Apple shares during the quarter for its buyback. Even though the company is spending $20 billion or so every three months, that money doesn't go as far as $145 as it does at $125, obviously. Less shares repurchased means less of an earnings per share benefit, and lower long-term dividend raises. The good news is that Apple is on its way towards $100 billion a year in free cash flow, so investors don't need to worry about capital returns slowing down anytime soon.</p><p><blockquote>我希望管理层利用本季度苹果股价疲软的机会进行回购。尽管该公司每三个月花费200亿美元左右，但这笔钱显然不会像125美元那样达到145美元。回购的股票越少意味着每股收益收益越少，长期股息提高也越低。好消息是，苹果的自由现金流即将达到每年1000亿美元，因此投资者无需担心资本回报会很快放缓。</blockquote></p><p></p><p> The major issue for Apple right now is valuation. Shares finished last week trading at 33.4 times their trailing twelve-month earnings. That's basically double the mid-teens numbers from a couple of years ago, helped a lot by easy-money policies around the globe. My current price target of $162 is based on a 30X multiple of $5.40 in EPS for the September 2022 period. That number, however, assumes that the Fed and other central banks will remain fairly accommodative through most of next year. If we start to get a lot of tapering and or rate hikes earlier than expected, the overall market is likely to feel some pain, and I don't see how Apple would be immune from that.</p><p><blockquote>苹果目前的主要问题是估值。上周股价是过去12个月市盈率的33.4倍。这基本上是几年前青少年人数的两倍，这在很大程度上得益于全球宽松货币政策。我目前162美元的目标价是基于2022年9月期间每股收益5.40美元的30倍。然而，这个数字是假设美联储和其他央行在明年大部分时间里将保持相当宽松的政策。如果我们比预期更早地开始大量缩减和/或加息，整个市场可能会感到一些痛苦，我看不出苹果会如何免受此影响。</blockquote></p><p> A strong report from Apple could easily help shares to rise to a new all-time high. But just to play devil's advocate for a minute, what if there is a disappointment or a \"buy the rumor, sell the news\" reaction? Well, shares are quite a bit above their key moving averages as seen in the chart below (50-day in purple, 200-day in orange). As long as Apple can hold the shorter-term trend line, that rising technical level should be one of support. The stock has been able to hold the long-term trend line for quite a while, so I don't see any more than about 14% downside in the near term unless we get a major market pullback.</p><p><blockquote>苹果的强劲报告很容易帮助股价升至历史新高。但只是为了唱反调一分钟，如果出现失望或“买入谣言，卖出新闻”的反应怎么办？嗯，股价远高于其关键移动平均线，如下图所示（紫色为50日，橙色为200日）。只要苹果能够守住短期趋势线，上涨的技术水平应该是支撑之一。该股已经能够在相当长一段时间内保持长期趋势线，因此我认为短期内的下跌幅度不会超过14%左右，除非市场出现重大回调。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/dc37ee144edb22fd36fcd15cf5fc3470\" tg-width=\"640\" tg-height=\"273\" width=\"100%\" height=\"auto\"><span>(Source: Yahoo! Finance)</span></p><p><blockquote><p class=\"t-img-caption\"><span>（来源：雅虎财经）</span></p></blockquote></p><p> In the end, expectations for Apple are very high as earnings approach this week. Two massive quarterly beats have sent estimates through the roof, and the stock has recently run to a new all-time high. The market will be looking for signs that the iPhone supercycle has continued while work from home tailwinds have not subsided just yet. Investors hoping that this rally can continue will need to see a strong report, with management hopefully painting a bright sales picture for upcoming fall product launches.</p><p><blockquote>最后，随着本周财报的临近，人们对苹果的期望非常高。两个巨大的季度业绩超出了预期，该股最近创下了历史新高。市场将寻找iPhone超级周期仍在继续的迹象，而在家工作的顺风尚未消退。希望这种涨势能够持续下去的投资者需要看到一份强劲的报告，管理层希望为即将到来的秋季产品发布描绘一幅光明的销售图景。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Earnings Face High Expectations<blockquote>苹果盈利面临高预期</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Earnings Face High Expectations<blockquote>苹果盈利面临高预期</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">seekingalpha</strong><span class=\"h-time small\">2021-07-26 23:30</span>\n</p>\n</h4>\n</header>\n<article>\n<p><b>Summary</b></p><p><blockquote><b>总结</b></blockquote></p><p> <ul>  <li>Shares go into report near all-time high.</li>  <li>Estimates surge after two massive beats.</li>  <li>Timing of product launches will shift revenue picture.</li> </ul> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/bdd5b8fd99a0523d96bf052afd8c1b37\" tg-width=\"1536\" tg-height=\"988\" width=\"100%\" height=\"auto\"><span>Nikada/iStock Unreleased via Getty Images</span></p><p><blockquote><ul><li>股价接近历史新高。</li><li>两次大幅上涨后，预估值飙升。</li><li>产品发布的时间将改变收入状况。</li></ul><p class=\"t-img-caption\"><span>Nikada/iStock未通过Getty Images发布</span></p></blockquote></p><p> After the bell on Tuesday, we'll receive fiscal third quarter results from technology giant Apple (AAPL) for its June ending period. With the company's previous two quarterly earnings reports smashing street estimates, it's not really a surprise that expectations have continued to rise. With shares rallying in recent weeks to new all-time highs, another strong report will likely be needed to keep things going.</p><p><blockquote>周二盘后，我们将收到科技巨头苹果(AAPL)截至6月底的第三财季业绩。由于该公司前两个季度的收益报告超出了华尔街的预期，预期持续上升也就不足为奇了。随着最近几周股价上涨至历史新高，可能需要另一份强劲的报告来维持局面。</blockquote></p><p> For the first half of fiscal 2021, Apple's revenues have beaten street estimates by an average of $10.25 billion per quarter. The fiscal Q3&nbsp;current average estimate&nbsp;is $73.44 billion, which would represent growth of more than 23% from the year-ago period. It's quite impressive that the current average is up more than $13 billion over the past year. On the bottom line, the street is looking for $1.01, growth of more than 56%. In the table below, you can see some Q3 key financial items for the past two years, with the current estimates for this year's period in yellow. Dollar values are millions except per share amounts.</p><p><blockquote>2021财年上半年，苹果的收入平均每季度超出华尔街预期102.5亿美元。第三财季目前的平均预期为734.4亿美元，比去年同期增长23%以上。令人印象深刻的是，目前的平均水平在过去一年中增长了超过130亿美元。从底线来看，华尔街的目标是1.01美元，增长超过56%。在下表中，您可以看到过去两年第三季度的一些关键财务项目，今年同期的当前估计为黄色。除每股金额外，美元价值为数百万。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/df8630a7ef0be70113aeac0d50265a57\" tg-width=\"476\" tg-height=\"361\" width=\"100%\" height=\"auto\"><span>(*Numbers estimated based on last year's split. Actual numbers to come from the company. Source: Fiscal Q3 2020 report)</span></p><p><blockquote><p class=\"t-img-caption\"><span>（*根据去年的拆分估算的数字。实际数字来自公司。资料来源：2020财年第三季度报告）</span></p></blockquote></p><p> Apple is comingoff arguably&nbsp;its best quarter ever. Revenues for the iPhone were up more than 65.5% over the prior-year period, with the Mac up more than 70% and iPad up nearly 79%. Fiscal Q2 overall revenue growth was nearly 54%, so this time around we're looking for about 40% of that figure. Don't forget, on the&nbsp;Q2 conference call, management talked about a $3 billion to $4 billion revenue hit in the June period from supply constraints.</p><p><blockquote>苹果可以说是有史以来最好的季度。iPhone的收入同比增长超过65.5%，Mac增长超过70%，iPad增长近79%。第二财季整体收入增长近54%，因此这次我们预计这一数字的40%左右。别忘了，在第二季度电话会议上，管理层谈到6月份期间供应限制导致收入损失30亿至40亿美元。</blockquote></p><p> I'm most curious to see how the iPhone does this time around, as it appears that the 5G supercycle seems to be going pretty well. This year, however, most expectations are that the smartphone will return to its usual September launch period, meaning new phone revenues would be generated in fiscal Q4 again. Last year's coronavirus delayed launch meant sales didn't start until well into October and even November for some models, completely changing the sales trajectory for Apple's current fiscal year. This year's launch isn't expected to see a major upgrade to the phone line itself, so demand trends will probably be more dependent on how many consumers are upgrading to 5G rather than switching to iPhones.</p><p><blockquote>我最好奇的是这一次iPhone的表现如何，因为5G超级周期似乎进展顺利。然而，今年，大多数人预计智能手机将回到通常的9月发布期，这意味着新手机收入将在第四财季再次产生。去年的冠状病毒推迟了上市，这意味着某些车型直到10月甚至11月才开始销售，这完全改变了苹果本财年的销售轨迹。今年的发布预计不会对电话线本身进行重大升级，因此需求趋势可能更多地取决于有多少消费者升级到5G，而不是转向iPhone。</blockquote></p><p> I'm sure analysts will also be looking to see how Apple has navigated the chip shortage as well as soaring commodity prices. I don't think we will see a repeat of the 575 basis point increase in product gross margins that Q2 saw this time around, but the iPhone 12 line should still provide a nice year-over-year boost. In the long run, investors will look at growing services margins helping the gross margin percentage overall, but don't forget that the services side of the business has a lot of its expenses on the operating line.</p><p><blockquote>我相信分析师也将关注苹果如何应对芯片短缺和大宗商品价格飙升的问题。我认为我们不会看到第二季度产品毛利率增长575个基点的重演，但iPhone 12系列仍然应该会带来不错的同比增长。从长远来看，投资者将关注不断增长的服务利润率，以帮助提高整体毛利率，但不要忘记，业务的服务方面在运营方面有大量费用。</blockquote></p><p> For the stock to stay elevated, management is going to need to show that work from home and stimulus money tailwinds are still ongoing. As I discussed in&nbsp;a previous article, estimates call for Apple to see quarterly revenues decline for its March 2022 fiscal period, as the company laps very high previous year bars. While that might bring out some of the bears again, the long-term trajectory still seems positive. Current estimates call for $355 billion in total revenue during this fiscal year with Apple adding another $50 billion to that total over the next three years.</p><p><blockquote>为了使股价保持高位，管理层需要证明在家工作和刺激资金的顺风仍在持续。正如我在上一篇文章中讨论的那样，看涨期权预计苹果2022年3月财年的季度收入将下降，因为该公司去年的收入水平非常高。虽然这可能会再次引发一些空头，但长期轨迹似乎仍然是积极的。目前估计看涨期权本财年的总收入为3550亿美元，苹果将在未来三年内再增加500亿美元。</blockquote></p><p> I hope that management took advantage of the weakness in Apple shares during the quarter for its buyback. Even though the company is spending $20 billion or so every three months, that money doesn't go as far as $145 as it does at $125, obviously. Less shares repurchased means less of an earnings per share benefit, and lower long-term dividend raises. The good news is that Apple is on its way towards $100 billion a year in free cash flow, so investors don't need to worry about capital returns slowing down anytime soon.</p><p><blockquote>我希望管理层利用本季度苹果股价疲软的机会进行回购。尽管该公司每三个月花费200亿美元左右，但这笔钱显然不会像125美元那样达到145美元。回购的股票越少意味着每股收益收益越少，长期股息提高也越低。好消息是，苹果的自由现金流即将达到每年1000亿美元，因此投资者无需担心资本回报会很快放缓。</blockquote></p><p></p><p> The major issue for Apple right now is valuation. Shares finished last week trading at 33.4 times their trailing twelve-month earnings. That's basically double the mid-teens numbers from a couple of years ago, helped a lot by easy-money policies around the globe. My current price target of $162 is based on a 30X multiple of $5.40 in EPS for the September 2022 period. That number, however, assumes that the Fed and other central banks will remain fairly accommodative through most of next year. If we start to get a lot of tapering and or rate hikes earlier than expected, the overall market is likely to feel some pain, and I don't see how Apple would be immune from that.</p><p><blockquote>苹果目前的主要问题是估值。上周股价是过去12个月市盈率的33.4倍。这基本上是几年前青少年人数的两倍，这在很大程度上得益于全球宽松货币政策。我目前162美元的目标价是基于2022年9月期间每股收益5.40美元的30倍。然而，这个数字是假设美联储和其他央行在明年大部分时间里将保持相当宽松的政策。如果我们比预期更早地开始大量缩减和/或加息，整个市场可能会感到一些痛苦，我看不出苹果会如何免受此影响。</blockquote></p><p> A strong report from Apple could easily help shares to rise to a new all-time high. But just to play devil's advocate for a minute, what if there is a disappointment or a \"buy the rumor, sell the news\" reaction? Well, shares are quite a bit above their key moving averages as seen in the chart below (50-day in purple, 200-day in orange). As long as Apple can hold the shorter-term trend line, that rising technical level should be one of support. The stock has been able to hold the long-term trend line for quite a while, so I don't see any more than about 14% downside in the near term unless we get a major market pullback.</p><p><blockquote>苹果的强劲报告很容易帮助股价升至历史新高。但只是为了唱反调一分钟，如果出现失望或“买入谣言，卖出新闻”的反应怎么办？嗯，股价远高于其关键移动平均线，如下图所示（紫色为50日，橙色为200日）。只要苹果能够守住短期趋势线，上涨的技术水平应该是支撑之一。该股已经能够在相当长一段时间内保持长期趋势线，因此我认为短期内的下跌幅度不会超过14%左右，除非市场出现重大回调。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/dc37ee144edb22fd36fcd15cf5fc3470\" tg-width=\"640\" tg-height=\"273\" width=\"100%\" height=\"auto\"><span>(Source: Yahoo! Finance)</span></p><p><blockquote><p class=\"t-img-caption\"><span>（来源：雅虎财经）</span></p></blockquote></p><p> In the end, expectations for Apple are very high as earnings approach this week. Two massive quarterly beats have sent estimates through the roof, and the stock has recently run to a new all-time high. The market will be looking for signs that the iPhone supercycle has continued while work from home tailwinds have not subsided just yet. Investors hoping that this rally can continue will need to see a strong report, with management hopefully painting a bright sales picture for upcoming fall product launches.</p><p><blockquote>最后，随着本周财报的临近，人们对苹果的期望非常高。两个巨大的季度业绩超出了预期，该股最近创下了历史新高。市场将寻找iPhone超级周期仍在继续的迹象，而在家工作的顺风尚未消退。希望这种涨势能够持续下去的投资者需要看到一份强劲的报告，管理层希望为即将到来的秋季产品发布描绘一幅光明的销售图景。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://seekingalpha.com/article/4441375-apple-earnings-face-high-expectations\">seekingalpha</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://seekingalpha.com/article/4441375-apple-earnings-face-high-expectations","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1100647798","content_text":"Summary\n\nShares go into report near all-time high.\nEstimates surge after two massive beats.\nTiming of product launches will shift revenue picture.\n\nNikada/iStock Unreleased via Getty Images\nAfter the bell on Tuesday, we'll receive fiscal third quarter results from technology giant Apple (AAPL) for its June ending period. With the company's previous two quarterly earnings reports smashing street estimates, it's not really a surprise that expectations have continued to rise. With shares rallying in recent weeks to new all-time highs, another strong report will likely be needed to keep things going.\nFor the first half of fiscal 2021, Apple's revenues have beaten street estimates by an average of $10.25 billion per quarter. The fiscal Q3 current average estimate is $73.44 billion, which would represent growth of more than 23% from the year-ago period. It's quite impressive that the current average is up more than $13 billion over the past year. On the bottom line, the street is looking for $1.01, growth of more than 56%. In the table below, you can see some Q3 key financial items for the past two years, with the current estimates for this year's period in yellow. Dollar values are millions except per share amounts.\n(*Numbers estimated based on last year's split. Actual numbers to come from the company. Source: Fiscal Q3 2020 report)\nApple is comingoff arguably its best quarter ever. Revenues for the iPhone were up more than 65.5% over the prior-year period, with the Mac up more than 70% and iPad up nearly 79%. Fiscal Q2 overall revenue growth was nearly 54%, so this time around we're looking for about 40% of that figure. Don't forget, on the Q2 conference call, management talked about a $3 billion to $4 billion revenue hit in the June period from supply constraints.\nI'm most curious to see how the iPhone does this time around, as it appears that the 5G supercycle seems to be going pretty well. This year, however, most expectations are that the smartphone will return to its usual September launch period, meaning new phone revenues would be generated in fiscal Q4 again. Last year's coronavirus delayed launch meant sales didn't start until well into October and even November for some models, completely changing the sales trajectory for Apple's current fiscal year. This year's launch isn't expected to see a major upgrade to the phone line itself, so demand trends will probably be more dependent on how many consumers are upgrading to 5G rather than switching to iPhones.\nI'm sure analysts will also be looking to see how Apple has navigated the chip shortage as well as soaring commodity prices. I don't think we will see a repeat of the 575 basis point increase in product gross margins that Q2 saw this time around, but the iPhone 12 line should still provide a nice year-over-year boost. In the long run, investors will look at growing services margins helping the gross margin percentage overall, but don't forget that the services side of the business has a lot of its expenses on the operating line.\nFor the stock to stay elevated, management is going to need to show that work from home and stimulus money tailwinds are still ongoing. As I discussed in a previous article, estimates call for Apple to see quarterly revenues decline for its March 2022 fiscal period, as the company laps very high previous year bars. While that might bring out some of the bears again, the long-term trajectory still seems positive. Current estimates call for $355 billion in total revenue during this fiscal year with Apple adding another $50 billion to that total over the next three years.\nI hope that management took advantage of the weakness in Apple shares during the quarter for its buyback. Even though the company is spending $20 billion or so every three months, that money doesn't go as far as $145 as it does at $125, obviously. Less shares repurchased means less of an earnings per share benefit, and lower long-term dividend raises. The good news is that Apple is on its way towards $100 billion a year in free cash flow, so investors don't need to worry about capital returns slowing down anytime soon.\nThe major issue for Apple right now is valuation. Shares finished last week trading at 33.4 times their trailing twelve-month earnings. That's basically double the mid-teens numbers from a couple of years ago, helped a lot by easy-money policies around the globe. My current price target of $162 is based on a 30X multiple of $5.40 in EPS for the September 2022 period. That number, however, assumes that the Fed and other central banks will remain fairly accommodative through most of next year. If we start to get a lot of tapering and or rate hikes earlier than expected, the overall market is likely to feel some pain, and I don't see how Apple would be immune from that.\nA strong report from Apple could easily help shares to rise to a new all-time high. But just to play devil's advocate for a minute, what if there is a disappointment or a \"buy the rumor, sell the news\" reaction? Well, shares are quite a bit above their key moving averages as seen in the chart below (50-day in purple, 200-day in orange). As long as Apple can hold the shorter-term trend line, that rising technical level should be one of support. The stock has been able to hold the long-term trend line for quite a while, so I don't see any more than about 14% downside in the near term unless we get a major market pullback.\n(Source: Yahoo! Finance)\nIn the end, expectations for Apple are very high as earnings approach this week. Two massive quarterly beats have sent estimates through the roof, and the stock has recently run to a new all-time high. The market will be looking for signs that the iPhone supercycle has continued while work from home tailwinds have not subsided just yet. Investors hoping that this rally can continue will need to see a strong report, with management hopefully painting a bright sales picture for upcoming fall product launches.","news_type":1,"symbols_score_info":{"AAPL":0.9}},"isVote":1,"tweetType":1,"viewCount":427,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":179563525,"gmtCreate":1626565025767,"gmtModify":1633925918627,"author":{"id":"4087514122562540","authorId":"4087514122562540","name":"74809e5c","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087514122562540","idStr":"4087514122562540"},"themes":[],"htmlText":"👌","listText":"👌","text":"👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/179563525","repostId":"1198202103","repostType":4,"isVote":1,"tweetType":1,"viewCount":240,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":898876730,"gmtCreate":1628488553820,"gmtModify":1631893327878,"author":{"id":"4087514122562540","authorId":"4087514122562540","name":"74809e5c","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087514122562540","idStr":"4087514122562540"},"themes":[],"htmlText":"🍎👍🆙🆙🆙","listText":"🍎👍🆙🆙🆙","text":"🍎👍🆙🆙🆙","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/898876730","repostId":"2157492988","repostType":4,"isVote":1,"tweetType":1,"viewCount":322,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":690311192,"gmtCreate":1639633092338,"gmtModify":1639633092597,"author":{"id":"4087514122562540","authorId":"4087514122562540","name":"74809e5c","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087514122562540","idStr":"4087514122562540"},"themes":[],"htmlText":"👌","listText":"👌","text":"👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690311192","repostId":"1170403163","repostType":4,"repost":{"id":"1170403163","kind":"news","pubTimestamp":1639631616,"share":"https://www.laohu8.com/m/news/1170403163?lang=zh_CN&edition=full","pubTime":"2021-12-16 13:13","market":"us","language":"en","title":"These were the 10 best performing IPOs of 2021 amid a record year for stock market debuts<blockquote>这些是2021年股市首次亮相创纪录的10家表现最佳的IPO</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1170403163","media":"Markets Insider","summary":"2021 was a record year for IPOs, with 2,388 new companies listing their shares around the globe.\nThe","content":"<p><ul>  <li><b>2021 was a record year for IPOs, with 2,388 new companies listing their shares around the globe.</b></li>  <li><b>The red-hot IPO market this year occurred amid a relentless grind higher in the broader stock market.</b></li>  <li><b>These are the 10 best performing US stocks that went public in 2021.</b></li> </ul> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4fc9bdacbbacd4a99b22407604d69e6e\" tg-width=\"790\" tg-height=\"395\" width=\"100%\" height=\"auto\"><span>A stock trader claps at the end of trade at the New York Stock Exchange.</span></p><p><blockquote><ul><li><b>2021年是IPO创纪录的一年，全球有2,388家新公司上市。</b></li><li><b>今年IPO市场火爆之际，大盘不断走高。</b></li><li><b>这些是2021年上市的10只表现最好的美国股票。</b></li></ul><p class=\"t-img-caption\"><span>一名股票交易员在纽约证券交易所交易结束时鼓掌。</span></p></blockquote></p><p> Record highs in the stock market&nbsp;have facilitated a boom in new company listings this year, with a record 2,388 firms going public around the globe, according to&nbsp;data from Ernst and Young.</p><p><blockquote>安永（Ernst and Young）的数据显示，股市创纪录的高点推动了今年新公司上市的热潮，全球有创纪录的2,388家公司上市。</blockquote></p><p> Helping drive a resurgence in new company listings were SPACs, which peaked in early 2021 after a surge last year. Altogether, companies have raised $453 billion in proceeds from their IPOs, representing a 67% increase relative to 2020 and a more than doubling from 2019 levels.</p><p><blockquote>SPAC帮助推动了新公司上市的复苏，在去年激增后，SPAC于2021年初达到顶峰。总的来说，公司通过IPO筹集了4530亿美元的资金，比2020年增长了67%，比2019年的水平增加了一倍多。</blockquote></p><p> Firms going public have predominately been in the technology sector, and the Nasdaq Exchange captured the most IPOs relative to other global stock exchanges.High profile IPOs&nbsp;this year include electric vehicle startups&nbsp;Rivian&nbsp;and&nbsp;Lucid Group, and direct-to-consumer brands&nbsp;Allbirds&nbsp;and&nbsp;Warby Parker.</p><p><blockquote>上市公司主要集中在科技行业，相对于其他全球证券交易所，纳斯达克交易所的IPO数量最多。今年备受瞩目的IPO包括电动汽车初创公司Rivian和Lucid Group，以及直接面向消费者的品牌Allbirds和Warby Parker。</blockquote></p><p> And with more than 900 IPOs this year on US exchanges alone, there have been plenty of big winners and losers.</p><p><blockquote>今年仅美国交易所就有900多起IPO，其中不乏大赢家和大输家。</blockquote></p><p> These are the 10 best performing US IPOs of 2021 of companies with at least a $1 billion market capitalization. All performance data is as of December 15 and was sourced from&nbsp;Koyfin.&nbsp;(However, the chart action shown below reflects performance based on the opening price of a stock on its first day of trades, not its IPO price.)</p><p><blockquote>这些是2021年美国市值至少10亿美元的10家公司中表现最好的IPO。所有业绩数据截至12月15日，均来自Koyfin。（但是，下面显示的图表操作反映的业绩基于股票首日交易的开盘价，而不是IPO价格。）</blockquote></p><p> <b>10. Prometheus Biosciences</b></p><p><blockquote><b>10.普罗米修斯生物科学公司</b></blockquote></p><p> <b>Ticker:RXDX</b></p><p><blockquote><b>股票代码：RXDX</b></blockquote></p><p> <b>Gain Since IPO Price: 72%</b></p><p><blockquote><b>自IPO价格以来的涨幅：72%</b></blockquote></p><p> <b>Market Capitalization: $1.3 billion</b></p><p><blockquote><b>市值：13亿美元</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/bfb6ec8f3b653138c4425868d1d79de9\" tg-width=\"647\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p> <b>9. Verve Therapeutics</b></p><p><blockquote><b>9.神韵疗法</b></blockquote></p><p> <b>Ticker:VERV</b></p><p><blockquote><b>股票代码：VERV</b></blockquote></p><p> <b>Gain Since IPO Price: 75%</b></p><p><blockquote><b>自IPO价格以来的涨幅：75%</b></blockquote></p><p> <b>Market Capitalization: $1.6 billion</b></p><p><blockquote><b>市值：16亿美元</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3dc78c11f5c162a9c1e7a279f1708126\" tg-width=\"639\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p> <b>8. TaskUs</b></p><p><blockquote><b>8.我的任务</b></blockquote></p><p> <b>Ticker:TASK</b></p><p><blockquote><b>股票代码：任务</b></blockquote></p><p> <b>Gain Since IPO Price: 91%</b></p><p><blockquote><b>自IPO价格以来的涨幅：91%</b></blockquote></p><p> <b>Market Capitalization: $4.3 billion</b></p><p><blockquote><b>市值：43亿美元</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f59d1387b908b8e02697da615a3f5ba4\" tg-width=\"656\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p> <b>7. Kanzhun</b></p><p><blockquote><b>7.看准</b></blockquote></p><p> <b>Ticker:BZ</b></p><p><blockquote><b>股票代码：BZ</b></blockquote></p><p> <b>Gain Since IPO Price: 93%</b></p><p><blockquote><b>自IPO价格以来的涨幅：93%</b></blockquote></p><p> <b>Market Capitalization: $14.7 billion</b></p><p><blockquote><b>市值：147亿美元</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f04f7fc1885d88d97c1864a339e25d32\" tg-width=\"656\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p> <b>6. Dutch Bros</b></p><p><blockquote><b>6.荷兰兄弟</b></blockquote></p><p> <b>Ticker:BROS</b></p><p><blockquote><b>股票代码：兄弟</b></blockquote></p><p> <b>Gain Since IPO Price: 98%</b></p><p><blockquote><b>自IPO价格以来的涨幅：98%</b></blockquote></p><p> <b>Market Capitalization: $7.5 billion</b></p><p><blockquote><b>市值：75亿美元</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5b915d62d3fdfce5ea3188beb282ab47\" tg-width=\"668\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p> <b>5. Doximity</b></p><p><blockquote><b>5.剂量</b></blockquote></p><p> <b>Ticker:DOCS</b></p><p><blockquote><b>股票代码：DOCS</b></blockquote></p><p> <b>Gain Since IPO Price: 108%</b></p><p><blockquote><b>自IPO价格以来的涨幅：108%</b></blockquote></p><p> <b>Market Capitalization: $10.1 billion</b></p><p><blockquote><b>市值：101亿美元</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7d03dbe2dc83a8512105da91ac5151dc\" tg-width=\"669\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p> <b>4. Affirm</b></p><p><blockquote><b>4.确认</b></blockquote></p><p> <b>Ticker:AFRM</b></p><p><blockquote><b>股票代码：AFRM</b></blockquote></p><p> <b>Gain Since IPO Price: 111%</b></p><p><blockquote><b>自IPO价格以来的涨幅：111%</b></blockquote></p><p> <b>Market Capitalization: $29.0 billion</b></p><p><blockquote><b>市值：290亿美元</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/27a04903a7c07c0ecf5edf3ddaf2d730\" tg-width=\"670\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p> <b>3. Global-e Online</b></p><p><blockquote><b>3.Global-E Online</b></blockquote></p><p> <b>Ticker:GLBE</b></p><p><blockquote><b>股票代码：GLBE</b></blockquote></p><p> <b>Gain Since IPO Price: 120%</b></p><p><blockquote><b>自IPO价格以来的涨幅：120%</b></blockquote></p><p> <b>Market Capitalization: $8.0 billion</b></p><p><blockquote><b>市值：80亿美元</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0d88ded78988981e08d54b1287cbf948\" tg-width=\"664\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p> <b>2. ZIM Integrated Shipping Services</b></p><p><blockquote><b>2.以星综合航运服务</b></blockquote></p><p> <b>Ticker:ZIM</b></p><p><blockquote><b>股票代码：ZIM</b></blockquote></p><p> <b>Gain Since IPO Price: 208%</b></p><p><blockquote><b>自IPO价格以来的涨幅：208%</b></blockquote></p><p> <b>Market Capitalization: $5.8 billion</b></p><p><blockquote><b>市值：58亿美元</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f32668f19b1e8678dcd33e3bbe3b0d9c\" tg-width=\"613\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p> <b>1. Digital World Acquisition</b></p><p><blockquote><b>1.数字世界收购</b></blockquote></p><p> <b>Ticker:DWAC</b></p><p><blockquote><b>股票代码：DWAC</b></blockquote></p><p> <b>Gain Since IPO Price: 508%</b></p><p><blockquote><b>自IPO价格以来的涨幅：508%</b></blockquote></p><p> <b>Market Capitalization: $1.9 billion</b></p><p><blockquote><b>市值：19亿美元</b></blockquote></p><p></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/573ffacec216fcb41798f52b67583456\" tg-width=\"615\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These were the 10 best performing IPOs of 2021 amid a record year for stock market debuts<blockquote>这些是2021年股市首次亮相创纪录的10家表现最佳的IPO</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese were the 10 best performing IPOs of 2021 amid a record year for stock market debuts<blockquote>这些是2021年股市首次亮相创纪录的10家表现最佳的IPO</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Markets Insider</strong><span class=\"h-time small\">2021-12-16 13:13</span>\n</p>\n</h4>\n</header>\n<article>\n<p><ul>  <li><b>2021 was a record year for IPOs, with 2,388 new companies listing their shares around the globe.</b></li>  <li><b>The red-hot IPO market this year occurred amid a relentless grind higher in the broader stock market.</b></li>  <li><b>These are the 10 best performing US stocks that went public in 2021.</b></li> </ul> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4fc9bdacbbacd4a99b22407604d69e6e\" tg-width=\"790\" tg-height=\"395\" width=\"100%\" height=\"auto\"><span>A stock trader claps at the end of trade at the New York Stock Exchange.</span></p><p><blockquote><ul><li><b>2021年是IPO创纪录的一年，全球有2,388家新公司上市。</b></li><li><b>今年IPO市场火爆之际，大盘不断走高。</b></li><li><b>这些是2021年上市的10只表现最好的美国股票。</b></li></ul><p class=\"t-img-caption\"><span>一名股票交易员在纽约证券交易所交易结束时鼓掌。</span></p></blockquote></p><p> Record highs in the stock market&nbsp;have facilitated a boom in new company listings this year, with a record 2,388 firms going public around the globe, according to&nbsp;data from Ernst and Young.</p><p><blockquote>安永（Ernst and Young）的数据显示，股市创纪录的高点推动了今年新公司上市的热潮，全球有创纪录的2,388家公司上市。</blockquote></p><p> Helping drive a resurgence in new company listings were SPACs, which peaked in early 2021 after a surge last year. Altogether, companies have raised $453 billion in proceeds from their IPOs, representing a 67% increase relative to 2020 and a more than doubling from 2019 levels.</p><p><blockquote>SPAC帮助推动了新公司上市的复苏，在去年激增后，SPAC于2021年初达到顶峰。总的来说，公司通过IPO筹集了4530亿美元的资金，比2020年增长了67%，比2019年的水平增加了一倍多。</blockquote></p><p> Firms going public have predominately been in the technology sector, and the Nasdaq Exchange captured the most IPOs relative to other global stock exchanges.High profile IPOs&nbsp;this year include electric vehicle startups&nbsp;Rivian&nbsp;and&nbsp;Lucid Group, and direct-to-consumer brands&nbsp;Allbirds&nbsp;and&nbsp;Warby Parker.</p><p><blockquote>上市公司主要集中在科技行业，相对于其他全球证券交易所，纳斯达克交易所的IPO数量最多。今年备受瞩目的IPO包括电动汽车初创公司Rivian和Lucid Group，以及直接面向消费者的品牌Allbirds和Warby Parker。</blockquote></p><p> And with more than 900 IPOs this year on US exchanges alone, there have been plenty of big winners and losers.</p><p><blockquote>今年仅美国交易所就有900多起IPO，其中不乏大赢家和大输家。</blockquote></p><p> These are the 10 best performing US IPOs of 2021 of companies with at least a $1 billion market capitalization. All performance data is as of December 15 and was sourced from&nbsp;Koyfin.&nbsp;(However, the chart action shown below reflects performance based on the opening price of a stock on its first day of trades, not its IPO price.)</p><p><blockquote>这些是2021年美国市值至少10亿美元的10家公司中表现最好的IPO。所有业绩数据截至12月15日，均来自Koyfin。（但是，下面显示的图表操作反映的业绩基于股票首日交易的开盘价，而不是IPO价格。）</blockquote></p><p> <b>10. Prometheus Biosciences</b></p><p><blockquote><b>10.普罗米修斯生物科学公司</b></blockquote></p><p> <b>Ticker:RXDX</b></p><p><blockquote><b>股票代码：RXDX</b></blockquote></p><p> <b>Gain Since IPO Price: 72%</b></p><p><blockquote><b>自IPO价格以来的涨幅：72%</b></blockquote></p><p> <b>Market Capitalization: $1.3 billion</b></p><p><blockquote><b>市值：13亿美元</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/bfb6ec8f3b653138c4425868d1d79de9\" tg-width=\"647\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p> <b>9. Verve Therapeutics</b></p><p><blockquote><b>9.神韵疗法</b></blockquote></p><p> <b>Ticker:VERV</b></p><p><blockquote><b>股票代码：VERV</b></blockquote></p><p> <b>Gain Since IPO Price: 75%</b></p><p><blockquote><b>自IPO价格以来的涨幅：75%</b></blockquote></p><p> <b>Market Capitalization: $1.6 billion</b></p><p><blockquote><b>市值：16亿美元</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3dc78c11f5c162a9c1e7a279f1708126\" tg-width=\"639\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p> <b>8. TaskUs</b></p><p><blockquote><b>8.我的任务</b></blockquote></p><p> <b>Ticker:TASK</b></p><p><blockquote><b>股票代码：任务</b></blockquote></p><p> <b>Gain Since IPO Price: 91%</b></p><p><blockquote><b>自IPO价格以来的涨幅：91%</b></blockquote></p><p> <b>Market Capitalization: $4.3 billion</b></p><p><blockquote><b>市值：43亿美元</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f59d1387b908b8e02697da615a3f5ba4\" tg-width=\"656\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p> <b>7. Kanzhun</b></p><p><blockquote><b>7.看准</b></blockquote></p><p> <b>Ticker:BZ</b></p><p><blockquote><b>股票代码：BZ</b></blockquote></p><p> <b>Gain Since IPO Price: 93%</b></p><p><blockquote><b>自IPO价格以来的涨幅：93%</b></blockquote></p><p> <b>Market Capitalization: $14.7 billion</b></p><p><blockquote><b>市值：147亿美元</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f04f7fc1885d88d97c1864a339e25d32\" tg-width=\"656\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p> <b>6. Dutch Bros</b></p><p><blockquote><b>6.荷兰兄弟</b></blockquote></p><p> <b>Ticker:BROS</b></p><p><blockquote><b>股票代码：兄弟</b></blockquote></p><p> <b>Gain Since IPO Price: 98%</b></p><p><blockquote><b>自IPO价格以来的涨幅：98%</b></blockquote></p><p> <b>Market Capitalization: $7.5 billion</b></p><p><blockquote><b>市值：75亿美元</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5b915d62d3fdfce5ea3188beb282ab47\" tg-width=\"668\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p> <b>5. Doximity</b></p><p><blockquote><b>5.剂量</b></blockquote></p><p> <b>Ticker:DOCS</b></p><p><blockquote><b>股票代码：DOCS</b></blockquote></p><p> <b>Gain Since IPO Price: 108%</b></p><p><blockquote><b>自IPO价格以来的涨幅：108%</b></blockquote></p><p> <b>Market Capitalization: $10.1 billion</b></p><p><blockquote><b>市值：101亿美元</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7d03dbe2dc83a8512105da91ac5151dc\" tg-width=\"669\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p> <b>4. Affirm</b></p><p><blockquote><b>4.确认</b></blockquote></p><p> <b>Ticker:AFRM</b></p><p><blockquote><b>股票代码：AFRM</b></blockquote></p><p> <b>Gain Since IPO Price: 111%</b></p><p><blockquote><b>自IPO价格以来的涨幅：111%</b></blockquote></p><p> <b>Market Capitalization: $29.0 billion</b></p><p><blockquote><b>市值：290亿美元</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/27a04903a7c07c0ecf5edf3ddaf2d730\" tg-width=\"670\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p> <b>3. Global-e Online</b></p><p><blockquote><b>3.Global-E Online</b></blockquote></p><p> <b>Ticker:GLBE</b></p><p><blockquote><b>股票代码：GLBE</b></blockquote></p><p> <b>Gain Since IPO Price: 120%</b></p><p><blockquote><b>自IPO价格以来的涨幅：120%</b></blockquote></p><p> <b>Market Capitalization: $8.0 billion</b></p><p><blockquote><b>市值：80亿美元</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0d88ded78988981e08d54b1287cbf948\" tg-width=\"664\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p> <b>2. ZIM Integrated Shipping Services</b></p><p><blockquote><b>2.以星综合航运服务</b></blockquote></p><p> <b>Ticker:ZIM</b></p><p><blockquote><b>股票代码：ZIM</b></blockquote></p><p> <b>Gain Since IPO Price: 208%</b></p><p><blockquote><b>自IPO价格以来的涨幅：208%</b></blockquote></p><p> <b>Market Capitalization: $5.8 billion</b></p><p><blockquote><b>市值：58亿美元</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f32668f19b1e8678dcd33e3bbe3b0d9c\" tg-width=\"613\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p> <b>1. Digital World Acquisition</b></p><p><blockquote><b>1.数字世界收购</b></blockquote></p><p> <b>Ticker:DWAC</b></p><p><blockquote><b>股票代码：DWAC</b></blockquote></p><p> <b>Gain Since IPO Price: 508%</b></p><p><blockquote><b>自IPO价格以来的涨幅：508%</b></blockquote></p><p> <b>Market Capitalization: $1.9 billion</b></p><p><blockquote><b>市值：19亿美元</b></blockquote></p><p></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/573ffacec216fcb41798f52b67583456\" tg-width=\"615\" tg-height=\"526\" width=\"100%\" height=\"auto\"><span>Markets Insider</span></p><p><blockquote><p class=\"t-img-caption\"><span>市场内幕</span></p></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://markets.businessinsider.com/news/stocks/2021-stock-market-review-10-best-performing-ipo-dwac-afrm-2021-12\">Markets Insider</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BROS":"Dutch Bros Inc.","VERV":"Verve Therapeutics","BZ":"BOSS直聘","AFRM":"Affirm Holdings, Inc.",".SPX":"S&P 500 Index",".DJI":"道琼斯","ZIM":"以星航运","DOCS":"Doximity, Inc.",".IXIC":"NASDAQ Composite","TASK":"TaskUs Inc.","RXDX":"Prometheus Biosciences, Inc.","GLBE":"Global-E Online Ltd."},"source_url":"https://markets.businessinsider.com/news/stocks/2021-stock-market-review-10-best-performing-ipo-dwac-afrm-2021-12","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1170403163","content_text":"2021 was a record year for IPOs, with 2,388 new companies listing their shares around the globe.\nThe red-hot IPO market this year occurred amid a relentless grind higher in the broader stock market.\nThese are the 10 best performing US stocks that went public in 2021.\n\nA stock trader claps at the end of trade at the New York Stock Exchange.\nRecord highs in the stock market have facilitated a boom in new company listings this year, with a record 2,388 firms going public around the globe, according to data from Ernst and Young.\nHelping drive a resurgence in new company listings were SPACs, which peaked in early 2021 after a surge last year. Altogether, companies have raised $453 billion in proceeds from their IPOs, representing a 67% increase relative to 2020 and a more than doubling from 2019 levels.\nFirms going public have predominately been in the technology sector, and the Nasdaq Exchange captured the most IPOs relative to other global stock exchanges.High profile IPOs this year include electric vehicle startups Rivian and Lucid Group, and direct-to-consumer brands Allbirds and Warby Parker.\nAnd with more than 900 IPOs this year on US exchanges alone, there have been plenty of big winners and losers.\nThese are the 10 best performing US IPOs of 2021 of companies with at least a $1 billion market capitalization. All performance data is as of December 15 and was sourced from Koyfin. (However, the chart action shown below reflects performance based on the opening price of a stock on its first day of trades, not its IPO price.)\n10. Prometheus Biosciences\nTicker:RXDX\nGain Since IPO Price: 72%\nMarket Capitalization: $1.3 billion\nMarkets Insider\n9. Verve Therapeutics\nTicker:VERV\nGain Since IPO Price: 75%\nMarket Capitalization: $1.6 billion\nMarkets Insider\n8. TaskUs\nTicker:TASK\nGain Since IPO Price: 91%\nMarket Capitalization: $4.3 billion\nMarkets Insider\n7. Kanzhun\nTicker:BZ\nGain Since IPO Price: 93%\nMarket Capitalization: $14.7 billion\nMarkets Insider\n6. Dutch Bros\nTicker:BROS\nGain Since IPO Price: 98%\nMarket Capitalization: $7.5 billion\nMarkets Insider\n5. Doximity\nTicker:DOCS\nGain Since IPO Price: 108%\nMarket Capitalization: $10.1 billion\nMarkets Insider\n4. Affirm\nTicker:AFRM\nGain Since IPO Price: 111%\nMarket Capitalization: $29.0 billion\nMarkets Insider\n3. Global-e Online\nTicker:GLBE\nGain Since IPO Price: 120%\nMarket Capitalization: $8.0 billion\nMarkets Insider\n2. ZIM Integrated Shipping Services\nTicker:ZIM\nGain Since IPO Price: 208%\nMarket Capitalization: $5.8 billion\nMarkets Insider\n1. Digital World Acquisition\nTicker:DWAC\nGain Since IPO Price: 508%\nMarket Capitalization: $1.9 billion\nMarkets Insider","news_type":1,"symbols_score_info":{"DWAC":0.9,"BROS":0.9,"ZIM":0.9,"AFRM":0.9,"DOCS":0.9,"GLBE":0.9,".IXIC":0.9,"VERV":0.9,".SPX":0.9,"TASK":0.9,".DJI":0.9,"RXDX":0.9,"BZ":0.9}},"isVote":1,"tweetType":1,"viewCount":2689,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":849491495,"gmtCreate":1635771868657,"gmtModify":1635771868744,"author":{"id":"4087514122562540","authorId":"4087514122562540","name":"74809e5c","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087514122562540","idStr":"4087514122562540"},"themes":[],"htmlText":"👌","listText":"👌","text":"👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/849491495","repostId":"1121087038","repostType":4,"isVote":1,"tweetType":1,"viewCount":357,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":822855992,"gmtCreate":1634118058149,"gmtModify":1634118058232,"author":{"id":"4087514122562540","authorId":"4087514122562540","name":"74809e5c","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087514122562540","idStr":"4087514122562540"},"themes":[],"htmlText":"👌","listText":"👌","text":"👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/822855992","repostId":"2175156801","repostType":4,"repost":{"id":"2175156801","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1634117411,"share":"https://www.laohu8.com/m/news/2175156801?lang=zh_CN&edition=full","pubTime":"2021-10-13 17:30","market":"us","language":"en","title":"5 Stocks To Watch For October 13, 2021<blockquote>2021年10月13日值得关注的5只股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2175156801","media":"Benzinga","summary":"Some of the stocks that may grab investor focus today are:\n\tWall Street expects  JPMorgan Chase &amp; Co.  (NYSE: JPM) to report quarterly earnings at $3.00 per share on revenue of $29.79 billion before the opening bell. JPMorgan shares fell 0.1% to $165.25 in after-hours trading.\n","content":"<p>Some of the stocks that may grab investor focus today are:</p><p><blockquote>今天可能引起投资者关注的一些股票包括：</blockquote></p><p> <ul>  <li>Wall Street expects <b>JPMorgan Chase &amp; Co. </b> (NYSE:JPM) to report quarterly earnings at $3.00 per share on revenue of $29.79 billion before the opening bell. JPMorgan shares fell 0.1% to $165.25 in after-hours trading.</li>  <li><b><a href=\"https://laohu8.com/S/SRPT\">Sarepta Therapeutics</a> Inc</b> (NASDAQ:SRPT) reported a proposed $500 million public offering of common stock. The company also issued guidance for the third quarter, expecting net product sales of $166.9 million. Sarepta Therapeutics shares dropped 5.8% to $89.60 in the after-hours trading session.</li>  <li>Analysts are expecting <b>Delta Air Lines, Inc. </b> (NYSE:DAL) to have earned $0.17 per share on revenue of $8.39 billion for the latest quarter. The company will release earnings before the markets open. Delta Air shares rose 0.4% to $43.70 in after-hours trading.</li> </ul> <ul>  <li><b>Vistra Corp</b> (NYSE:VST) reported a $2 billion buyback program. Vistra shares gained 6.2% to $18.95 in the after-hours trading session.</li>  <li>Analysts expect <b> BlackRock, Inc. </b> (NYSE:BLK) to post quarterly earnings at $9.23 per share on revenue of $4.81 billion before the opening bell. BlackRock shares rose 0.5% to $840.00 in after-hours trading.</li> </ul></p><p><blockquote><ul><li>华尔街预计<b>摩根大通公司。</b>（纽约证券交易所股票代码：JPM）将在开盘前公布季度收益为每股3.00美元，营收为297.9亿美元。摩根大通股价在盘后交易中下跌0.1%，至165.25美元。</li><li><b><a href=\"https://laohu8.com/S/SRPT\">Sarepta治疗公司</a>Inc</b>（纳斯达克：SRPT）宣布拟公开发行5亿美元普通股。该公司还发布了第三季度指引，预计产品净销售额为1.669亿美元。Sarepta Therapeutics股价在盘后交易时段下跌5.8%，至89.60美元。</li><li>分析师预计<b>达美航空公司。</b>（纽约证券交易所股票代码：DAL）最近一个季度每股收益0.17美元，营收为83.9亿美元。该公司将在开市前发布财报。达美航空股价在盘后交易中上涨0.4%，至43.70美元。</li></ul><ul><li><b>瑞致达公司</b>（纽约证券交易所股票代码：VST）报告了一项20亿美元的回购计划。瑞致达股价在盘后交易时段上涨6.2%，至18.95美元。</li><li>分析师预计<b>贝莱德公司。</b>（纽约证券交易所股票代码：BLK）开盘前公布季度收益为每股9.23美元，营收为48.1亿美元。贝莱德股价在盘后交易中上涨0.5%，至840.00美元。</li></ul></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks To Watch For October 13, 2021<blockquote>2021年10月13日值得关注的5只股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks To Watch For October 13, 2021<blockquote>2021年10月13日值得关注的5只股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time smaller\">2021-10-13 17:30</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p>Some of the stocks that may grab investor focus today are:</p><p><blockquote>今天可能引起投资者关注的一些股票包括：</blockquote></p><p> <ul>  <li>Wall Street expects <b>JPMorgan Chase &amp; Co. </b> (NYSE:JPM) to report quarterly earnings at $3.00 per share on revenue of $29.79 billion before the opening bell. JPMorgan shares fell 0.1% to $165.25 in after-hours trading.</li>  <li><b><a href=\"https://laohu8.com/S/SRPT\">Sarepta Therapeutics</a> Inc</b> (NASDAQ:SRPT) reported a proposed $500 million public offering of common stock. The company also issued guidance for the third quarter, expecting net product sales of $166.9 million. Sarepta Therapeutics shares dropped 5.8% to $89.60 in the after-hours trading session.</li>  <li>Analysts are expecting <b>Delta Air Lines, Inc. </b> (NYSE:DAL) to have earned $0.17 per share on revenue of $8.39 billion for the latest quarter. The company will release earnings before the markets open. Delta Air shares rose 0.4% to $43.70 in after-hours trading.</li> </ul> <ul>  <li><b>Vistra Corp</b> (NYSE:VST) reported a $2 billion buyback program. Vistra shares gained 6.2% to $18.95 in the after-hours trading session.</li>  <li>Analysts expect <b> BlackRock, Inc. </b> (NYSE:BLK) to post quarterly earnings at $9.23 per share on revenue of $4.81 billion before the opening bell. BlackRock shares rose 0.5% to $840.00 in after-hours trading.</li> </ul></p><p><blockquote><ul><li>华尔街预计<b>摩根大通公司。</b>（纽约证券交易所股票代码：JPM）将在开盘前公布季度收益为每股3.00美元，营收为297.9亿美元。摩根大通股价在盘后交易中下跌0.1%，至165.25美元。</li><li><b><a href=\"https://laohu8.com/S/SRPT\">Sarepta治疗公司</a>Inc</b>（纳斯达克：SRPT）宣布拟公开发行5亿美元普通股。该公司还发布了第三季度指引，预计产品净销售额为1.669亿美元。Sarepta Therapeutics股价在盘后交易时段下跌5.8%，至89.60美元。</li><li>分析师预计<b>达美航空公司。</b>（纽约证券交易所股票代码：DAL）最近一个季度每股收益0.17美元，营收为83.9亿美元。该公司将在开市前发布财报。达美航空股价在盘后交易中上涨0.4%，至43.70美元。</li></ul><ul><li><b>瑞致达公司</b>（纽约证券交易所股票代码：VST）报告了一项20亿美元的回购计划。瑞致达股价在盘后交易时段上涨6.2%，至18.95美元。</li><li>分析师预计<b>贝莱德公司。</b>（纽约证券交易所股票代码：BLK）开盘前公布季度收益为每股9.23美元，营收为48.1亿美元。贝莱德股价在盘后交易中上涨0.5%，至840.00美元。</li></ul></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VST":"Vistra Energy Corp.","DAL":"达美航空","SRPT":"Sarepta Therapeutics","JPM":"摩根大通","BLK":"贝莱德"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2175156801","content_text":"Some of the stocks that may grab investor focus today are:\n\nWall Street expects JPMorgan Chase & Co.  (NYSE:JPM) to report quarterly earnings at $3.00 per share on revenue of $29.79 billion before the opening bell. JPMorgan shares fell 0.1% to $165.25 in after-hours trading.\nSarepta Therapeutics Inc (NASDAQ:SRPT) reported a proposed $500 million public offering of common stock. The company also issued guidance for the third quarter, expecting net product sales of $166.9 million. Sarepta Therapeutics shares dropped 5.8% to $89.60 in the after-hours trading session.\nAnalysts are expecting Delta Air Lines, Inc.  (NYSE:DAL) to have earned $0.17 per share on revenue of $8.39 billion for the latest quarter. The company will release earnings before the markets open. Delta Air shares rose 0.4% to $43.70 in after-hours trading.\n\n\nVistra Corp (NYSE:VST) reported a $2 billion buyback program. Vistra shares gained 6.2% to $18.95 in the after-hours trading session.\nAnalysts expect  BlackRock, Inc.  (NYSE:BLK) to post quarterly earnings at $9.23 per share on revenue of $4.81 billion before the opening bell. BlackRock shares rose 0.5% to $840.00 in after-hours trading.","news_type":1,"symbols_score_info":{"SRPT":0.9,"VST":0.9,"JPM":0.9,"BLK":0.9,"DAL":0.9}},"isVote":1,"tweetType":1,"viewCount":771,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}